Advertisement

Classification of Non-Hodgkin’s Lymphomas

  • K. Lennert
Part of the Handbuch der Speziellen Pathologischen Anatomie und Histologie book series (SPEZIELLEN, volume 1 / 3 / B)

Abstract

Since Rosenberg et al.1 and Kaplan2 have already presented comprehensive reviews of the history of malignant lymphoma (M.L.), we may forego repeating them in detail. A few especially important milestones, however, should be pointed out.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ablashi, D.V., de T, G.B., Easton, J.M., Liabeuf, A., Levine, P.H., Armstrong, G.R.: Antibodies to Epstein-Barr virus (EBV) antigens in sera of American Burkitt lymphoma patients. Biomedicine 20, 288–293 (1974)Google Scholar
  2. Ahlström, C.G.: Gleichzeitiges Vorkommen eines Retikelzellsarkoms und einer lymphatischen Leukämie. Virchows Arch. path. Anat. 301, 49–61 (1938)Google Scholar
  3. Aisenberg, A.C.: Malignant lymphoma. New Engl. J. Med. 288, 883–890, 935–941 (1973)PubMedGoogle Scholar
  4. Aisenberg, A.C., Bloch, K.J.: Immunoglobulins on the surface of neoplastic lymphocytes. New Engl. J. Med. 287, 272–276 (1972)PubMedGoogle Scholar
  5. Aisenberg, A.C., Bloch, K.J., Long, J.C.: Cell-surface immunoglobulins in chronic lymphocytic leukemia and allied disorders. Amer. J. Med. 55, 184–191 (1973)PubMedGoogle Scholar
  6. Aisenberg, A.C., Long, J.C.: Lymphocyte surface characteristics in malignant lymphoma. Amer. J. Med. 58, 300–306 (1975)PubMedGoogle Scholar
  7. Akazaki, K.: Reticulosarcoma. (Japanese) Byorigaku Zasshi 2, 483–515 (1943), cit. of Akazaki, 1953Google Scholar
  8. Akazaki, K.: Tumors of the reticulo-endothelial system. Acta path. jap. 3, 24–43 (1953)Google Scholar
  9. Akazaki, K.: Reticulosarcoma in Japan. In: Malignant Diseases of the Hematopoietic System. GANN Monograph on Cancer Research, Vol. 15, pp. 71–82. Akazaki, K., Rappaport, H., Berard, C.W., Bennett, J.M., Ishikawa, E., Eds. Tokyo: University of Tokyo Press 1973Google Scholar
  10. Akazaki, K., Wakasa, H.: Pathological studies of tumors of RES in Japan. Tohoku J. exp. Med. 82, 21–41 (1964)PubMedGoogle Scholar
  11. Akazaki, K., Wakasa, H.: Frequency of lymphoreticular tumors and leukemias in Japan. J. nat. Cancer Inst. 52, 339–343 (1974)PubMedGoogle Scholar
  12. von Albertini, A., Rüttner, J.R.: Über das Wesen des großfollikulären Lymphoblastoms (Brill-Symmers-Disease). Dtsch. med. Wschr. 75, 27–29 (1950)Google Scholar
  13. Aly, F.W., Braun, H.J., Missmahl, H.P.: Amyloid involvement and monoclonal immunoglobulins. Curr. Probl. Immunol., Bayer-Symp. I, 295–301 (1969)Google Scholar
  14. Anday, G.J., Goodman, J.R., Tishkoff, G.H.: An unusual cytoplasmic ribosomal structure in pathologic lymphocytes. Blood 41, 439–449 (1973)PubMedGoogle Scholar
  15. Anday, G.J., Schmitz, H.L.: Follicular lymphoma with transient leukemic phase. Brief review of literature and report of a case. Arch. intern. Med. 89, 621–634 (1952)Google Scholar
  16. Andersen, P.E.: Extramedullary plasmocytomas. Acta radiol. (Stockh.) 32, 365–374 (1949)Google Scholar
  17. Anderson, R.E., Walford, R.L.: Fibroblastic type of leukemic reticuloendotheliosis. Cancer (Phil-ad.) 16, 993–997 (1963)Google Scholar
  18. André, R., Dreyfus, B.: La ponction ganglionnaire. Atlas de cytologie ganglionnaire pathologique. Expansion scientifique française 1955Google Scholar
  19. Apitz, K.: Die Leukämien als Neubildungen. Virchows Arch. path. Anat. 299, 1–69 (1937a)Google Scholar
  20. Apitz, K: Über die Bildung Russellscher Körperchen in den Plasmazellen multipler Myelome. (2. Beitrag zur Pathologie des Zellkernes.) Virchows Arch. path. Anat. 300, 113–129 (1937b)Google Scholar
  21. Apitz, K.: Allgemeine Pathologie der menschlichen Leukämien. Ergebn. allg. Path. path. Anat. 35, 1–104 (1940)Google Scholar
  22. Aresu, M., Scalabrino, R.: Iperplasie e sarcomatosi delle ghiandole linfatiche. Tumori 1, 307–345 u. 403–571 (1927)Google Scholar
  23. Arsenau, J.C., Canellos, G.P., Banks, P.M., Berard, C.W., Gralnick, H.R., DeVita, Jr., V.T.: American Burkitt’s lymphoma: A clinicopathologic study of 30 cases. I. Clinical factors relating to prolonged survival. Amer. J. Med. 58, 314–321 (1975)Google Scholar
  24. Astaldi, G., Bernardelli, E., Rondanelli, E.G.: Ricerche sul contenuto in glicogeno delle cellule del sangue e del midollo osseo. Haematologica 36, 749–771 (1952)PubMedGoogle Scholar
  25. Astaldi, G., Verga, L.: The glycogen content of the cells of lymphatic leukaemia. Acta haemat. (Basel) 17, 129–135 (1957)Google Scholar
  26. Aur, R.J.A., Pinkel, D.: Total therapy of acute lymphocytic leukemia. Progr. clin. Cancer 5, 155–170 (1973)Google Scholar
  27. Azar, H.A.: Pathology of multiple myeloma and related growths. In: Multiple Myeloma and Related Disorders, Vol. 1, pp. 1–85. Azar, H.A., Potter, M., Eds. New York: Harper & Row 1973Google Scholar
  28. Azar, H.A., Hill, W.T., Osserman, E.F.: Malignant lymphoma and lymphatic leukemia associated with myeloma-type serum proteins. Amer. J. Med. 23, 239–249 (1957)PubMedGoogle Scholar
  29. Baccaredda, A.: Reticulohistiocytosis cutanea hyperplastica benigna cum melanodermia. Arch. Derm. Syph. (Berl.) 179, 209–256 (1939)Google Scholar
  30. Ballard, H.S., Hamilton, L.M., Marcus, A.J., Illes, C.H.: A new variant of heavy-chain disease (μ-chain disease). New Engl. J. Med. 282, 1060–1062 (1970)PubMedGoogle Scholar
  31. Barandun, S., Sordat, B., Spengler, G.A.: The giant follicular lymphoma (Brill-Symmers’ disease). In: Germinal Centers in Immune Responses, pp. 447–449. Cottier, H., Odartchenko, N., Schindler, R., Kongdon, C.C., Eds. Berlin-Heidelberg-New York: Springer 1967Google Scholar
  32. Barcos, M.P., Lukes, R.J.: Malignant lymphoma of convoluted lymphocytes: A new entity of possible T-cell type. In: Conflicts in Childhood Cancer. An Evaluation of Current Management, Vol. 4, pp. 147–178. Sinks, L.F., Godden, J.O., Eds. New York: Liss 1975Google Scholar
  33. Basset, A., Scapier, J.: Sur un cas d’un plasmocytome cervical. Monde méd. 47, 7–8 (1937)Google Scholar
  34. Bauer-Sic, P., Lambers, K.: Zur Glykogenverteilung in Blutzellen. In: Zyto- und Histochemie in der Hämatologie, pp. 426–431. Merker, H., Ed. Berlin-Göttingen-Heidelberg: Springer 1963Google Scholar
  35. Beard, M.E.J.: A tentative classification of the non-Hodgkin’s tumors of the lymphoid system to enable inclusion of the lymphoid leukaemias. Brit. J. Cancer 31, Suppl. II, 94–95 (1975)Google Scholar
  36. Becker, E. Ein Beitrag zur Lehre von den Lymphomen. Dtsch. med. Wschr. 27, 726–728 (1901)Google Scholar
  37. Beckmann, H., Landbeck, G., Neth, R., Schmidtke, H.: Akute Leukämien mit erythropoetischen Differenzierungsmerkmalen. Ein Beitrag zur Differenzierung der Leukämien des Kindesalters. Mschr. Kinderheilk. 119, 8–13 (1971)PubMedGoogle Scholar
  38. Belpomme, D., Dantchev, D., Du Rusquec, E., Grandjon, D., Huchet, R., Pinon, F., Pouillart, P., Schwarzenberg, L., Amiel, J.-L., Mathé, G.: La nature T ou B des cellules néoplasiques des leucémies lymphoides. Bull. Cancer 61, 387–402 (1974)PubMedGoogle Scholar
  39. Ben-Bassat, H., Goldblum, N., Mitrani, S., Goldblum, T., Yoffey, J.M., Cohen, M.M., Bent-wich, Z., Ramot, B., Klein, E., Klein, G.: Establishment in continuous culture of a new type of lymphocyte from a “Burkitt-like” malignant lymphoma (Line D.G.-75). Int. J. Cancer 19, 27–33 (1977)PubMedGoogle Scholar
  40. Bennett, J.M.: Discussion for: Catovsky, D., Frisch, B., van Noorden, S.: B, T and ‘null’ cell leukaemias. Electron cytochemistry and surface morphology. Blood Cells 1, 125 (1975)Google Scholar
  41. Bennett, J.M., Reed, C.E.: Acute leukemia cytochemical profile: Diagnostic and clinical implications. Blood Cells 1, 101–108 (1975)Google Scholar
  42. Bennett, M.H.: Discussion. Workshop on Non-Hodgkin’s Lymphomas, Chicago, June 1973Google Scholar
  43. Bennett, M.H.: Sclerosis in non-Hodgkin’s lymphomata. Brit. J. Cancer 31, Suppl. II, 44–52 (1975a)Google Scholar
  44. Bennett, M.H.: Sclerosis in non-Hodgkin’s lymphomas. 5th Congr. Europ. Soc. Path., Vienna 1975bGoogle Scholar
  45. Bennett, M.H., Farrer-Brown, G., Henry, K., Jelliffe, A.M.: Classification of non-Hodgkin’s lymphomas. [Letter to the Editor.] Lancet 1974, II, pp. 405–406Google Scholar
  46. Bennett, M.H., Millett, Y.L.: Nodular sclerotic lymphosarcoma. A possible new clinico-pathological entity. Clin. Radiol. 20, 339–343 (1969)PubMedGoogle Scholar
  47. Bentwich, Z., Kunkel, H.G.: Specific properties of human B and T lymphocytes and alterations in disease. Transplant. Rev. 16, 29–50 (1973)PubMedGoogle Scholar
  48. Berard, C.W.: Histopathology of the lymphomas. In: Hematology, pp. 901–912. Williams, W.J., Beutler, E., Erslev, A.J., Rundles, R.W., Eds. New York-Düsseldorf: McGraw-Hill 1972Google Scholar
  49. Berard, C.W.: Reticuloendothelial system: an overview of neoplasia. In: The Reticuloendothelial System. Monographs in Pathology, No. 16, pp. 301–317. Rebuck, J.W., Berard, C.W., Abell, M.R., Eds. Baltimore: Williams & Wilkins 1975Google Scholar
  50. Berard, C.W., Dorfman, R.F.: Histopathology of malignant lymphomas. In: Hodgkin’s Disease and Other Lymphomas. Clinics in Haematology, Vol. 3,1, pp. 39–76. Rosenberg, S.A., Ed. London-Philadelphia-Toronto: W.B. Saunders 1974Google Scholar
  51. Berard, C., O’Conor, G.T., Thomas, L.B., Torloni, H.: Histopathological definition of Burkitt’s tumour. Bull. Wld Hlth Org. 40, 601–607 (1969)Google Scholar
  52. Berg, B., Brandt, L.: The cytology, distribution and function of the neoplastic cells in leukaemic reticuloendotheliosis. Scand. J. Haemat. 7, 428–434 (1970)PubMedGoogle Scholar
  53. Berman, L.: Malignant lymphomas. Their classification and relation to leukemia. Blood 8, 195–210 (1953)PubMedGoogle Scholar
  54. Bernard, J.: Les sarcomes africains. Nouv. Rev. franç. Hémat. 3, 101–104 (1963)PubMedGoogle Scholar
  55. Bernard, J.: La tumeur de Burkitt en 1966. Nouv. Rev. franç. Hémat. 6, 183–186 (1966)PubMedGoogle Scholar
  56. Bernhard, W.: Fine structure of Burkitt’s lymphoma. In: Burkitt’s Lymphoma, pp. 103–117. Burkitt, D.P., Wright, D.H., Eds. Edinburgh-London: Livingstone 1970Google Scholar
  57. Bernhard, W., Lambert, D.: Ultrastructure des tumeurs de Burkitt de l’enfant africain. In: Symposium on Lymphoreticular Tumours in Africa, Paris 1963, pp. 270–284. Roulet, F.C., Ed. Basel-New York: Karger 1964Google Scholar
  58. Bessis, M.: Contribution à l’étude cytologiques des réticulo-sarcomes. Sang 18, 7–33 (1946)Google Scholar
  59. Bessis, M.: Études au microscope électronique des leucocytes normaux et leucémiques. Acta Un. int. Cancr. 7, 646–659 (1951)PubMedGoogle Scholar
  60. Bessis, M.: Traité de cytologie sanguine. Paris: Masson & Cie. 1954Google Scholar
  61. Bichel, J., Bing, J., Harboe, N.: Another case of hyperglobulinemia and affection of the central nervous system. Acta med. scand. 138, 1–14 (1950)PubMedGoogle Scholar
  62. Bichel, J., Effersøe, P., Gormsen, H., Harboe, N.: Leukemic myelomatosis (plasma cell leukemia). A review with report of four cases. Acta radiol. (Stockh.) 37, 196–207 (1952)Google Scholar
  63. Bilger, R.: Das großfollikuläre Lymphoblastom (die Brill-Symmerssche Krankheit). Ergebn. inn. Med. Kinderheilk. N.F. 5, 642–706 (1954)Google Scholar
  64. Billington, R.W., Itzhaki, R.F.: Ribosomal RNA synthesis in chronic lymphocytic leukaemia. Brit. J. Cancer 29, 318–323 (1974)PubMedGoogle Scholar
  65. Binder, R.A., Jencks, J.A., Chun, B., Rath, C.E.: ‘B’ cell origin of malignant cells in a case of American Burkitt’s lymphoma. Characterization of cells from a pleural effusion. Cancer (Philad.) 36, 161–168 (1975)Google Scholar
  66. Blatrix, C., Fine, J.-M., Yeme, D., Lambin, P.: Les formes tumorales de la macroglobulinémie de Waldenström. À propos d’un cas comportant deux localisations, orbitaire et hépatique. Sem. Hôp. Paris 49, 2847–2851 (1973)PubMedGoogle Scholar
  67. Block, J.B., Edgcomb, J., Eisen, A., van Scott, E.J.: Mycosis fungoides. Natural history and aspects of its relationship to other malignant lymphomas. Amer. J. Med. 34, 228–235 (1963)PubMedGoogle Scholar
  68. Bloomfield, C.D., Goldman, A., Dick, F., Brunning, R.D., Kennedy, B.J.: Multivariate analysis of prognostic factors in the non-Hodgkin’s malignant lymphomas. Cancer (Philad.) 33, 870–879 (1974)Google Scholar
  69. Blumenberg, R.M., Olson, K.B., Stein, A.A., Hawkins, T.L.: Giant follicle lymphoma. A clinico-pathologic review of forty-six cases, with special emphasis on prognosis. Amer. J. Med. 35, 832–841 (1963)PubMedGoogle Scholar
  70. Bösken, W., Noltenius, H.: Großzelliges Retikulumzellsarkom als Spätzustand einer endoxanbe-handelten Makroglobulinämie Waldenström. Zbl. allg. Path. 111, 407–413 (1968)PubMedGoogle Scholar
  71. Bognel, J.C., Rambaud, J.C., Modigliani, R., Matuchansky, C., Bognel, C., Bernier, J.J., Scotto, J., Hautefeuille, P., Mihaesco, E., Hurez, D., Preud’Homme, J.L., Seligmann, M.: Étude clinique, anatomo-pathologique et immunochimique d’un nouveau cas de maladie des chaînes alpha suivi pendant cinq ans. Rev. europ. Étud. clin. biol. 17, 362–374 (1972)Google Scholar
  72. Boiron, M., Jacquillat, C., Lévy, D.: Bilan de l’asparaginase. In: Actualités hématol. IV, 79–86. Paris: Masson & Cie., 1970Google Scholar
  73. Bonhomme, J., Seligmann, M., Mihaesco, C., Clauvel, J.P., Danon, F., Brouet, J.C., Bouvry, P., Martine, J., Clerc, M.: MU-chain disease in an African patient. Blood 43, 485–492 (1974)PubMedGoogle Scholar
  74. Booth, K., Burkitt, D.P., Bassett, D.J., Cooke, R.A., Biddulph, J.: Burkitt lymphoma in Papua, New Guinea. Brit. J. Cancer 21, 657–664 (1967)PubMedGoogle Scholar
  75. Borella, L., Sen, L.: T cell surface markers on lymphoblasts from acute lymphocytic leukemia. J. Immunol. 111, 1257–1260 (1973)PubMedGoogle Scholar
  76. Borella, L., Sen, L.: T- and B-lymphocytes and lymphoblasts in untreated acute lymphocytic leukemia. Cancer (Philad.) 34, 646–654 (1974)Google Scholar
  77. Bornkamm, G.W., Stein, H., Lennert, K., Rüggeberg, F., Bartels, H., Zur Hausen, H.: Attempts to demonstrate virus-specific sequences in human tumors. IV. EB viral DNA in European Burkitt lymphoma and immunoblastic lymphadenopathy with excessive plasmacytosis. Int. J. Cancer 17, 177–181 (1976)PubMedGoogle Scholar
  78. Bosman, F.T., van Vloten, W.A.: Sézary’s syndrome: A cytogenetic, cytophotometric and autoradiographic study. J. Path. 118, 49–57 (1975)Google Scholar
  79. Bouroncle, B.A., Wiseman, B.K., Doan, C.A.: Leukemic reticuloendotheliosis. Blood 13, 609–630 (1958)PubMedGoogle Scholar
  80. Bousser, J., Delarue, J., Bilski-Pasquier, G., Diebold, J., Zittoun, R., Dao, C.: Lymphome nodulaire de la rate. Nouv. Rev. franç. Hémat. 10, 289–297 (1970)PubMedGoogle Scholar
  81. Boutis, L., Obrecht, P., Musshoff, K., Jochmann, P.: Zur Prognose der chronischen lymphatischen Leukämie. Freiburger Ergebnisse 1946–1966. Dtsch. med. Wschr. 93, 2111–2114 (1968)PubMedGoogle Scholar
  82. Braband, H.: Der Burkitt-Tumor. Dtsch. med. J. 18, 573–578 (1967)PubMedGoogle Scholar
  83. Braband, H.: Burkitt-Tumor. Stuttgart Thieme 1968Google Scholar
  84. Bradfield, J.W.B.: Classification of non-Hodgkin’s lymphomas. [Letter to the Editor.] Lancet 1974, II, pp. 652–653Google Scholar
  85. Brass, K.: Die Eiweißstoffwechselstörungen des Plasmocytomkranken. Frankfurt. Z. Path. 57, 367–480 (1943 a)Google Scholar
  86. Brass, K.: Zur Cytologie und Funktion der Plasma- und Plasmocytomzellen. Frankfurt. Z. Path. 57, 481–491 (1943 b)Google Scholar
  87. Brass, K.: Die Eiweißstoffwechselstörungen des Plasmocytomkranken. III. Mitteilung. Frankfurt. Z. Path. 59, 413–433 (1947/48)Google Scholar
  88. Braun, H.J.: Beziehungen zwischen monoklonalen Gammopathien und Amyloidosen. In: Maligne Lymphome und monoklonale Gammopathien. Hämatologie und Bluttransfusion, Bd. 18, pp. 419–432. Löffler, H., Ed. München: Lehmanns 1976Google Scholar
  89. Braun, H.J., Bruchhaus, K.-F., Aly, F.W.: Monoklonale Makroglobulinämien. Dtsch. med. Wschr. 98, 1835–1842 (1973)PubMedGoogle Scholar
  90. Braunstein, H., Freiman, D.G., Thomas, Jr., W., Gall, E.A.: A histochemical study of the enzymatic activity of lymph nodes. II. Further investigation of normal and hyperplastic lymph nodes. Cancer (Philad.) 15, 130–138 (1962a)Google Scholar
  91. Braunstein, H., Freiman, D.G., Thomas, Jr., W., Gall, E.A.: A histochemical study of the enzymatic activity of lymph nodes. III. Granulomatous and primary neoplastic conditions of lymphoid tissue. Cancer (Philad.) 15, 139–152 (1962b)Google Scholar
  92. Braunsteiner, H., Sailer, S: Lymphatische Leukämie mit Makroglobulinämie Waldenström. Acta haemat. (Basel) 23, 306–308 (1960)Google Scholar
  93. Braylan, R.C., Rappaport, H.: Tissue immunoglobulins in nodular lymphomas as compared with reactive follicular hyperplasias. Blood 42, 579–589 (1973)PubMedGoogle Scholar
  94. Braylan, R., Variakojis, D., Yachnin, S.: The Sézary syndrome lymphoid cell: Abnormal surface properties and mitogen responsiveness. Brit. J. Haemat. 31, 553–564 (1975)PubMedGoogle Scholar
  95. Brecher, G., Tanaka, Y., Malmgren, R.A., Fahey, J.L.: Morphology and protein synthesis in multiple myeloma and macroglobulinemia. Ann. N.Y. Acad. Sci. 113, 642–653 (1963)Google Scholar
  96. Bremer, K.: Chronische lymphatische Leukämie: Störungen der Kinetik der Lymphozyten. Pathophysiologische Aspekte und therapeutische Überlegungen. Dtsch. med. Wschr. 100, 1250–1255 (1975)PubMedGoogle Scholar
  97. Bremer, K., Cohnen, G., Augener, W., Brittinger, G.: Normal recirculation of T lymphocytes in chronic lymphocytic leukaemia. [Letter to the Editor.] Lancet 1975, I, p. 1247Google Scholar
  98. Brill, N.E., Baehr, G., Rosenthal, N.: Generalized giant lymph follicle hyperplasia of lymph nodes and spleen. A hitherto undescribed type. Amer. J. Med. 13, 570–574 (1952). Republished from J. Amer. med. Ass. 84, 668–671 (1925)PubMedGoogle Scholar
  99. Brittin, G.M., Tanaka, Y., Brecher, G.: Intranuclear inclusions in multiple myeloma and macro-globulinemia. Blood 21, 335–351 (1963)PubMedGoogle Scholar
  100. Brittinger, G., Bartels, H., Bremer, K., Dühmke, E., Gunzer, U., König, E., Stein, H. (Kieler Lymphomgruppe): Klinik der malignen Non-Hodgkin-Lymphome entsprechend der Kiel-Klassifikation: Centrocytisches Lymphom, centroblastisch-centrocytisches Lymphom, lymphoblastisches Lymphom, immunoblastisches Lymphom. In: Maligne Lymphome und monoklonale Gammopathien. Hämatologie und Bluttransfusion, Bd. 18, pp. 211–223. Löffler, H., Ed. München: Lehmanns 1976Google Scholar
  101. Brittinger, G., König, E., Aberle, H.G., Zimmerschitt, E.: Lysosomale Enzyme in Blutlymphozyten von Gesunden und Patienten mit chronischer Lymphadenose bei kurzdauernder unspezifischer Stimulierung in vitro. Schweiz. med. Wschr. 100, 341–344 (1970)PubMedGoogle Scholar
  102. Brittinger, G., König, E., Cohnen, G., Aberle, H.G.: Lysosomale Enzyme in Lymphozyten. I. Lymphoretikuläre Erkrankungen: Vergleich des Enzymgehaltes (saure Phosphatase, β-Glucuronidase) unstimulierter Blutlymphozyten mit der Blastentransformation nach Phytohämagglu-tinin-Stimulierung in vitro. Acta haemat. (Basel) 44, 205–221 (1970)Google Scholar
  103. Broder, S., Edelson, R.L., Lutzner, M.A., Nelson, D.L., MacDermott, R.P., Durm, M.E., Goldman, C.K., Meade, B.D., Waldmann, T.A.: The Sézary syndrome. A malignant proliferation of helper T cells. J. clin. Invest. 58, 1297–1306 (1976)PubMedGoogle Scholar
  104. Brody, J.I., Oski, F.A., Singer, D.E.: Impaired pentose phosphate shunt and decreased glycolytic activity in lymphocytes of chronic lymphocytic leukemia. Metabolic pathway …? Blood 34, 421–429 (1969)PubMedGoogle Scholar
  105. Broome, J.D., Zucker-Franklin, D., Weiner, M.S., Bianco, C., Nussenzweig, V.: Leukemic cells with membrane properties of thymus-derived (T) lymphocytes in a case of Sézary’s syndrome: Morphologic and immunologic studies. Clin. Immunol. Immunopath. 1, 319–329 (1973)Google Scholar
  106. Brouet, J.-C., Flandrin, G., Sasportes, M., Preud’Homme, J.-L., Seligmann, M.: Chronic lymphocytic leukaemia of T-cell origin. Immunological and clinical evaluation in eleven patients. Lancet 1975, II, pp. 890–893Google Scholar
  107. Brouet, J.-C., Flandrin, G., Seligmann, M.: Indications of the thymus-derived nature of the proliferating cells in six patients with Sézary’s syndrome. New Engl. J. Med. 289, 341–344 (1973)PubMedGoogle Scholar
  108. Brouet, J.C., Labaume, S., Seligmann, M.: Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata. Brit. J. Cancer 31, Suppl. II, 121–127 (1975)Google Scholar
  109. Brouet, J.C., Preud’Homme, J.L., Flandrin, G., Chelloul, N., Seligmann, M.: Membrane markers in ‘histiocytic’ lymphomas (reticulum cell sarcomas). J. nat. Cancer Inst. 56, 631–633 (1976)PubMedGoogle Scholar
  110. Brouet, J.-C., Preud’Homme, J.-L., Seligmann, M.: The use of B and T membrane markers in the classification of human leukemias, with special reference to acute lymphoblastic leukemia. Blood Cells 1, 81–90 (1975)Google Scholar
  111. Brouet, J.-C., Preud’Homme, J.-L., Seligmann, M., Bernard, J.: Blast cells with monoclonal surface immunoglobulin in two cases of acute blast crisis supervening on chronic lymphocytic leukaemia. Brit. med. J. 1973, IV, pp. 23–24Google Scholar
  112. Brouet, J.C., Prieur, A.-M.: Membrane markers on chronic lymphocytic leukemia cells: A B cell leukemia with rosettes due to anti-sheep erythrocyte antibody activity of the membrane bound IgM and a T cell leukemia with surface Ig. Clin. Immunol. Immunopath. 2, 481–487 (1974)Google Scholar
  113. Brouet, J.C., Toben, H.R., Chevalier, A., Seligmann, M.: T and B membrane markers on blast cells in 69 patients with acute lymphoblastic leukemia. Ann. Immunol. 125C, 691–696 (1974)Google Scholar
  114. Brown, R.S., Schiff, M., Mitchell, M.S.: Reticulum-cell sarcoma of host origin arising in a transplanted kidney. Ann. intern. Med. 80, 459–463 (1974)PubMedGoogle Scholar
  115. Brown, T.C., Peters, M.V., Bergsagel, D.E., Reid, J.: A retrospective analysis of the clinical results in relation to the Rappaport histological classification. Brit. J. Cancer 31, Suppl. II, 174–186 (1975)Google Scholar
  116. Bruce, R.M., Blaese, R.M.: Monoclonal gammopathy in the Wiskott-Aldrich syndrome. J. Pediat. 85, 204–207 (1974)PubMedGoogle Scholar
  117. Buffa, F., Rappaport, H.: Chronic lymphocytic leukemia associated with dysproteinemia and acquired hemolytic anemia. Amer. J. Med. 22, 504–510 (1957)PubMedGoogle Scholar
  118. Burchenal, J.H.: Summary of conference and implications for acute leukemia. In: Treatment of Burkitt’s Tumour. UICC Monograph Series, Vol. 8, pp. 258–262. Burchenal, J.H., Burkitt, D.P., Eds. Berlin-Heidelberg-New York: Springer 1967Google Scholar
  119. Burchenal, J.H., Burkitt, D.P. (Eds.): Treatment of Burkitt’s Tumour. Proceedings of a Conference organized by the Chemotherapy Panel of the International Union Against Cancer. (UICC Monograph Series, Vol. 8.) Berlin-Heidelberg-New York: Springer 1967Google Scholar
  120. Burchenal, J.H., Wollner, N.: Present status of research on Burkitt’s tumor. In: Neoplasia in Childhood, pp. 293–303. Chicago: Year Book Medical Publ. 1969Google Scholar
  121. Burke, J.S., Byrne, Jr., G.E., Rappaport, H.: Hairy cell leukemia (leukemic reticuloendotheliosis). I. A clinical pathologic study of 21 patients. Cancer (Philad.) 33, 1399–1410 (1974)Google Scholar
  122. Burke, J.S., Mackay, B., Rappaport, H.: Hairy cell leukemia (leukemic reticuloendotheliosis). II. Ultrastructure of the spleen. Cancer (Philad.) 37, 2267–2274 (1976)Google Scholar
  123. Burkitt, D.P.: A sarcoma involving the jaws in African children. Brit. J. Surg. 46, 218–223 (1958/59)PubMedGoogle Scholar
  124. Burkitt, D.P.: A lymphoma syndrome in tropical Africa. With a note on histology, cytology, and histochemistry by D.H. Wright. In: International Review of Experimental Pathology, Vol. 2, pp. 67–138. Richter, G.W., Epstein, M.A., Eds. New York-London: Academic Press 1963Google Scholar
  125. Burkitt, D.P.: A lymphoma syndrome dependent on environment. Part I. Clinical aspects. In: Symposium on Lymphoreticular Tumours in Africa, Paris 1963, pp. 80–93. Roulet, F.C., Ed. Basel-New York: Karger 1964aGoogle Scholar
  126. Burkitt, D.P.: A lymphoma syndrome dependent on environment. Part II. Epidemiological features. In: Symposium on Lymphoreticular Tumours in Africa, Paris 1963, pp. 119–136. Roulet, F.C., Ed. Basel-New York: Karger 1964bGoogle Scholar
  127. Burkitt, D.P.: Possible Relationships between the African Lymphoma and Acute Leukemia. Third guest lecture. Leukaemia Research Fund. London: Queen Anne Press 1967aGoogle Scholar
  128. Burkitt, D.P.: African lymphoma. Epidemiological evidence suggesting a viral aetiology. In: Racial and Geographical Factors in Tumour Incidence, pp. 19–23. Shivas, A.A., Ed. Edinburgh: University Press 1967 bGoogle Scholar
  129. Burkitt, D.P.: Recent developments in geographical distribution. In: Treatment of Burkitt’s Tumour. UICC Monograph Series, Vol. 8, pp. 36–41. Burchenal, J.H., Burkitt, D.P., Eds. Berlin-Heidelberg-New York: Springer 1967cGoogle Scholar
  130. Burkitt, D.P.: Clinical demonstration of long-term survivors. In: Treatment of Burkitt’s Tumour. UICC Monograph Series, Vol. 8, pp. 102–104. Burchenal, J.H., Burkitt, D.P., Eds. Berlin-Heidelberg-New York: Springer 1967dGoogle Scholar
  131. Burkitt, D.P.: General features and facial tumours. In: Burkitt’s Lymphoma, pp. 6–15. Burkitt, D.P., Wright, D.H., Eds. Edinburgh-London: Livingstone 1970aGoogle Scholar
  132. Burkitt, D.P.: Lesions outside the jaws. In: Burkitt’s Lymphoma, pp. 16–22. Burkitt, D.P., Wright, D.H., Eds. Edinburgh-London: Livingstone 1970bGoogle Scholar
  133. Burkitt, D.P.: Treatment. General features. In: Burkitt’s Lymphoma, pp. 43–51. Burkitt, D.P., Wright, D.H., Eds. Edinburgh-London: Livingstone 1970cGoogle Scholar
  134. Burkitt, D.P.: Geographical distribution. In: Burkitt’s Lymphoma, pp. 186 – 197. Burkitt, D.P., Wright, D.H., Eds. Edinburgh-London: Livingstone 1970dGoogle Scholar
  135. Burkitt, D.P.: An alternative hypothesis to a vectored virus. In: Burkitt’s Lymphoma, pp. 210–214. Burkitt, D.P., Wright, D.H., Eds. Edinburgh-London: Livingstone 1970eGoogle Scholar
  136. Burkitt, D.P., Hutt, M.S.R., Wright, D.H.: The African lymphoma. Preliminary observations on response to therapy. Cancer (Philad.) 18, 399–410 (1965)Google Scholar
  137. Burkitt, D.P., O’Conor, G.T.: Malignant lymphoma in African children. I. A clinical syndrome. Cancer (Philad.) 14, 258–269 (1961)Google Scholar
  138. Burkitt, D.P., Wright, D.: Geographical and tribal distribution of the African lymphoma in Uganda. Brit. med. J. 1966, I, pp. 569–573Google Scholar
  139. Burkitt, D.P., Wright, D.H. (Eds.): Burkitt’s lymphoma. Edinburgh-London: Livingstone 1970Google Scholar
  140. Buskard, N.A., Catovsky, D., Okos, A., Goldman, J.M., Galton, D.A.G.: Prolymphocytic leukaemia: Cell studies and treatment by leucapheresis. In: Maligne Lymphome und monoklonale Gammopathien. Hämatologie und Bluttransfusion, Bd. 18, pp. 237–253. Löffler, H., Ed. München: Lehmanns 1976Google Scholar
  141. Butler, J.J., Stryker, J.A., Shullenberger, C.C.: A clinicopathological study of Stages I and II non-Hodgkin’s lymphomata using the Lukes-Collins classification. Brit. J. Cancer 31, Suppl. II, 208–216 (1975)Google Scholar
  142. Byrne, Jr., E., Rappaport, H.: Malignant histiocytosis. In: Malignant Diseases of the Hematopoietic System. GANN Monograph on Cancer Research, Vol. 15, pp. 145–162. Akazaki, K., Rappaport, H., Berard, C.W., Bennett, J.M., Ishikawa, E., Eds. Tokyo: University of Tokyo Press 1973Google Scholar
  143. Camain, R., Baylet, R., Bres, P., Lambert, D.: Les hématosarcomes de la face chez l’enfant en Afrique Occidentale et Centrale francophone. III. Histopathologie, tentatives de culture et autres examens biologiques. In: Symposium on Lymphoreticular Tumours in Africa, Paris 1963, pp. 265–269. Roulet, F.C., Ed. Basel-New York: Karger 1964Google Scholar
  144. Camain, R., Lambert, D.: Les hématosarcomes de la face chez l’enfant en Afrique Occidentale et Centrale francophone. I. Considérations générales, répartition géographique, incidence de l’âge et du sexe. In: Symposium on Lymphoreticular Tumours in Africa, Paris 1963, pp. 94–100. Roulet, F.C., Ed. Basel-New York: Karger 1964Google Scholar
  145. Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W., Tubiana, M.: Report of the committee on Hodgkin’s disease staging classification. Cancer Res. 31, 1860–1861 (1971)PubMedGoogle Scholar
  146. Catovsky, D.: T-cell origin of acid-phosphatase-positive lymphoblasts. Lancet 1975, II, pp. 327–328Google Scholar
  147. Catovsky, D., Frisch, B., van Noorden, S.: B, T and ‘null’ cell leukaemias. Electron cytochemistry and surface morphology. Blood Cells 1, 115–124 (1975)Google Scholar
  148. Catovsky, D., Frisch, B., Okos, A., van Noorden, S.: Scanning electron microscopy and the nature of the hairy cell. [Letter to the Editor.] Lancet 1975, I, p. 462Google Scholar
  149. Catovsky, D., Galetto, J., Okos, A., Galton, D.A.G., Wiltshaw, E., Stathopoulos, G.: Prolym-phocytic leukaemia of B and T cell type. Lancet 1973, II, pp. 232–234Google Scholar
  150. Catovsky, D., Galetto, J., Okos, A., Miliani, E., Galton, D.A.G.: Cytochemical profile of B and T leukaemic lymphocytes with special reference to acute lymphoblastic leukaemia. J. clin. Path. 27, 767–771 (1974)PubMedGoogle Scholar
  151. Catovsky, D., Galton, D.A.G.: Lysozyme activity and nitroblue-tetrazolium reduction in leukaemic cells. J. clin. Path. 26, 60–69 (1973)PubMedGoogle Scholar
  152. Catovsky, D., Goldman, J.M., Okos, A., Frisch, B., Galton, D.A.G.: T-lymphoblastic leukaemia: A distinct variant of acute leukaemia. Brit. med. J. 1974, II, pp. 643–646Google Scholar
  153. Catovsky, D., Papamichail, M., Okos, A., Miliani, E., Holborow, E.J.: Formation of mouse red cell rosettes by “hairy” cells. Biomedicine 23, 81–84 (1975)PubMedGoogle Scholar
  154. Catovsky, D., Pettit, J.E., Galetto, J., Okos, A., Galton, D.A.G.: The B-lymphocyte nature of the hairy cell of leukaemic reticuloendotheliosis. Brit. J. Haemat. 26, 29–37 (1974)PubMedGoogle Scholar
  155. Catovsky, D., Pettit, J.E., Galton, D.A.G., Spiers, A.S.D., Harrison, C.V.: Leukaemic reticuloendotheliosis (‘hairy’ cell leukaemia): A distinct clinico-pathological entity. Brit. J. Haemat. 26, 9–27 (1974)PubMedGoogle Scholar
  156. Cejka, J., Bollinger, R.O., Schuit, H.R.E., Lusher, J.M., Chang, C.-H., Zuelzer, W.W.: Macro-globulinemia in a child with acute leukemia. Blood 43, 191–199 (1974)PubMedGoogle Scholar
  157. Chantar, C., Escartín, P., Plaza, A.G., Corugedo, A.F., Arenas, J.I., Sanz, E., Anaya, A., Bootello, A., Segovia, J.M.: Diffuse plasma cell infiltration of the small intestine with malabsorption associated to IgA monoclonal gammapathy. Cancer (Philad.) 34, 1620–1630 (1974)Google Scholar
  158. Chelloul, N.: Moyens d’approche d’une classification nosologique des sarcomes ganglionnaires. Bull. Cancer 61, 35–36 (1974)PubMedGoogle Scholar
  159. Chelloul, N., Daniel, M.T., Flandrin, G.: Histiolymphocytose de l’adulte ou leucémie à tricholeu-cocytes. Étude histologique, cytologique et ultrastructurale. Path. Europ. 8, 235–251 (1973)Google Scholar
  160. Chelloul, N., Diebold, J., Flandrin, G., Gérard-Marchant, R., Nezelof, C.: Commentaires sur la classification du centre de références de l’O.M.S. Les hématosarcomes non hodgkiniens. Ann. Anat. path. 21, 301–304 (1976)Google Scholar
  161. Chiari, H.: Über eigentümliche Verlaufsformen von Haemoblastosen. Beitr. path. Anat. 130, 51–68 (1964)Google Scholar
  162. Chin, A.H., Saiki, J.H., Trujillo, J.M., Williams, Jr., R.C.: Peripheral blood T- and B-lymphocytes in patients with lymphoma and acute leukemia. Clin. Immunol. Immunopath. 1, 499–510 (1973)Google Scholar
  163. Churg, J., Gordon, A.J.: Multiple myeloma. Lesions of the extra-osseous hematopoietic system. Amer. J. clin. Path. 20, 934–945 (1950)Google Scholar
  164. Claudy, A.L.: The immunological identification of the Sézary cell. Brit. J. Derm. 91, 597–600 (1974)PubMedGoogle Scholar
  165. Clendenning, W.E., Brecher, G., van Scott, E.J.: Mycosis fungoides. Relationship to malignant cutaneous reticulosis and the Sézary syndrome. Arch. Derm. 89, 785–792 (1964)PubMedGoogle Scholar
  166. Clifford, P.: Malignant disease of the nose, paranasal sinuses and post-nasal space in East Africa. J. Laryng. 75, 707–733 (1961)PubMedGoogle Scholar
  167. Clifford, P.: Treatment of Burkitt’s lymphoma. Lancet 1968, I, p. 599Google Scholar
  168. Clifford, P.: Treatment. Response in particular chemotherapeutic and other agents and treatment of CNS involvement. In: Burkitt’s Lymphoma, pp. 52—63. Burkitt, D.P., Wright, D.H., Eds. Edinburgh-London: Livingstone 1970Google Scholar
  169. Cocchi, U., Meier, E.: Zur Frage der Therapie des großfollikulären Lymphoblastoms. Oncologia (Basel) 3, 1–26 (1950)Google Scholar
  170. Cohen, M.H., Bennett, J.M., Berard, C.W., Ziegler, J.L., Vogel, C.L., Sheagren, J.N., Carbone, P.P.: Burkitt’s tumor in the United States. Cancer (Philad.) 23, 1259–1272 (1969)Google Scholar
  171. Cohnen, G.: Klinisch-diagnostische Bedeutung der Oberflächenmarker menschlicher T- und B-Lymphozyten. Dtsch. med. Wschr. 99, 2302–2307 (1974)PubMedGoogle Scholar
  172. Cohnen, G.: T- and B-Lymphozyten bei chronischer lymphatischer Leukämie und Lymphogranulomatose. Elektronenmikroskopische und immunologische Untersuchungen. Veröff. Path. H. 97. Stuttgart: G. Fischer 1975Google Scholar
  173. Cohnheim, J.: Ein Fall von Pseudoleukämie. Virchows Arch. A 33, 451–454 (1865)Google Scholar
  174. Cooke, J.V.: Mediastinal tumor in acute leukemia. A clinical and roentgenologic study. Amer. J. Dis. Child. 44, 1153–1177 (1932)Google Scholar
  175. Cooper, E.H., Frank, G.L., Wright, D.H.: Cell proliferation in Burkitt tumours. Europ. J. Cancer 2, 377–384 (1966)Google Scholar
  176. Cooper, J.H., Haq, B.M., Bagnell, H.: Intrafollicular hyalinosis and arterial hyalinosis of the spleen: Histochemical and immunofluorescence studies. J. Path. 98, 193–199 (1969)PubMedGoogle Scholar
  177. Cooper, M.D., Peterson, R.D.A., Gabrielsen, A.E., Good, R.A.: Lymphoid malignancy and development, differentiation, and function of the lymphoreticular system. Cancer Res. 26, 1165–1169 (1966)PubMedGoogle Scholar
  178. Cottier, H., Hess, M.W., Keller, H.U., Luscieti, P., Sordat, B.: Immunological deficiency states and malignancy. Sympos. on “ Interaction of Radiation and Host Immune Defense Mechanisms in Malignancy,” Greenbrier, W. Va., March 1974Google Scholar
  179. Cox, J.N., Widgren, S.: Tumeur de Burkitt. A propos de sept cas au Libéria. Schweiz. med. Wschr. 95, 355–360 (1965)PubMedGoogle Scholar
  180. Craciun, E.C., Ursu, A.: Le réticulo-sarcome des ganglions lymphatiques. Bull. Ass. franç. Cancer 22, 711–756 (1933)Google Scholar
  181. Cronkite, E.P., Schiffer, L.M.: Kinetics of normal lymphopoiesis and chronic lymphocytic leukemia. In: Regulation of Hematopoiesis, Vol. 2, pp. 1455–1476. Gordon, A.S., Ed. New York: Appleton-Century-Crofts 1970Google Scholar
  182. Crossen, P.E., Mellor, J.E.L., Finley, A.G., Ravich, R.B.M., Vincent, P.C., Gunz, F.W.: The Sézary syndrome. Cytogenetic studies and identification of the Sézary cell as an abnormal lymphocyte. Amer. J. Med. 50, 24–34 (1971)PubMedGoogle Scholar
  183. Custer, R.P., Bernhard, W.G.: The interrelationship of Hodgkin’s disease and other lymphatic tumors. Amer. J. med. Sci. 216, 625–642 (1948)PubMedGoogle Scholar
  184. Cutler, S.J., Axtell, L., Heise, H.: Ten thousand cases of leukemia: 1940–1962. J. Nat. Cancer Inst. 39, 993–1026 (1967)PubMedGoogle Scholar
  185. Cyr, D.P., Geokas, M.C.G., Worsley, G.H.: Mycosis fungoides. Hematologic findings and terminal course. Arch. Derm. (Chic.) 94, 558–573 (1966)Google Scholar
  186. Da Gradi, A., de Amicis, M.: Ein Fall von primärem Endotheliom der Lymphdrüsen. Virchows Arch. path. Anat. 207, 323–330 (1912)Google Scholar
  187. Dameshek, W.: In: Case records of the Massachusetts General Hospital No. 26–1964. New Engl. J. Med. 270, 1190–1197 (1964)Google Scholar
  188. Dammacco, F., Bonomo, L., Franklin, E.C.: A new case of mu heavy chain disease: Clinical and immunochemical studies. Blood 43, 713–719 (1974)PubMedGoogle Scholar
  189. Daniel, M.T., Flandrin, G.: Fine structure of abnormal cells in hairy cell (tricholeukocytic) leukemia, with special reference to their in vitro phagocytic capacity. Lab. Invest. 30, 1–8 (1974)PubMedGoogle Scholar
  190. Danon, F., Clauvel, J.P., Seligmann, M.: Les “paraprotéines” de type IgG et IgA en dehors de la maladie de Kahler. Rev. franç, Étud. clin. biol. 12, 681–701 (1967)Google Scholar
  191. Da Silva Parreira, F., Salvidio, E.: Osservazioni sul sangue periferico nei reticolosarcomi. Haematologica (Pavia) 36, 705–715 (1952)Google Scholar
  192. Davies, J.N.P.: Lymphomas and leukaemias in Uganda Africans. In: Symposium on Lymphoreticular Tumours in Africa, Paris 1963, pp. 67–79. Roulet, F.C., Ed. Basel-New York: Karger 1964Google Scholar
  193. Davis, B.J., Ornstein, L.: High resolution enzyme localization with a new diazo reagent, ‘Hexazonium’ pararose aniline. J. Histochem. Cytochem. 7, 297–298 (1959)Google Scholar
  194. Dawson, E.K., Innes, J.R.M., Harvey, W.F.: Debatable tumours. II. Lymphosarcoma. Edinb. med. J. 44, 645–657 (1937)Google Scholar
  195. Debusscher, L., Bernheim, J.L., Collard-Rongé, E., Govaerts, A., Hooghe, R., Lejeune, F.J., Zeicher, M., Stryckmans, P.A.: Hairy cell leukemia: Functional, immunologic, kinetic, and ultrastructural characterization. Blood 46, 495–507 (1975)PubMedGoogle Scholar
  196. Degos, R., Ossipovski, B., Civatte, J., Touraine, R.: Réticuloses cutanées. (Réticuloses histiomonocytaires). Ann. Derm. Syph. (Paris) 84, 125–152 (1957)Google Scholar
  197. Delmas-Marsalet, Y., Voisin, D., Hennache, G., Bauters, F., Goudemand, M.: Étude clinique et biologique de la maladie des chaînes lourdes gamma. À propos d’une nouvelle observation. Nouv. Rev. franç. Hémat. 11, 717–734 (1971)PubMedGoogle Scholar
  198. Desaga, J.F., Schmidt, D.M.R., Schmidt-Menard, A., Lück, R., Löffler, H.: Die proliferative Aktivität der Blastenpopulationen bei Leukämien vom PAS-Typ. Verh. Dtsch. Ges. inn. Med. 80, 1490–1492 (1974)PubMedGoogle Scholar
  199. Desai, P.B., Meher-Homji, D.R., Paymaster, J.C.: Malignant lymphomas. A clinical study of 800 Indian patients. Cancer (Philad.) 18, 25–33 (1965)Google Scholar
  200. DeVita, Jr., V.T., Canellos, G.P., Chabner, B., Schein, P., Hubbard, S.P., Young, R.C.: Advanced diffuse histiocytic lymphoma, a potentially curable disease. Results with combination chemotherapy. Lancet 1975, I, p. 248Google Scholar
  201. Dewar, A.E., Habeshaw, J.A., Young, G.A., Stuart, A.E., Parker, A.C., Wilson, C.D.: Mixed receptors. [Letter to the Editor.] Lancet 1974, II, p. 216Google Scholar
  202. Dickler, H.B., Siegal, F.P., Bentwich, Z.H., Kunkel, H.G.: Lymphocyte binding of aggregated IgG and surface Ig staining in chronic lymphocytic leukaemia. Clin. exp. Immunol. 14, 97–106 (1973)PubMedGoogle Scholar
  203. Diebold, J.: Classification morphologique des hématosarcomes lymphoïdes non hodgkiniens. Nouv. Presse méd. 3, 1818 (1974 a)PubMedGoogle Scholar
  204. Diebold, J.: Réflexions sur les classifications morphologiques des hématosarcomes lymphoides. Bull. Cancer 61, 37–38 (1974b)PubMedGoogle Scholar
  205. Diebold, J., Reynes, M., Kalifat, R., Tricot, G.: Les inclusions intranucléaires de la maladie de Waldenström. Nouv. Presse méd. 3, 1067–1070 (1974)PubMedGoogle Scholar
  206. Diebold, J., Reynes, M., Kalifat, R., Tricot, G.: Les expressions morphologiques de la maladie de Waldenström. Sem. Hôp. Paris 51, 2927–2934 (1975)PubMedGoogle Scholar
  207. Diebold, J., Zittoun, R., Fine, J.M., Tricot, G., Camilleri, J.P., Simon, F., Alcalay, M., Bousser, J.: Syndrome lymphoprolifératif avec production de macroglobuline IgM purement intracellulaire. Nouv. Rev. franç. Hémat. 11, 429–433 (1971)PubMedGoogle Scholar
  208. Doe, W.F.: Alpha chain disease. Clinicopathological features and relationship to so-called Mediterranean lymphoma. Brit. J. Cancer 31, Supp. II, 350–355 (1975)Google Scholar
  209. Doe, W.F., Henry, K., Hobbs, J.R., Avery Jones, F., Dent, C.E., Booth, C.C.: Five cases of alpha chain disease. Gut 13, 947–957 (1972)PubMedGoogle Scholar
  210. Döring, G.: Beiträge zur Kenntnis des Retothelsarkoms. Beitr. path. Anat. 101, 348–374 (1938)Google Scholar
  211. Domenici, A.: Considerazioni sui processi iperplastici e neoplastici dei linfonodi. (Rilievi citologici sulle iperplasie secondarie, iperplasie primitive, granuloma maligno e tumori del reticolo.) Arch. De Vecchi Anat. pat. 24, 187–233 (1956)PubMedGoogle Scholar
  212. Dorfman, R.F.: Enzyme histochemistry of the cells in Hodgkin’s disease and allied disorders. Nature (Lond.) 190, 925–926 (1961)Google Scholar
  213. Dorfman, R.F.: Enzyme histochemistry of normal, hyperplastic and neoplastic lymphoreticular tissues. In: Symposium on Lymphoreticular Tumours in Africa, Paris 1963, pp. 304–326. Roulet, F.C., Ed. Basel-New York: Karger 1964aGoogle Scholar
  214. Dorfman, R.F.: Follicular (nodular) lymphoma in South Africa. A study of 94 cases. In: Symposium on Lymphoreticular Tumours in Africa, Paris 1963, pp. 211–228. Roulet, F.C., Ed. Basel-New York: Karger 1964bGoogle Scholar
  215. Dorfman, R.F.: Childhood lymphosarcoma in St. Louis, Missouri, clinically and histologically resembling Burkitt’s tumor. Cancer (Philad.) 18, 418–430 (1965)Google Scholar
  216. Dorfman, R.F.: Classical concepts of nodular (follicular) lymphomas. In: Malignant Diseases of the Hematopoietic System. GANN Monograph on Cancer Research, Vol. 15, pp. 177–194. Akazaki, K., Rappaport, H., Berard, C.W., Bennett, J.M., Ishikawa, E., Eds. Tokyo: University of Tokyo Press 1973Google Scholar
  217. Dorfman, R.F.: Classification of non-Hodgkin’s lymphomas. [Letter to the Editor.] Lancet 1974a, I, pp. 1295–1296Google Scholar
  218. Dorfman, R.F.: Classification of non-Hodgkin’s lymphomas. [Letter to the Editor.] Lancet 1974b, II, pp. 961–962Google Scholar
  219. Dorfman, R.F.: The non-Hodgkin’s lymphomas. In: The Reticuloendothelial System. Monographs in Pathology, No. 16, pp. 262–281. Rebuck, J.W., Berard, C.W., Abell, M.R., Eds. Baltimore: Williams & Wilkins 1975Google Scholar
  220. Douglas, S.D., Cohnen, G., König, E., Brittinger, G.: Lymphocyte lysosomes and lysosomal enzymes in chronic lymphocytic leukemia. Blood 41, 511–518 (1973)PubMedGoogle Scholar
  221. Drescher, J., Hansen, H.G., Althoff, H., Graucob, E.: Das Di-Guglielmo-Syndrom im Kindesalter. Dtsch. med. Wschr. 94, 2415–2421 (1969)PubMedGoogle Scholar
  222. Drescher, J., Leder, L.-D.: Zur Frage der akuten, extrem unreifzelligen Erythrämie. Z. Kinderheilk. 108, 117–137 (1970)PubMedGoogle Scholar
  223. Dreschfeld, J.: Clinical lecture on acute Hodgkin’s disease. Brit. med. J. 1892, I, pp. 893–896Google Scholar
  224. Dreyfus, B., André, R.: Le diagnostic précoce des sarcomes des organes lymphoïdes. Rev. Hémat. 5, 57–77 (1950)PubMedGoogle Scholar
  225. Düllmann, J., Wulfhekel, U., Drescher, S., Hausmann, K.: Die Haarzellenhämoblastose (“hairy cell leukemia”). Klinische, licht- und elektronenmikroskopische Befunde. Dtsch. med. Wschr. 99, 859–863 (1974)PubMedGoogle Scholar
  226. Duhamel, G.: Histopathologie du ganglion lymphatique. Paris: Masson 1969Google Scholar
  227. Duhamel, G.: Histopathologie clinique de la moelle osseuse. Paris: Masson 1974Google Scholar
  228. Duhamel, G., Guerra, L.: Un syndrome hématologique difficile à définir: La myélofibrose lymphoide. Étude nosologique de 6 observations. Presse méd. 74, 585–596 (1966)Google Scholar
  229. Dumont, J., Duffillot, C., Flandrin, G., Chelloul, N., Tristant, H., Bernard, J.: Non-Hodgkin’s lymphomata: Clinical and immunological data in relation to histology. Brit. J. Cancer 31, Suppl. II, 187–200 (1975)Google Scholar
  230. Dumont, J., Duffillot, C., Thiebaut, F., Chelloul, N., Bernard, J.: Étude de la durée de vie des lymphoet réticulosarcomes en fonction de différents facteurs cliniques et histologiques. Bull. Cancer 61, 51–60 (1974)PubMedGoogle Scholar
  231. Dumont, J., Flandrin, G., Basch, A., Ripault, J., Lortholary, P., Bernard, J.: Le syndrome de Richter. Nouv. Rev. franç. Hémat. 11, 496–502 (1971)PubMedGoogle Scholar
  232. Dutcher, T.F., Fahey, J.L.: The histopathology of the macroglobulinemia of Waldenström. J. nat. Cancer Inst. 22, 887–918 (1959)PubMedGoogle Scholar
  233. Dutz, W., Asvadi, S., Sadri, S., Kohout, E.: Intestinal lymphoma and sprue: A systematic approach. Gut 12, 804–810 (1971)PubMedGoogle Scholar
  234. Edelson, R.L.: Cutaneous T-cell lymphomas: Clues of a skin-thymus interaction. J. invest. Derm. 67, 419–424 (1976)PubMedGoogle Scholar
  235. Edelson, R.L., Kirkpatrick, C.H., Shevach, E.M., Schein, P.S., Smith, R.W., Green, I., Lutzner, M.: Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes. Morphologic and functional studies. Ann. intern. Med. 80, 685–692 (1974)PubMedGoogle Scholar
  236. Edelson, R.L., Lutzner, M.A., Kirkpatrick, C.H., Shevach, E.M., Green, I.: Morphologic and functional properties of the atypical T lymphocytes of the Sezary syndrome. Mayo Clin. Proc. 49, 558–566 (1974)PubMedGoogle Scholar
  237. Edington, G.M., Maclean, C.M.U.: The relative incidence of tumours of the reticulo-endothelial system in Ibadan, Nigeria. In: Symposium on Lymphoreticular Tumours in Africa, Paris 1963, pp. 54–66. Roulet, F.C., Ed. Basel-New York: Karger 1964Google Scholar
  238. Edington, G.M., Maclean, C.M.U., Okubadejo, O.A.: 101 necropsies on tumours of the reticuloendothelial system in Ibadan, Nigeria, with special reference to childhood lymphoma. In: Symposium on Lymphoreticular Tumours in Africa, Paris 1963, pp. 236–252. Roulet, F.C., Ed. Basel-New York: Karger 1964Google Scholar
  239. [Editorial:] Follicular lymphomas. Lancet 1974, I, pp. 1088–1089Google Scholar
  240. Eichenberger-de Beer, H., Storck, H.: Zur Klinik und Therapie der Mycosis fungoides. Hautarzt 21, 458–464 (1970)Google Scholar
  241. Eidelmann, S., Parkins, R., Rubin, C.E.: Abdominal lymphoma presenting as malabsorption. A clinico-pathological study of nine cases in Israel and review of the literature. Medicine (Balt.) 45, 111–137 (1966)Google Scholar
  242. El Castro, B., Lewis, J.S., Strong, E.W.: Plasmacytoma of paranasal sinuses and nasal cavity. Arch. Otolaryng. 97, 326–329 (1973)Google Scholar
  243. Emberger, J.M., Navarro, M., Rizkalla, N., Izarn, P.: Étude histologique et cytologique de la moelle osseuse et de la rate au cours de l’histiolymphocytose primitive médullaire et splénique. Nouv. Rev. franç. Hémat. 13, 365–375 (1973)PubMedGoogle Scholar
  244. Engeset, A., Frøland, S.S., Bremer, K.: Studies of human peripheral lymph. II. Low lymphocyte count and few B-lymphocytes in peripheral lymph of patients with chronic lymphocytic leukaemia. Scand. J. Haemat. 13, 93–100 (1974)PubMedGoogle Scholar
  245. Epstein, Jr., E.H., Levin, D.L., Croft, Jr., J.D., Lutzner, M.A.: Mycosis fungoides. Survival, prognostic features, response to therapy and autopsy findings. Medicine (Baltimore) 51, 61–72 (1972)Google Scholar
  246. Epstein, M.A., Achong, B.G., Barr, Y.M.: Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1964, I, pp. 702–703Google Scholar
  247. Epstein, M.A., Hunt, R.D., Rabin, H.: Pilot experiments with EB virus in owl monkeys (aotus trivirgatus). I. Reticuloproliferative disease in an inoculated animal. Int. J. Cancer 12, 309–318 (1973)PubMedGoogle Scholar
  248. Erkman-Balis, B., Rappaport, H.: Cytogenetic studies of lymph nodes in patients with mycosis fungoides. [Abstr.] Amer. J. Path. 59, 54 a (1970)Google Scholar
  249. Erkman-Balis, B., Rappaport, H.: Cytogenetic studies in mycosis fungoides. Cancer (Philad.) 34, 626–633 (1974)Google Scholar
  250. Evans, R.W.: Histological Appearances of Tumours. With a consideration of their histogenesis and certain aspects of their clinical features and behaviour. Edinburgh-London: Livingstone 1966Google Scholar
  251. Ewald, O.: Die leukämische Reticuloendotheliose. Dtsch. Arch. klin. Med. 142, 222–228 (1923)Google Scholar
  252. Ewing, J.: Neoplastic Diseases. A Treatise on Tumors. 3. Ed., pp. 368–373. Philadelphia-London: Saunders 1928Google Scholar
  253. Ewing, J.: Neoplastic Diseases. 4. Ed. Philadelphia-London: Saunders 1940Google Scholar
  254. Ewing, M.R., Foote, Jr., F.W.: Plasma-cell tumors of the mouth and upper air passages. Cancer (Philad.) 5, 499–513 (1952)Google Scholar
  255. Faber, V.: Mycosis fungoides in den inneren Organen ohne Hautveränderungen. Zbl. allg. Path. 72, 152–153 (1939)Google Scholar
  256. Farrer-Brown, G.: Discussion. Workshop on Non-Hodgkin’s Lymphomas, Chicago, June 1973Google Scholar
  257. Fateh-Moghadam, A.: Paraproteinämische Hämoblastosen. In: Handbuch der inneren Medizin, Bd. 2,5: Krankheiten des lymphocytären Systems. pp. 245–452. Begemann, H., Ed. Berlin-Heidelberg-New York: Springer 1974Google Scholar
  258. Fateh-Moghadam, A., Prechtel, K., Wolf-Hornung, B., Lamerz, R., Ehrhart, H.: Pulmonale Verlaufsform der Makroglobulinämie Waldenström. Dtsch. med. Wschr. 99, 87–90 (1974)PubMedGoogle Scholar
  259. Faux, J.A., Crain, J.D., Rosen, F.S., Merler, E.: An alpha heavy chain abnormality in a child with hypogammaglobulinemia. Clin. Immunol. Immunopath. 1, 282–290 (1973)Google Scholar
  260. Fayolle, J., Cœur, P., Bryon, P.A., Gentilhomme, O., Morel, P.: Valeur pronostique de l’atteinte de la peau au cours de la leucémie lymphoïde chronique. Nouv. Rev. franç. Hémat. 11, 462–468 (1971)PubMedGoogle Scholar
  261. Feldges, A.J., Aur, R.J.A., Verzosa, M.S., Daniels, S.: Periodic acid-Schiff reaction, a useful index of duration of complete remission in acute childhood lymphocytic leukemia. Acta haemat. (Basel) 52, 8–13 (1974)Google Scholar
  262. Ferguson, D.J., Allen, L.W., Griem, M.L., Moran, M.E., Rappaport, H., Ultmann, J.E.: Surgical experience with staging laparotomy in 125 patients with lymphoma. Arch. intern. Med. 131, 356–361 (1973)PubMedGoogle Scholar
  263. Firat, D., Stutzman, L., Studenski, E.R., Pickren, J.: Giant follicular lymph node disease. Clinical and pathological review of sixty-four cases. Amer. J. Med. 39, 252–259 (1965)PubMedGoogle Scholar
  264. Fischer, R., Lorbacher, P., Käufer, C.: Untersuchungen zur enzymhistochemischen Differenzierung von leukämischen Erkrankungen am Schnittpräparat. Virchows Arch. path. Anat. 337, 525–534 (1964)Google Scholar
  265. Fitzgerald, P.H., Rastrick, J.M., Hamer, J.W.: Acute plasma cell leukaemia following chronic lymphatic leukaemia: Transformation or two separate diseases? Brit. J. Haemat. 25, 171–177 (1973)PubMedGoogle Scholar
  266. Flad, H.-D., Huber, C., Bremer, K., Menne, H.-D., Huber, H.: Impaired recirculation of B lymphocytes in chronic lymphocytic leukemia. Europ. J. Immunol. 3, 688–693 (1973)Google Scholar
  267. Flandrin, G.: Discussion for: Catovsky, D., Frisch, B., van Noorden, S.: B, T and ‘null’ cell leukaemias. Electron cytochemistry and surface morphology. Blood Cells 1, 125 (1975)Google Scholar
  268. Flandrin, G., Bernard, J.: Cytological classification of acute leukemias. A survey of 1400 cases. Blood Cells 1, 7–15 (1975)Google Scholar
  269. Flandrin, G., Brouet, J.-C.: The Sézary cell: Cytologic, cytochemical and immunologic studies. Mayo Clin. Proc. 49, 575–583 (1974)PubMedGoogle Scholar
  270. Flandrin, G., Brouet, J.C., Daniel, M.T., Preud’Homme, J.L.: Acute leukemia with Burkitt’s tumor cells: A study of six cases with special reference to lymphocyte surface markers. Blood 45, 183–188 (1975)PubMedGoogle Scholar
  271. Flandrin, G., Daniel, M.-T., Blanchet, P., Brière, J., Bernard, J.: La leucémie aiguë monocytaire. Situation clinique et pronostique actuelle à la lumière des techniques de détermination des estérases spécifiques. Nouv. Rev. franç. Hémat. 11, 241–254 (1971)PubMedGoogle Scholar
  272. Flandrin, G., Daniel, M.T., El Yafi, G., Chelloul, N.: Sarcomatoses ganglionnaires diffuses à différenciation plasmocytaire avec anémie hémolytique auto-immune. Actualités Hémat. 6, 25–41 (1972)Google Scholar
  273. Flandrin, G., Daniel, M.T., Fourcade, M., Chelloul, N.: Leucémie à “tricholeucocyte” (hairy cell leukemia), étude clinique et cytologique de 55 observations. Nouv. Rev. franç. Hémat. 13, 609–640 (1973)PubMedGoogle Scholar
  274. Flashman, D.H., Leopold, S.S.: Leukosarcoma. With report of a case beginning with a primary retroperitoneal lymphosarcoma and terminating with leukemia. Amer. J. med. Sci. 177, 651–663 (1929)Google Scholar
  275. Flaxman, B.A., Zelazny, G., van Scott, E.J.: Nonspecificity of characteristic cells in mycosis fungoides. Arch. Derm. 104, 141–147 (1971)PubMedGoogle Scholar
  276. Fleischmajer, R., Eisenberg, S.: Sézary’s reticulosis. Its relationship with neoplasias of the lymphoreticular system. Arch. Derm. 89, 69–79 (1964)Google Scholar
  277. Foot, N.C.: Report of a case of malignant endothelioma with necropsy. J. med. Res. 44, 417–430 (1924)PubMedGoogle Scholar
  278. Forkner, C.E.: Material from lymph nodes of man. I. Method to obtain material by puncture of lymph nodes for study with supravital and fixed stains. Arch. intern. Med. 40, 532–537 (1927 a)Google Scholar
  279. Forkner, C.F.: Material from lymph nodes of man. II. Studies on living and fixed cells withdrawn from lymph nodes of man. Arch. intern. Med. 40, 647–660 (1927 b)Google Scholar
  280. Forster, G., Moeschlin, S.: Extramedulläres, leukämisches Plasmocytom mit Dysproteinämie und erworbener hämolytischer Anämie. Schweiz. med. Wschr. 84, 1106–1110 (1954)PubMedGoogle Scholar
  281. Forte, F.A., Prelli, F., Yount, W.J., Jerry, L.M., Kochwa, S., Franklin, E.C., Kunkel, H.G.: Heavy chain disease of the μ (γM) type: Report of the first case. Blood 36, 137–144 (1970)PubMedGoogle Scholar
  282. Foulis, A.K., Cochran, A.J., Anderson, J.R.: Surface immunoglobulins of leukaemic cells. Clin. exp. Immunol. 14, 481–490 (1973)PubMedGoogle Scholar
  283. Frangione, B., Franklin, E.C.: Heavy chain diseases: Clinical features and molecular significance of the disordered immunoglobulin structure. Semin. Hemat. 10, 53–64 (1973)PubMedGoogle Scholar
  284. Franklin, E.C., Lowenstein, J., Bigelow, B., Meltzer, M.: Heavy chain disease —A new disorder of serum γ-globulins. Report of the first case. Amer. J. Med. 37, 332–350 (1964)PubMedGoogle Scholar
  285. Fraumeni, Jr., J.F.: Clinical epidemiology of leukemia. Semin. Hemat. 6, 250–260 (1969)PubMedGoogle Scholar
  286. Fresen, O.: Untersuchungen zur Struktur und Genese des Tuberkels als Beitrag zur tuberkulösen Entzündung. I. Mitteilung. Die Epitheloidzelle. Virchows Arch. path. Anat. 317, 491–516 (1949/50)Google Scholar
  287. Fresen, O.: Die retothelialen Hämoblastosen. Virchows Arch. path. Anat. 323, 312–350 (1953)Google Scholar
  288. Fresen, O.: Über Örtlichkeit und Wertigkeit des Morbus Brill-Symmers. Zbl. allg. Path. path. Anat. 95, 284–306 (1956)Google Scholar
  289. Fritze, E., van de Loo, J.: Makroglobulinämie Waldenström mit plasmazellulärer Leukämie. Med. Klin. 60, 173–176 (1965)Google Scholar
  290. Frizzera, G., Moran, E.M., Rappaport, H.: Angio-immunoblastic lymphadenopathy with dysproteinaemia. Lancet 1974, I, pp. 1070–1073Google Scholar
  291. Fruhling, L., Chadli, A.: Le sarcome plasmocytaire extrasquelettique. Ann. Anat. path. 8, 317–376 (1963)Google Scholar
  292. Fülle, H.H., Albrecht, M.: Plasmazellenleukämie. In: Leukämie, pp. 365–368. Gross, R., van de Loo, J., Eds. Berlin-Heidelberg-New York: Springer 1972Google Scholar
  293. Fülle, H.H., Pribilla, W.: Diagnose und Therapie der Plasmazellenleukämie. Dtsch. med. Wschr. 98, 874–881 (1973)PubMedGoogle Scholar
  294. Fuks, Z.Y., Bagshaw, M.A., Farber, E.M.: Prognostic signs and the management of the mycosis fungoides. Cancer (Philad.) 32, 1385–1395 (1973)Google Scholar
  295. Fuks, Z.Y., Castellino, R.A., Carmel, J.A., Farber, E.M., Bagshaw, M.A.: Lymphography in mycosis fungoides. Cancer (Philad.) 34, 106–112 (1974)Google Scholar
  296. van Furth, R., Cohn, Z.A., Hirsch, J.G., Humphrey, J.H., Spector, W.G., Langevoort, H.L.: The mononuclear phagocyte system: A new classification of macrophages, monocytes, and their precursor cells. Bull. Wld Hlth Org. 46, 845–852 (1972)Google Scholar
  297. van Furth, R., Gorter, H., Nadkarni, J.S., Nadkarni, J.J., Klein, E., Clifford, P.: Synthesis of immunoglobulins by biopsied tissues and cell lines from Burkitt’s lymphoma. Immunology 22, 847–857 (1972)PubMedGoogle Scholar
  298. Gajl-Peczalska, K.J., Bloomfield, C.D., Coccia, P.F., Sosin, H., Brunning, R.D., Kersey, J.H.: B and T cell lymphomas. Analysis of blood and lymph nodes in 87 patients. Amer. J. Med. 59, 674–685 (1975)PubMedGoogle Scholar
  299. Gajl-Peczalska, K.J., Bloomfield, C.D., Nesbit, M.E., Kersey, J.H.: B-cell markers on lymphoblasts in acute lymphoblastic leukaemia. Clin. exp. Immunol. 17, 561–569 (1974)PubMedGoogle Scholar
  300. Gall, E.A., Mallory, T.B.: Malignant lymphoma. A clinico-pathologic survey of 618 cases. Amer. J. Path. 18, 381–429 (1942)PubMedGoogle Scholar
  301. Gall, E.A., Morrison, H.R., Scott, A.T.: The follicular type of malignant lymphoma; a survey of 63 cases. Ann. intern. Med. 14, 2073–2090 (1941)Google Scholar
  302. Gallmeier, W.M., Göbel, F.W., Hartung, W., Schmidt, C.G.: Studien an einem Burkitt-Lymphom. Klin. Wschr. 48, 537–542 (1970)PubMedGoogle Scholar
  303. Galton, D.A.G.: Chronic lymphocytic leukaemia: Its pathogenesis and relationship to lymphosarcoma. In: Symposium on Lymphoreticular Tumours in Africa, Paris 1963, pp. 163–172. Roulet, F.C., Ed. Basel-New York: Karger 1964Google Scholar
  304. Galton, D.A.G.: The pathogenesis of chronic lymphocytic leukemia. Canad. med. Ass. J. 94, 1005–1010 (1967)Google Scholar
  305. Galton, D.A.G., Goldman, J.M., Wiltshaw, E., Catovsky, D., Henry, K., Goldenberg, G.J.: Prolymphocytic leukaemia. Brit. J. Haemat. 27, 7–23 (1974)PubMedGoogle Scholar
  306. Gans, O., Steigleder, G.K.: Histologie der Hautkrankheiten. Bd. 1 u. 2. 2. Aufl. Berlin-Göttingen-Heidelberg: Springer 1955, 1957Google Scholar
  307. Garner, A.: Pathology of “pseudotumours” of the orbit: A review. J. clin. Path. 26, 639–648 (1973)PubMedGoogle Scholar
  308. Garwicz, S., Landberg, T., Åkerman, M.: Malignant lymphomas in children. A clinico-pathologic retrospective study. II. Non-Hodgkin’s lymphomas. Acta paediat. scand. 63, 679–686 (1974)PubMedGoogle Scholar
  309. Gaston, E.A., Dollinger, M.R., Strong, E.W., Hajdu, S.I.: Primary plasmacytoma of lymph nodes. Lymphology 2, 7–15 (1969)PubMedGoogle Scholar
  310. Gatien, J.G., Schneeberger, E.E., Merler, E.: Analysis of human thymocyte subpopulations using discontinuous gradients of albumin: Precursor lymphocytes in human thymus. Eur. J. Immunol. 5, 312–317 (1975)PubMedGoogle Scholar
  311. Gatien, J.G., Schneeberger, E.E., Parkman, R., Merler, E.: Isolation on discontinuous gradients of bovine albumin of a subpopulation of human lymphocytes exhibiting precursor characteristics. Eur. J. Immunol. 5, 306–312 (1975)PubMedGoogle Scholar
  312. Gee, T.S., Haghbin, M., Dowling, Jr., M.D., Cunningham, I., Middleman, M.P., Clarkson, B.D.: Acute lymphoblastic leukemia in adults and children. Differences in response with similar therapeutic regimens. Cancer (Philad.) 37, 1256–1264 (1976)Google Scholar
  313. Gérard-Marchant, R.: Une nouvelle approche physio-morphologique des lymphomes malins non hodgkiniens. Bull. Cancer 61, 1–10 (1974a)Google Scholar
  314. Gérard-Marchant, R.: Conceptions nosologiques actuelles des lymphomes malins non hodgkiniens. Ann. Anat. path. 19, 149–162 (1974b)Google Scholar
  315. Gérard-Marchant, R., Hamlin, I., Lennert, K., Rilke, F., Stansfeld, A.G., van Unnik, J.A.M.: Classification of non-Hodgkin’s lymphomas. [Letter to the Editor.] Lancet 1974, II, pp. 406–408Google Scholar
  316. Germann, H.-J., Westerhausen, M., Kickhöfen, B.: μ-Kettenkrankheit. Dtsch. med. Wschr. 97, 1902–1905 (1972)PubMedGoogle Scholar
  317. Ghon, A., Roman, B.: Über das Lymphosarkom. Frankfurt. Z. Path. 19, 1–138 (1916)Google Scholar
  318. Gingold, N., Stoica, G.: Protéines pathologiques du type gamma G et gamma M au cours de la leucémie lymphatique chronique. In: Proc. 10. Congr. europ. Soc. Haemat., Strasbourg 1965; part II, pp. 756–760. Basel-New York: Karger 1967Google Scholar
  319. Givler, R.L.: Lymphocytic leukemia with coexistent localized reticulum cell sarcoma. Cancer (Philad.) 21, 1184–1192 (1968)Google Scholar
  320. Glatstein, E., Kim, H., Donaldson, S.S., Dorfman, R.F., Gribble, T.J., Wilbur, J.R., Rosenberg, S.A., Kaplan, H.S.: Non-Hodgkin’s lymphomas. VI. Results of treatment in childhood. Cancer (Philad.) 34, 204–211 (1974)Google Scholar
  321. Gleichmann, E., Gleichmann, H., Schwartz, R.S.: Immunologic induction of malignant lymphoma: Genetic factors in the graft-versus-host model. J. nat. Cancer Inst. 49, 793–804 (1972)PubMedGoogle Scholar
  322. Gleichmann, H., Gleichmann, E., André-Schwartz, J., Schwartz, R.S.: Chronic allogeneic disease. III. Genetic requirements for the induction of glomerulonephritis. J. exp. Med. 135, 516–532 (1972)PubMedGoogle Scholar
  323. Glenner, G.G., Ein, D., Terry, W.D.: The immunoglobulin origin of amyloid. Amer. J. Med. 52, 141–147 (1972)PubMedGoogle Scholar
  324. Glenner, G.G., Terry, W.D., Isersky, C.: Amyloidosis: its nature and pathogenesis. Semin. Hemat. 10, 65–86 (1973)PubMedGoogle Scholar
  325. Glick, A.D., Leech, J.H., Waldron, J.A., Flexner, J.M., Horn, R.G., Collins, R.D.: Malignant lymphomas of follicular center cell origin in man. II. Ultrastructural and cytochemical studies. J. nat. Cancer Inst. 54, 23–36 (1975)PubMedGoogle Scholar
  326. Godeau, P., Sicard, D., Herreman, G., Slama, G.: Macroglobulinémie de Waldenström de localisation pleuro-pulmonaire, orbitaire et sous-cutanée. Effet favorable du chlorambucil. Sem. Hôp. Paris 48, 3111–3116 (1972)PubMedGoogle Scholar
  327. Goetz, O., Lampert, F., Peller, P., Prechtel, K.: Histologisch und virologisch gesicherter Burkitt-Tumor bei einem 10jährigen Knaben. Münch. med. Wschr. 112, 1373–1376 (1970)PubMedGoogle Scholar
  328. Goldberg, A.F., Barka, T.: Acid phosphatase activity in human blood cells. Nature (Lond.) 195, 297 (1962)Google Scholar
  329. Goldner, J.: A modification of the Masson trichrome technique for routine laboratory purposes. Amer. J. Path. 14, 237–243 (1938)PubMedGoogle Scholar
  330. Goldstone, A.H., Cawley, J.C., Roberts, S.O., Leventine, A., Barker, C.R.: A case of small-cell Sézary’s syndrome with null-cell features. J. clin. Path. 29, 848–851 (1976)PubMedGoogle Scholar
  331. Golomb, H.M., Braylan, R., Polliack, A.: “Hairy” cell leukaemia (leukaemic reticuloendotheliosis): A scanning electron microscopic study of eight cases. Brit. J. Haemat. 29, 455–460 (1975)PubMedGoogle Scholar
  332. Gomez Orbaneja, J., Sanchez Yus, E., Diaz-Flores, L., Simon Huarte, P.: Cytology of the mycosis fungoides and the Sézary syndrome. Correlation between light and electron microscopy. Brit. J. Derm. 87, 96–105 (1972)Google Scholar
  333. Good, R.A.: Congenital and acquired abnormalities of the immune system in relation to the aetiology of the lymphomas. Symposium on Non-Hodgkin’s Lymphomata, London, Oct. 1973Google Scholar
  334. Goormaghtigh, N.: Sur la prolifération maligne du tissu réticulo-endothélial des ganglions lymphatiques. C.R. Soc. Biol. (Paris) 92, 457–458 (1925)Google Scholar
  335. Goos, M., Kaiserling, E., Lennert, K.: Mycosis fungoides: Model for T-lymphocyte homing to the skin. Brit. J. Derm. 94, 221–222 (1976)PubMedGoogle Scholar
  336. Gordon, S.: Problems in the laboratory diagnosis of acute leukaemias. Med. J. Aust. 1974, I, pp. 989–991Google Scholar
  337. de Graciansky, P., Timsit, E., Daniel, F., Revuz, J., Larrègue, M.: Les manifestations ganglionnaires du mycosis fongoide. Étude anatomo-pathologique et essai d’interprétation. Sem. Hôp. Paris 43, 3412–3419 (1967)PubMedGoogle Scholar
  338. Gravell, M., Levine, P.H., McIntyre, R.F., Land, V.J., Pagano, J.S.: Epstein-Barr virus in an American patient with Burkitt’s lymphoma: detection of viral genome in tumor tissue and establishment of a tumor-derived cell line (NAB). J. nat. Cancer Inst. 56, 701–704 (1976)PubMedGoogle Scholar
  339. Gray, J.L., Jacobs, A., Block, M.: Bone marrow and peripheral blood lymphocytosis in the prognosis of chronic lymphocytic leukemia. Cancer (Philad.) 33, 1169–1178 (1974)Google Scholar
  340. Greaves, M.F.: Leukaemia-associated membrane antigens. 7th Workshop on Leucocyte Cultures, Ulm, 31.3.–2.4.1976Google Scholar
  341. Greaves, M., Capellaro, D., Brown, G., Revesz, T., Janossy, G., Lister, T.A., Beard, M., Rapson, N., Catovsky, D.: Analysis of human leukaemic cells using cell surface binding probes and the fluorescence activated cell sorter. In: Modern Trends in Human Leukemia II. Hämatologie und Bluttransfusion, Bd. 19, pp. 243–260. Neth, R., Gallo, R.C., Mannweiler, K., Moloney, W.C., Eds. München: Lehmanns 1976Google Scholar
  342. Green, I., Jaffe, E.S., Shevach, E.M., Edelson, R.L., Frank, M.M., Berard, C.W.: Determination of the origin of malignant reticular cells by the use of surface membrane markers. In: The Reticuloendothelial System. Monographs in Pathology, No. 16, pp. 282–300. Rebuck, J.W., Berard, C.W., Abell, M.R., Eds. Baltimore: Williams & Wilkins 1975Google Scholar
  343. Greenwood, M.F., Holland, P.: Plasma membrane characteristics in acute leukemia. J. reticuloendothel. Soc. 16, Abstr. Suppl., p. 1a (1974)Google Scholar
  344. Gross, R.L., Steel, C.M., Levin, A.G., Singh, S., Brubaker, G.: In vitro immunological studies on East African cancer patients. III. Spontaneous rosette formation by cells from Burkitt lymphoma biopsies. Int. J. Cancer 15, 139–143 (1975)PubMedGoogle Scholar
  345. Grundmann, E., Hobik, H.P.: Graft-Versus-Host-Reaktion — Allogen-Krankheiten — Lymphome. Beitr. Path. 150, 323–329 (1973)Google Scholar
  346. Gunvén, P., Klein, G., Henle, G., Henle, W., Clifford, P.: Antibodies to EBV-associated membrane and viral capsid antigens in Burkitt lymphoma patients. Nature (Lond.) 228, 1053–1056 (1970)Google Scholar
  347. Gunz, F.W., Angus, H.B.: Leukemia and cancer in the same patient. Cancer (Philad.) 18, 145–152 (1965)Google Scholar
  348. Gunz, F.W., Hough, R.F.: Acute leukemia over the age of fifty: A study of its incidence and natural history. Blood 11, 882–901 (1956)PubMedGoogle Scholar
  349. Gunzer, U., Nürnberger, R., Thiemann, R.: Nachweis von Epstein-Barr-Virus-Capsidantigen, IgG-Antikörpern und Early Antigen bei malignen Non-Hodgkin-Lmphomen. Paper presented at Meeting of the German-Austrian Society of Hematology, Bad Nauheim, Sept. 29–Oct. 10, 1975Google Scholar
  350. Guthrie, C.G.: Gland puncture as a diagnostic measure. Bull. Johns Hopk. Hosp. 32, 266–269 (1921)Google Scholar
  351. Gutterman, J., Rodriguez, V., McMullan, G.: Remission induction of acute leukemia developing in Burkitt’s lymphoma. Cancer (Philad.) 29, 626–629 (1972)Google Scholar
  352. Haak, H.L., de Man, J.C.H., Hijmans, W., Knapp, W., Speck, B.: Further evidence for the lymphocytic nature of leukaemic reticuloendotheliosis (hairy-cell leukaemia). Brit. J. Haemat. 27, 31–38 (1974)PubMedGoogle Scholar
  353. Haas, W., Knorre, D.: Über eine ungewöhnliche Kombination einer malignen Retikulose mit kavernösen Lymphangiomen der peripheren Lymphknoten. Dtsch. Arch. klin. Med. 203, 335–350 (1956)PubMedGoogle Scholar
  354. Habeshaw, J.A., Stuart, A.E.: Cell receptor studies on seven cases of diffuse histiocytic malignant lymphoma (reticulum cell sarcoma). J. clin. Path. 28, 289–297 (1975)PubMedGoogle Scholar
  355. Haddow, A.J.: Epidemiological evidence suggesting an infective element in the aetiology. In: Burkitt’s Lymphoma, pp. 198–209. Burkitt, D.P., Wright, D.H., Eds. Edinburgh-London: Livingstone 1970Google Scholar
  356. Haegert, D.G., Cawley, J.C., Collins, R.D., Flemans, R.J., Smith, J.L.: Leukaemic reticuloendotheliosis: A morphological and immunological study of four cases. J. clin. Path. 27, 967–972 (1974)PubMedGoogle Scholar
  357. Haegert, D.G., Cawley, J.C., Karpas, A., Goldstone, A.H.: Combined T and B cell acute lymphoblastic leukaemia. Brit. med. J. 1974, IV, pp. 79–82Google Scholar
  358. Haferkamp, O., Rosenau, W., Lennert, K.: Vascular transformation of lymph node sinuses due to venous obstruction. Arch. Path. 92, 81–83 (1971)PubMedGoogle Scholar
  359. Hamburg, A., Brynes, R.K., Reese, C., Golomb, H.M.: Human cord blood lymphocytes. Ultra-structural and immunologic surface marker characteristics; a comparison with B- and T-cell lymphomas. Lab. Invest. 34, 207–215 (1976)PubMedGoogle Scholar
  360. Hamilton-Fairley, G., Freeman, J.E.: Blood and neoplastic diseases. Treatment of the lymphomas. Brit. med. J. 1974, IV, pp. 761–765Google Scholar
  361. Hansen, J.A., Good, R.A.: Malignant disease of the lymphoid system in immunological perspective. Hum. Path. 5, 567–599 (1974)PubMedGoogle Scholar
  362. Harms, D.: Milz und Blutgerinnung. In: Die Milz, pp. 306–316. Lennert, K., Harms, D., Eds. Berlin-Heidelberg-New York: Springer 1970Google Scholar
  363. Harris, J., Bagai, R.C.: Immune deficiency states associated with malignant disease in man. Med. Clin. N. Amer. 56, 501–514 (1972)PubMedGoogle Scholar
  364. Harris, O.D., Cooke, W.T., Thompson, H., Waterhouse, J.A.H.: Malignancy in adult coeliac disease and idiopathic steatorrhoea. Amer. J. Med. 42, 899–912 (1967)PubMedGoogle Scholar
  365. Harris, R.J.C.: Aetiology of central African lymphomata. Brit. med. Bull. 20, 149–153 (1964)PubMedGoogle Scholar
  366. Harrison, C.V.: The morphology of the lymph node in the macroglobulinaemia of Waldenström. J. clin. Path. 25, 12–16 (1972)PubMedGoogle Scholar
  367. Hayes, D.W., Bennett, W.A., Heck, F.J.: Extramedullary lesions in multiple myeloma. Review of literature and pathologic studies. Arch. Path. 53, 262–272 (1952)Google Scholar
  368. Hayhoe, F.G.J.: Leukaemia. Research and Clinical Practice. London: J. & A. Churchill Ltd. 1960Google Scholar
  369. Hayhoe, F.G.J.: Cytochemical aspects of leukemia and lymphoma. In: Leukemia and Lymphoma, pp. 37–46. Holland, J.F., Miescher, P.A., Jaffé, E.R., Eds. New York-London: Grune & Stratton 1969Google Scholar
  370. Hayhoe, F.G.J., Quaglino, D., Doll, R.: The Cytology and Cytochemistry of Acute Leukemias. London: Her Majesty’s Stationary Office 1964Google Scholar
  371. Heckner, F.: Extramedulläres lymphatisches Plasmocytom. Acta haemat. (Basel) 5, 158–168 (1951)Google Scholar
  372. Heckner, F.: Polysaccharide in Blut- und Knochenmarkszellen. In: Zyto- und Histochemie in der Hämatologie, pp. 408–425. Merker, H., Ed. Berlin-Göttingen-Heidelberg: Springer 1963Google Scholar
  373. Heckner, F., Voth, H.: Cytologische Begriffsbestimmung der Reticulumzellen. II. Mitteilung. Untersuchungen am Lymphknoten. Dtsch. Arch. klin. Med. 201, 582–595 (1954)PubMedGoogle Scholar
  374. Heenan, P.J., Mason, D.Y., Skinner, J.M., Taylor, C.R.: Waldenström’s disease of the jejunum. Beitr. Path. 157, 76–83 (1976)Google Scholar
  375. van Heerde, P., Hijmans, W., Wagenaar, S.S., Schuit, H.R.E., Bleeker, G.M.: Twee gevallen van lymforeticulaire orbitatumoren. Ned. T. Geneesk. 118, p. 488 (1974)Google Scholar
  376. Heidelberger, K.P., LeGolvan, D.P.: Wiskott-Aldrich syndrome and cerebral neoplasia: Report of a case with localized reticulum cell sarcoma. Cancer (Philad.) 33, 280–284 (1974)Google Scholar
  377. Heilmeyer, L., Begemann, H.: Atlas der klinischen Hämatologie und Cytologie. Berlin-Göttingen-Heidelberg: Springer 1955Google Scholar
  378. Heine, J.: Lymphozytom der Lunge und generalisierte Plasmozytose. Zbl. allg. Path. path. Anat. 96, 16–20 (1957)Google Scholar
  379. Heller, A.: Cytochemische Befunde bei M. Waldenström. In: Leukämie, pp. 429–432. Gross, R., van de Loo, J., Eds. Berlin-Heidelberg-New York: Springer 1972Google Scholar
  380. Hellwig, C.A.: Extramedullary plasma cell tumors as observed in various locations. Arch. Path. 36, 95–111 (1943)Google Scholar
  381. Henderson, E.S.: Treatment of acute leukemia. Sem. Hemat. 6, 271–319 (1969)Google Scholar
  382. Henle, G., Henle, W.: Immunofluorescence in cells derived from Burkitt’s lymphoma. J. Bact. 91, 1248–1256 (1966)PubMedGoogle Scholar
  383. Henle, G., Henle, W., Diehl, V.: Relation of Burkitt’s tumor-associated herpes-type virus to infectious mononucleosis. Proc. nat. Acad. Sci. (Wash.) 59, 94–101 (1968)Google Scholar
  384. Henle, W.: Evidence for viruses in acute leukemia and Burkitt’s tumor. Cancer (Philad.) 21, 580–586 (1968)Google Scholar
  385. Henle, W., Diehl, V., Kohn, G., Zur Hausen, H., Henle, G.: Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science 157, 1064–1065 (1967)PubMedGoogle Scholar
  386. Henle, W., Henle, G.: Epstein-Barr virus and infectious mononucleosis. New Engl. J. Med. 288, 263–264 (1973)PubMedGoogle Scholar
  387. Henle, W., Henle, G.E., Horwitz, C.A.: Epstein-Barr virus specific diagnostic tests in infectious mononucleosis. Hum. Path. 5, 551–565 (1974)PubMedGoogle Scholar
  388. Henle, W., Henle, G., Zajac, B.A., Pearson, G., Waubke, R., Scriba, M.: Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science 169, 188–190 (1970)PubMedGoogle Scholar
  389. Hennemann, H.H., Rathenow, H.W.: Leukämiestudien (III). Das elektrophoretische Serumeiweißbild bei Leukämien. Z. ges. inn. Med. 10, 616–621 (1955)PubMedGoogle Scholar
  390. Henry, K.: Electron microscopy in the non-Hodgkin’s lymphomata. Brit. J. Cancer 31, Suppl. II, 73–93 (1975)Google Scholar
  391. Henry, K., Howarth, C., Farrer-Brown, G.: New concepts of primary gastrointestinal lymphomas. XI Congress Intern. Acad. Path., Washington, Oct. 1976Google Scholar
  392. Hertl, M.: Zytochemie der Zellen der akuten Leukose. In: Zyto- und Histochemie in der Hämatologie, pp. 5–19. Merker, H., Ed. Berlin-Göttingen-Heidelberg: Springer 1963Google Scholar
  393. Hertl, M.: Zytochemie der Zellen der akuten Leukose. (Theoretische und klinische Medizin in Einzeldarstellungen, Bd. 30) Heidelberg: Hüthig 1966Google Scholar
  394. Hertl, M., Landbeck, G. [Eds.]: Leukämie bei Kindern. Stuttgart: Thieme 1969Google Scholar
  395. Hess, M.W.: Discussion for: Catovsky, D., Frisch, B., van Noorden, S.: B, T and ‘null’ cell leukaemias. Electron cytochemistry and surface morphology. Blood Cells 1, 126 (1975)Google Scholar
  396. Heuchel, G., Eitner, H.: Über besondere Bluteiweißbefunde bei Retothelsarkomatose. Acta haemat. (Basel) 12, 27–34 (1954)Google Scholar
  397. von Heyden, H.W., Waller, H.D., Pape, G.R., Benöhr, H.C., Braun, H.J., Wilms, K., Rieber, E.P., Riethmüller, G.: Haarzell-Leukämie. I. Klinik, Zytochemie, Phagozytosefähigkeit von Haarzellen, Etablierung permanent wachsender Zellinien. Dtsch. med. Wschr. 101, 3–8 (1976)PubMedGoogle Scholar
  398. Hirscher, H.: Über extramedulläres lympho-retikuläres diffuses Plasmocytom. Folia haemat. (Lpz.) 72, 74–86 (1953/54)Google Scholar
  399. Hittmair, A.: Zur Ätiologie lymphatischer Hyperplasien bzw. lymphatischer Leukämien. Schweiz. med. Wschr. 82, 1130–1131 (1952)PubMedGoogle Scholar
  400. Hoagland, H.C.: Atypical lymphocytes. Morphologic features. Mayo Clin. Proc. 49, 526–530 (1974)PubMedGoogle Scholar
  401. Hobbs, J.R.: Growth rates and responses to treatment in human myelomatosis. Brit. J. Haemat. 16, 607–617 (1969)PubMedGoogle Scholar
  402. Hobbs, J.R.: Immunocytoma o’ mice an’ men. Brit. med. J. 1971, II, pp. 67–72Google Scholar
  403. Hobbs, J.R., Jacobs, A.: A half-molecule GK plasmacytoma. Clin. exp. Immunol. 5, 199–207 (1969)PubMedGoogle Scholar
  404. Hodgkin, T.: On some morbid appearances of the absorbent glands and spleen. Med.-Chir. Trans. 17, 68–114 (1832)PubMedGoogle Scholar
  405. Hoerni, B., Laporte, G.: Immunological disorders in the aetiology of lymphoreticular neoplasms. Europ. J. clin. biol. Res. 15, 841–850 (1970)Google Scholar
  406. Hohl, K., Gretener, A.: Das Reticulosarkom. Zürcher Material von 1936–1951 (39 Fälle). Oncologia (Basel) 9, 338–352 (1956)Google Scholar
  407. Holdaway, D.R., Winkelmann, R.K.: Histopathology of Sezary syndrome. Mayo Clin. Proc. 49, 541–547 (1974)PubMedGoogle Scholar
  408. Holton, C.P., Vietti, T.J., Nora, A.H., Donaldson, M.H., Stuckey, Jr., W.J., Watkins, W.L., Lane, D.M.: Clinical study of Daunomycin and prednisone for induction of remission in children with advanced leukemia. New Engl. J. Med. 280, 171–174 (1969)PubMedGoogle Scholar
  409. Hopper, J.E.: Immunoglobulin D: A predominant surface Ig in poorly differentiated lymphocytic (PDL) lymphoma. [Abstr.] Clin. Res. 22, 394A (1974)Google Scholar
  410. Horster, J.A.: Über das großfollikuläre Lymphoblastom. Dtsch. Arch. klin. Med. 198, 295–304 (1951)PubMedGoogle Scholar
  411. Huang, C.C., Hou, Y., Woods, L.K., Moore, G.E., Minowada, J.: Cytogenetic study of human lymphoid T-cell lines derived from lymphocytic leukemia. J. nat. Cancer Inst. 53, 655–660 (1974)PubMedGoogle Scholar
  412. Huber, C., Michlmayr, G., Huber, H.: Immunologische Marker in der Differentialdiagnose lymphatischer Systemerkrankungen. Dtsch. med. Wschr. 99, 2262–2268 (1974)PubMedGoogle Scholar
  413. Huber, H., Braunsteiner, H.: Pathophysiologie und Differentialdiagnose der chronischen lymphatischen Leukämie. In: Leukämie, pp. 415–421. Gross, R., van de Loo, J., Eds. Berlin-Heidelberg-New York: Springer 1972Google Scholar
  414. Huhn, D., Dobbelstein, H., Engelhardt, D.: Sézary-Syndrom. Blut 25, 352–363 (1972)PubMedGoogle Scholar
  415. Huhn, D., Stich, W.: Fine Structure of Blood and Bone Marrow. An Introduction in Electron Microscopic Hematology. München: J.F. Lehmanns 1969Google Scholar
  416. Hurez, D., Flandrin, G., Preud’Homme, J.L., Seligmann, M.: Unreleased intracellular monoclonal macroglobulin in chronic lymphocytic leukaemia. Clin. exp. Immunol. 10, 223–234 (1972)PubMedGoogle Scholar
  417. Hurst, D.W., Meyer, O.O.: Giant follicular lymphoblastoma. Cancer (Philad.) 14, 753–778 (1961)Google Scholar
  418. Hutt, M.S.R.: The pathology of Burkitt’s tumour in the context of lymphomas and leukaemias. In: Treatment of Burkitt’s Tumour. UICC Monograph Series, Vol. 8, pp. 11–13. Burchenal, J.H., Burkitt, D.P., Eds. Berlin-Heidelberg-New York: Springer 1967Google Scholar
  419. Hutt, M.S.R.: Introduction and historical background. In: Burkitt’s Lymphoma, pp. 1–5. Burkitt, D.P., Wright, D.H., Eds. Edinburgh-London: Livingstone 1970Google Scholar
  420. Hutter, Jr., J.J., Favara, B.E., Nelson, M., Holton, C.P.: Non-Hodgkin’s lymphoma in children. Correlation of CNS disease with initial presentation. Cancer (Philad.) 36, 2132–2137 (1975)Google Scholar
  421. Iijima, S.: Leukemic reticuloendotheliosis. Tohoku J. exp. Med. 89, 35–44 (1966)PubMedGoogle Scholar
  422. Iijima, S.: Leukemic reticuloendotheliosis. In: Malignant Diseases of the Hematopoietic System. GANN Monograph on Cancer Research, Vol. 15, pp. 163–176. Akazaki, K., Rappaport, H., Berard, C.W., Bennett, J.M., Ishikawa, E., Eds. Tokyo: University of Tokyo Press 1973Google Scholar
  423. Insel, R.A., Melewicz, F.M., La Via, M.F., Balch, C.M.: Morphology, surface markers, and in vitro responses of a human leukemic T cell. Clin. Immunol. Immunopath. 4, 382–391 (1975)Google Scholar
  424. Isaacs, R.: ‘Notched nucleus cell’ leukemia. Proc. Cent. Soc. clin. Res. 12, 37 (1939)Google Scholar
  425. Isobe, T., Osserman, E.F.: Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins. New Engl. J. Med. 290, 473–477 (1974)PubMedGoogle Scholar
  426. Iversen, O.H., Harket, R.: Burkitt’s tumour in Norway. A survey of possible cases occurring in the period 1953–1962. Europ. J. Cancer 4, 383–389 (1968)Google Scholar
  427. Iversen, O.H., Iversen, U., Ziegler, J.L., Bluming, A.Z.: Cell kinetics in Burkitt lymphoma. Europ. J. Cancer 10, 155–163 (1974)Google Scholar
  428. Iversen, U., Iversen, O.H., Bluming, A.Z., Ziegler, J.L., Kyalwasi, S.: Cell kinetics of African cases of Burkitt lymphoma. A preliminary report. Europ. J. Cancer 8, 305–308 (1972)Google Scholar
  429. Jackson, Jr., H., Parker, Jr., F.: Hodgkin’s Disease and Allied Disorders. New York: Oxford University Press 1947Google Scholar
  430. Jackson, Jr., H., Parker, Jr., F., Bethea, J.M.: Studies of diseases of the lymphoid and myeloid tissues. II. Plasmatocytomata and their relation to multiple myelomata. Amer. J. med. Sci. 181, 169–180 (1931)Google Scholar
  431. Jacobs, M.L.: Malignant lymphomas and their management. (Recent Results in Cancer Research, Vol. 16.) Berlin-Heidelberg-New York: Springer 1968Google Scholar
  432. Jacquillat, C., Weil, M., Gemon, M.-F., Auclerc, G., Loisel, J.-P., Delobel, J., Flandrin, G., Schaison, G., Izrael, V., Bussel, A., Dresch, C., Weisgerber, C., Rain, D., Tanzer, J., Najean, Y., Seligmann, M., Boiron, M., Bernard, J.: Combination therapy in 130 patients with acute lymphoblastic leukemia (Protocol 06 LA 66-Paris). Cancer Res. 33, 3278–3284 (1973)PubMedGoogle Scholar
  433. Jaeger, E.: Das extramedulläre Plasmocytom. Z. Krebsforsch. 52, 349–383 (1942)Google Scholar
  434. Jaffe, E.S., Shevach, E.M., Frank, M.M., Berard, C.W., Green, I.: Nodular lymphoma —evidence for origin from follicular B lymphocytes. New Engl. J. Med. 290, 813–819 (1974)PubMedGoogle Scholar
  435. Jaffe, E.S., Shevach, E.M., Sussman, E.H., Frank, M., Green, I., Berard, C.W.: Membrane receptor sites for the identification of lymphoreticular cells in benign and malignant conditions. Brit. J. Cancer 31, Suppl. II, 107–120 (1975)Google Scholar
  436. Jaiyesimi, F., Oluboyede, O., Taylor, D., Familusi, J.B.: Burkitt’s lymphoma presenting as acute leukaemia. Acta haemat. (Basel) 54, 115–119 (1975)Google Scholar
  437. Jarvis, J.E., Ball, G., Rickinson, A.B., Epstein, M.A.: Cytogenetic studies on human lymphoblastoid cell lines from Burkitt’s lymphomas and other sources. Int. J. Cancer 14, 716–721 (1974)PubMedGoogle Scholar
  438. Jellinger, K., Radaszkiewicz, T., Slowik, F.: Primary malignant lymphomas of the central nervous system in man. Acta neuropath. (Berl.) Suppl. 6, 95–102 (1975)Google Scholar
  439. Jenkin, R.D.T.: Report on patterns of disease in lymphosarcoma and reticulum cell sarcoma. Meeting Internat. Soc. Paediat. Oncology, Oct. 1972, ManchesterGoogle Scholar
  440. Jéquier-Doge, E., Nicod, J.-L., Chapuis, J.-P.: Un cas de plasmocytome à localisation ganglionnaire observé cliniquement pendant plus de 6 ans et contrôlé anatomiquement. Schweiz. med. Wschr. 77, 186–190 (1947)PubMedGoogle Scholar
  441. Jønsson, V., Videbaek, A., Axelsen, N.H., Harboe, M.: μ-Chain disease in a case of chronic lymphocytic leukaemia and malignant histiocytoma. I. Clinical aspects. Scand. J. Haemat. 16, 209–217 (1976)PubMedGoogle Scholar
  442. Jondal, M., Wigzell, H., Aiuti, F.: Human lymphocyte subpopulations: Classification according to surface markers and/or functional characteristics. Transplant. Rev. 16, 163–195 (1973)PubMedGoogle Scholar
  443. Jones, S.E.: Autoimmune disorders and malignant lymphoma. Cancer (Philad.) 31, 1092–1098 (1973)Google Scholar
  444. Jones, S.E., Fuks, Z., Bull, M., Kadin, M.E., Dorfman, R.F., Kaplan, H.S., Rosenberg, S.A., Kim, H.: Non-Hodgkin’s lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer (Philad.) 31, 806–823 (1973)Google Scholar
  445. Jones, S.E., Kaplan, H.S., Rosenberg, S.A.: Non-Hodgkin’s lymphomas. III. Preliminary results of radiotherapy and a proposal for new clinical trials. Radiology 103, 657–662 (1972)PubMedGoogle Scholar
  446. Joseph, R.R., Zarafonetis, C.J.D., Durant, J.R.: ‘Lymphoma’ in chronic granulocytic leukemia. Amer. J. med. Sci. 251, 417–427 (1966)PubMedGoogle Scholar
  447. Kahn, L.B.: Pathology of the lymphomas. S. Afr. med. J. 46, 1153–1159 (1972)PubMedGoogle Scholar
  448. Kaiserling, E.: Feinstrukturelle Befunde bei Non-Hodgkin-Lymphomen. Habil. Schrift, Kiel 1975Google Scholar
  449. Kaiserling, E.: Elektronenmikroskopische Befunde bei Non-Hodgkin-Lymphomen. In: Maligne Lymphome und monoklonale Gammopathien. Hämatologie und Bluttransfusion, Bd. 18, pp. 185–198. Löffler, H., Ed. München: Lehmanns 1976Google Scholar
  450. Kaplan, H.S.: Hodgkin’s Disease. Cambridge, Mass.: Harvard University Press 1972Google Scholar
  451. Kaplan, J., Mastrangelo, R., Peterson, Jr., W.D.: Childhood lymphoblastic lymphoma, a cancer of thymus-derived lymphocytes. Cancer Res. 34, 521–525 (1974)PubMedGoogle Scholar
  452. Kappeler, R., Krebs, A., Riva, G.: Klinik der Makroglobulinämie Waldenström. Beschreibung von 21 Fällen und Übersicht der Literatur. Helv. med. Acta 25, 54–152 (1958)PubMedGoogle Scholar
  453. Karitzky, D., Jacobi, H.: IgM-Paraproteinämie bei lymphoblastischem Lymphosarkom im Kindesalter. Dtsch. med. Wschr. 99, 954–957 (1974)PubMedGoogle Scholar
  454. Katayama, I., Finkel, H.E.: Leukemic reticuloendotheliosis. A clinicopathologic study with review of the literature. Amer. J. Med. 57, 115–126 (1974)PubMedGoogle Scholar
  455. Katayama, I., Li, C.Y., Yam, L.T.: Histochemical study of acid phosphatase isoenzyme in leukemic reticuloendotheliosis. Cancer (Philad.) 29, 157–164 (1972 a)Google Scholar
  456. Katayama, I., Li, C.Y., Yam, L.T.: Ultrastructural characteristics of the “hairy cells” of leukemic reticuloendotheliosis. Amer. J. Path. 67, 361–370 (1972b)PubMedGoogle Scholar
  457. Katayama, I., Nagy, G.K.: Hairy-cell leukemia versus leukemic reticuloendotheliosis. [Letter to the Editor.] Amer. J. clin. Path. 62, 442 (1974)Google Scholar
  458. Katayama, I., Nagy, G.K., Balogh, Jr., K.: Light microscopic identification of the ribosome-lamella complex in “hairy cells” of leukemic reticuloendotheliosis. Cancer (Philad.) 32, 843–846 (1973)Google Scholar
  459. Katayama, I., Pechet, L.: Classification of non-Hodgkin’s lymphomas. [Letter to the Editor.] Lancet 1974, II, p. 1211Google Scholar
  460. Kaufmann, E.: Lehrbuch der speziellen pathologischen Anatomie für Studierende und Ärzte. Bd. 1, S. 207 u. Bd. 2. 7. u. 8. Aufl. Berlin-Leipzig: de Gruyter 1928/29Google Scholar
  461. Kay, H.E.M.: Classification of non-Hodgkin’s lymphomas. [Letter to the Editor.] Lancet 1974, II, p. 586Google Scholar
  462. Keiser, G., Uehlinger, E., Virieux, C.: Zwei Fälle von chronisch-lymphatischer Leukämie und Morbus Hodgkin. Acta haemat. (Basel) 26, 29–43 (1961)Google Scholar
  463. Keller, H., Spengler, G.A., Skvařil, F., Flury, W., Noseda, G., Riva, G.: Zur Frage der Heavy chain disease. Ein Fall von IgG-heavy-chain-Fragment- und IgM-Typ K-Paraproteinämie mit Plasmazellenleukämie. Schweiz. med. Wschr. 100, 1012–1022 (1970)PubMedGoogle Scholar
  464. Kellner, B., Lapis, K., Eckhardt, S.: Lymphknotengeschwülste. Budapest: Akadémiai Kiadó 1966Google Scholar
  465. Kersey, J.H., Gajl-Peczalska, K.J., Nesbit, M.E.: The lymphoid system: Abnormalities in immunodeficiency and malignancy. J. Pediat. 84, 789–796 (1974)PubMedGoogle Scholar
  466. Kersey, J.H., Nesbit, M., Hallgren, H., Sabad, A., Yunis, E., Gajl-Peczalska, K.: Evidence for origin of certain childhood acute lymphoblastic leukemias and lymphomas in thymus-derived lymphocytes. Cancer (Philad.) 36, 1348–1352 (1975)Google Scholar
  467. Kersey, J.H., Nesbit, M.E., Luckasen, J.R., Hallgren, H.M., Sabad, A., Yunis, E.J., Gajl-Pec-zalska, K.J.: Acute lymphoblastic leukemic and lymphoma cells with thymus-derived (T) markers. Mayo Clin. Proc. 49, 584–587 (1974)PubMedGoogle Scholar
  468. Keuning, F.J.: Dynamics of immunoglobulin forming cells and their precursors. In: Immunoglobulins, pp. 1–14. Amsterdam: North Holland Publ. 1972Google Scholar
  469. Keuning, F.J., Bos, W.H.: Regeneration patterns of lymphoid follicles in the rabbit spleen after sublethal X-irradiation. In: Germinal Centers in Immune Responses. Proc. of a Symp. held at the Univ. of Bern, June 22–24, 1966, pp. 250–257. Cottier, H., Odartchenko, N., Schindler, R., Congdon, C.C., Eds. Berlin-Heidelberg-New York: Springer 1967Google Scholar
  470. Khan, A.G.: The multifocal lymphoma syndrome in African children in Kenya. J. Laryng. 78, 480–498 (1964)PubMedGoogle Scholar
  471. Kharazmi, A., Haghighi, P., Haghshenas, M., Nasr, K., Abadi, P., Rezai, H.R.: Alpha-chain disease and its association with intestinal lymphoma. Clin. exp. Immunol. 26, 124–128 (1976)PubMedGoogle Scholar
  472. Kim, H., Dorfman, R.F.: Morphological studies of 84 untreated patients subjected to laparotomy for the staging of non-Hodgkin’s lymphomas. Cancer (Philad.) 33, 657–674 (1974)Google Scholar
  473. Kim, H., Heller, P., Rappaport, H.: Monoclonal gammopathies associated with lymphoproliferative disorders: A morphologic study. Amer. J. clin. Path. 59, 282–294 (1973)Google Scholar
  474. Kimura, K.: Clinical and statistical studies of tumors of the reticuloendothelial system in Japan. Tohoku J. exp. Med. 82, 1–20 (1964)PubMedGoogle Scholar
  475. King, G.W., Hurtubise, P.E., Sagone, Jr., A.L., LoBuglio, A.F., Metz, E.N.: Leukemic reticuloendotheliosis. A study of the origin of the malignant cell. Amer. J. Med. 59, 411–416 (1975)PubMedGoogle Scholar
  476. Klajman, A., Yaretzky, A., Manor, J., Steiner, Z.: Acute lymphoblastic crisis in a patient with chronic lymphatic leukemia. Acta haemat. (Basel) 54, 306–311 (1975)Google Scholar
  477. Klein, G.: Some immunological studies. In: Burkitt’s Lymphoma, pp. 172–185. Burkitt, D.P., Wright, D.H., Eds. Edinburgh-London: Livingstone 1970Google Scholar
  478. Klein, G., Geering, G., Old, L.J., Henle, G., Henle, W., Clifford, P.: Comparison of the anti-EBV titer and the EBV-associated membrane reactive and precipitating antibody levels in the sera of Burkitt lymphoma and nasopharyngeal carcinoma patients and controls. Int. J. Cancer 5, 185–194 (1970)PubMedGoogle Scholar
  479. Klima, R., Herzog, E.: Beziehungen der lymphatischen Leukämie zu Entzündung und Karzinom. Zehnjährige klinische Beobachtungen. Wien. med. Wschr. 106, 6–10 (1956)PubMedGoogle Scholar
  480. Knapp, W., Schuit, H.R.E., Bolhuis, R.L.H., Hijmans, W.: Surface immunoglobulins in chronic lymphatic leukaemia, macroglobulinaemia and myelomatosis. Clin. exp. Immunol. 16, 541–552 (1974)Google Scholar
  481. Knospe, W.H., Loeb, Jr., V., Huguley, Jr., C.M.: Bi-weekly chlorambucil treatment of chronic lymphocytic leukemia. Cancer (Philad.) 33, 555–562 (1974)Google Scholar
  482. Knoth, W.: Zur Cyto- und Histogenese und zur klinischen Einteilung der reticulo-histiocytären Erkrankungen der Haut. Arch. klin. exp. Derm. 209, 130–170 (1959)PubMedGoogle Scholar
  483. König, E., Brittinger, G., Cohnen, G.: Relation of lysosomal fragility in CLL lymphocytes to PHA reactivity. Nature (Lond.) 244, 247–248 (1973)Google Scholar
  484. Kojima, M., Imai, Y., Mori, N.: A concept of follicular lymphoma. A proposal for the existence of a neoplasm originating from the germinal center. In: Malignant Diseases of the Hematopoietic System. GANN Monograph on Cancer Research, No. 15, pp. 195–207. Akazaki, K., Rappaport, H., Berard, C.W., Bennett, J.M., Ishikawa, E., Eds. Tokyo: University of Tokyo Press 1973Google Scholar
  485. Komocki, W.: Über eine Geschwulst von eigenartigem Bau (Reticuloma s. Adenoidoma). Virchows Arch. path. Anat. 250, 517–521 (1924)Google Scholar
  486. Krämer, F.: PAS-positive Zelleinschlüsse beim Plasmozytom und bei der Makroglobulinämie Waldenström. Diss. med., Kiel 1971Google Scholar
  487. Krauss, S., Sokal, J.E.: Paraproteinemia in the lymphomas. Amer. J. Med. 40, 400–413 (1966)Google Scholar
  488. Krüger, G.: Chronic immunosuppression and lymphomagenesis in man and mice. Nat. Cancer Inst. Monogr. 35, 183–190 (1972)Google Scholar
  489. Krüger, G., Harris, D., Sussman, E.: Effect of dilantin in mice. II. Lymphoreticular tissue atypia and neoplasia after chronic exposure. Z. Krebsforsch. 78, 290–302 (1972)Google Scholar
  490. Krüger, G., O’Conor, G.T.: Epidemiologic and immunologic considerations on the pathogenesis of Burkitt’s tumor. In: Recent Results in Cancer Research, Vol. 39, pp. 211–224. Grundmann, E., Tulinius, H., Eds. Berlin-Heidelberg-New York: Springer 1972Google Scholar
  491. Kundrat, H.: Ueber Lympho-Sarkomatosis. Wien. klin. Wschr. 6, 211–213 u. 234–239 (1893)Google Scholar
  492. Kurz, R., Haas, H.: Value of the combined cytological and cytochemical classification in the management of acute childhood leukemia. Acta haemat. (Basel) 52, 1–7 (1974)Google Scholar
  493. Kyle, R.A., Bayrd, E.D., McKenzie, B.F., Heck, F.J.: Diagnostic criteria for electrophoretic patterns of serum and urinary proteins in multiple myeloma. Study of one hundred and sixty-five multiple myeloma patients and of seventy-seven nonmyeloma patients with similar electrophoretic patterns. J. Amer. med. Ass. 174, 245–251 (1960)Google Scholar
  494. Ladewig, P.: Über eine einfache und vielseitige Bindegewebsfärbung (Modifikation der Mallory-Heidenhainschen Methode). Z. wiss. Mikr. 55, 215–217 (1938)Google Scholar
  495. Lampert, F.: Diagnose, Ätiologie und Therapie des Burkitt-Lymphoms. In: Leukämien und maligne Lymphome, pp. 483–486. Stacher, A., Ed. München-Berlin-Wien: Urban & Schwarzenberg 1973Google Scholar
  496. Landbeck, G.: Besonderheiten maligner Lymphome im Kindesalter. In: Leukämien und maligne Lymphome, pp. 487–493. Stacher, A., Ed. München-Berlin-Wien: Urban & Schwarzenberg 1973Google Scholar
  497. Landbeck, G., Gaedicke, G., Winkler, K., Stein, H.: Besonderheiten der malignen Lymphome im Kindesalter. In: Maligne Lymphome und monoklonale Gammopathien. Hämatologie und Bluttransfusion, Bd. 18, pp. 225–235. Löffler, H., Ed. München: Lehmanns 1976Google Scholar
  498. Landberg, T., Garwicz, S., Åkerman, M.: A clinico-pathological study of non-Hodgkin’s lymphomata in childhood. Brit. J. Cancer 31, Suppl. II, 332–336 (1975)Google Scholar
  499. Lane, C.G., Greenwood, A.M.: Lymphoblastoma (mycosis fungoides) and hemorrhagic sarcoma of Kaposi in the same person. Arch. Derm. Syph. (Chic.) 27, 643–657 (1933)Google Scholar
  500. Laszlo, J., Gerber, H.J., Sommer, J.R.: Composition and structure of cytoplasmic globules in leukemic lymphocytes. Blood 29, 77–86 (1967)PubMedGoogle Scholar
  501. Le Beux, Y., Ganter, P.: Étude histopathologique et cytologique de la maladie de Waldenström. (À propos de 8 cas de macroglobulinémie.) Ann. Anat. path. 8, 377–416 (1963)Google Scholar
  502. Leder, L.-D.: Über die selektive fermentcytochemische Darstellung von neutrophilen myeloischen Zellen und Gewebsmastzellen im Paraffinschnitt. Klin. Wschr. 42, 553 (1964)PubMedGoogle Scholar
  503. Leder, L.-D.: Fermenthistochemische Befunde bei chronischer Erythroblastose und akuter Erythrämie. Klin. Wschr. 43, 795–796 (1965)PubMedGoogle Scholar
  504. Leder, L.-D.: Der Blutmonocyt. (Experimentelle Medizin, Pathologie und Klinik, Bd. 23.) Berlin-Heidelberg-New York: Springer 1967aGoogle Scholar
  505. Leder, L.-D.: Die fermentcytochemische Erkennung normaler und neoplastischer Erythropoesezellen in Schnitt und Ausstrich. Blut 15, 289–293 (1967b)PubMedGoogle Scholar
  506. Leder, L.-D.: Die Herkunft der Blutmonozyten und ihre Beziehungen zu den sog. Histiozyten. In: Der Monozyt. Hämatologie und Bluttransfusion, Bd. 7, pp. 19–26. Brücher, H., Ed. München: Lehmanns 1969 aGoogle Scholar
  507. Leder, L.-D.: On the PAS reaction in acute paraerythroblastic hemoblastoses. Acta haemat. (Basel) 41, 328–330 (1969b)Google Scholar
  508. Leder, L.-D.: Zur Praxis der bioptischen Hämoblastosediagnostik mit zytochemischen Methoden. Beitr. Path. 141, 396–401 (1970)Google Scholar
  509. Leder, L.-D.: Diagnostic application of cytochemistry in hematology. Proc. 8. Wld Congr. of Anat. Clin. Path., Munich, Sept. 1972. Int. Congr. Ser. No. 285: Anatomic and Clinical Pathology, pp. 105–109. Amsterdam: Excerpta Medica 1973Google Scholar
  510. Leder, L.-D., Lennert, K.: Über iatrogene Lymphknotenveränderungen. Verh. dtsch. Ges. Path. 56, 310–320 (1972)Google Scholar
  511. Leder, L.-D., Stutte, H.J.: Seminar für hämatologisch-zytochemische Techniken. Verh. dtsch. Ges. Path. 59, 503–509 (1975)Google Scholar
  512. Lee, S.L., Rosner, F., Ruberman, W., Glasberg, S.: Mu-chain disease. Ann. intern. Med. 75, 407–414 (1971)PubMedGoogle Scholar
  513. Leech, J.H., Glick, A.D., Waldron, J.A., Flexner, J.M., Horn, R.G., Collins, R.D.: Malignant lymphomas of follicular center cell origin in man. I. Immunologic studies. J. nat. Cancer Inst. 54, 11–21 (1975)PubMedGoogle Scholar
  514. van Leeuwen, A.W.F.M., Meijer, C.J.L.M., de Man, J.C.H.: T-cell membrane characteristics of ‘mycosis cells’ in the skin and lymph node. J. invest. Derm. 65, 367–369 (1975)PubMedGoogle Scholar
  515. Leibetseder, F.: Lymphdrüsenpunktion beim großfollikulären Lymphoblastom. Klin. Med. (Wien) 4, 131–135 (1949)Google Scholar
  516. Leibetseder, F., Tuba, J.: Splenektomie bei Lymphomen. Folia haemat. (Frankfurt) N.F. 1, 116–131 (1956)Google Scholar
  517. Lejeune, F., Turpin, F., Lecouturier, J.-P., Bouvier, J.-B., Lortholary, P.: Plasmocytome ganglionnaire. Association à une anémie hémolytique à auto-anticorps avec agglutinines froides. Nouv. Presse méd. 1, 1065–1068 (1972)PubMedGoogle Scholar
  518. Lelbach, W.K.: Ein Beitrag zur Morphologie der Makroglobulinämie Waldenström. Frankfurt. Z. Path. 68, 440–464 (1957)PubMedGoogle Scholar
  519. Lemerle, M., Gérard-Marchant, R., Sancho, H., Schweisguth, O.: Natural history of non- Hodgkin’s malignant lymphomata in children. A retrospective study of 190 cases. Brit. J. Cancer 31, Suppl. II, 324–331 (1975)Google Scholar
  520. Lennert, K.: Über Morphologie und Mechanismus der Urethanwirkung. Klin. Wschr. 26, 735–736 (1948)Google Scholar
  521. Lennert, K.: Zur Praxis der pathologisch-anatomischen Knochenmarksuntersuchung. Frankfurt. Z. Path. 63, 267–299 (1952a)PubMedGoogle Scholar
  522. Lennert, K.: Zur histologischen Diagnose der Lymphogranulomatose. Habil. Schrift Frankfurt/M. 1952bGoogle Scholar
  523. Lennert, K.: Die pathologische Anatomie der Makroglobulinämie Waldenström. Frankfurt. Z. Path. 66, 201–226 (1955)PubMedGoogle Scholar
  524. Lennert, K.: Über die Erkennung von Keimzentrumszellen im Lymphknotenausstrich. Klin. Wschr. 35, 1130–1132 (1957)PubMedGoogle Scholar
  525. Lennert, K.: Über Morphologie, Funktion und maligne Neoplasien der Lymphocyten. Z. Hautu. Geschl.-Kr. 28, 389–406 (1960)Google Scholar
  526. Lennert, K.: Lymphknoten. Diagnostik in Schnitt und Ausstrich. Bandteil A: Cytologie und Lymphadenitis. Handbuch der speziellen pathologischen Anatomie und Histologie 1, 3A. Lubarsh, O., Henke, F., Rössle, R., Uehlinger, E., (Eds.). Berlin-Göttingen-Heidelberg: Springer 1961Google Scholar
  527. Lennert, K.: Pathologie der Halslymphknoten. Ein Abriß für Pathologen, Kliniker und praktizierende Ärzte. Berlin-Göttingen-Heidelberg-New York: Springer 1964aGoogle Scholar
  528. Lennert, K.: Zur normalen und pathologischen Histologie hautnaher Lymphknoten. In: Handbuch der Haut- und Geschlechtskrankheiten. Ergänzungswerk 1, 2: Normale und pathologische Anatomie der Haut II, pp. 830–896. Berlin-Göttingen-Heidelberg-New York: Springer 1964bGoogle Scholar
  529. Lennert, K.: Classification of malignant lymphomas (European concept). In: Progress in Lymphology, pp. 103–109. Rüttimann, A., Ed. Stuttgart: G. Thieme 1967Google Scholar
  530. Lennert, K.: Pathologisch-anatomische Klassifikation der malignen Lymphome. Strahlentherapie, Sonderbd. 69, 1–7 (1969a)Google Scholar
  531. Lennert, K.: Die derzeitige Häufigkeit der einzelnen Lymphknotenerkrankungen in Schleswig-Holstein. Dtsch. med. Wschr. 94, 2194–2202 (1969b)PubMedGoogle Scholar
  532. Lennert, K.: Germinal centers and germinal center neoplasms. Acta haemat. jap. 32, 495–500 (1969 c)PubMedGoogle Scholar
  533. Lennert, K.: Pathologie und Klassifikation der malignen Lymphome. Paper presented at the Congr. of Jap. Soc. Path., Fukuoka 1969dGoogle Scholar
  534. Lennert, K.: Follicular lymphoma: A special entity of malignant lymphomas. In: Plenary Session Papers. 1. Meeting Europ. Div. of Int. Soc. of Haemat., Milano 1971, pp. 109–122. Milano: Arti Grafiche Fratelli Ferrari 1971Google Scholar
  535. Lennert, K.: Follicular lymphoma and other malignant lymphomas as neoplasias of the B cell system. Symposium at the 9. Int. Congr. of the Int. Academy of Path., Helsinki/Finland, Sept. 1972Google Scholar
  536. Lennert, K.: Follicular lymphoma. A tumor of the germinal centers. In: Malignant Diseases of the Hematopoietic System. GANN Monograph on Cancer Research, Vol. 15, pp. 217–231. Akazaki, K., Rappaport, H., Berard, C.W., Bennett, J.M., Ishikawa, E., Eds. Tokyo: University of Tokyo Press 1973 aGoogle Scholar
  537. Lennert, K.: Ancillary approaches to the cellular identification and classification of non-Hodgkin’s lymphomas. A) Histochemistry and immunochemistry. Paper presented at a workshop on non-Hodgkin’s-lymphomas, Chicago 1973 bGoogle Scholar
  538. Lennert, K.: Pathologisch-histologische Klassifizierung der malignen Lymphome. In: Leukämien und maligne Lymphome, pp. 181–194. Stacher, A., Ed. München-Berlin-Wien: Urban & Schwarzenberg 1973 cGoogle Scholar
  539. Lennert, K.: Origin of malignant lymphomas. [Letter to the Editor.] Lancet 1974a, II, p. 586Google Scholar
  540. Lennert, K.: The germinal centers and their tumors. [Span.] Patologia 7, 81–88 (1974b)Google Scholar
  541. Lennert, K.: Reticuloses and Reticulosarcoma. [Span.] Patologia 7, 35–38 (1974c)Google Scholar
  542. Lennert, K.: Morphology and classification of malignant lymphomas and so-called reticuloses. In: Malignant Lymphomas of the Nervous System. Jellinger, K., Seitelberger, F., Eds. Acta neuropath. (Berlin) Suppl. 6, 1–16 (1975)Google Scholar
  543. Lennert, K.: Klassifikation und Morphologie der Non-Hodgkin-Lymphome. In: Maligne Lymphome und monoklonale Gammopathien. Hämatologie und Bluttransfusion, Bd. 18, pp. 145–166. Löffler, H., Ed. München: Lehmanns 1976Google Scholar
  544. Lennert, K., Elschner, H.: Zur Kenntnis der lipomelanotischen Reticulo(cyto)se. Frankfurt. Z. Path. 65, 559–577 (1954)PubMedGoogle Scholar
  545. Lennert, K., Illert, E.: Die Häufigkeit der Gewebsmastzellen im Lymphknoten bei verschiedenen Erkrankungen. Frankfurt. Z. Path. 70, 121–131 (1959)PubMedGoogle Scholar
  546. Lennert, K., Kaiserling, E., Müller-Hermelink, H.K.: T-associated plasma-cells. [Letter to the Editor.] Lancet 1975, I, pp. 1031–1032Google Scholar
  547. Lennert, K., Leder, L.-D., Löffler, H.: Fermenthistochemische Untersuchungen des Lymphknotens. V. Mitt. Saure Phosphatase in Schnitt und Ausstrich. Virchows Arch. path. Anat. 338, 285–304 (1965)Google Scholar
  548. Lennert, K., Löffler, H., Grabner, F.: Fermenthistochemische Untersuchungen des Lymphknotens. IV. Mitt. Esterase in Schnitt und Ausstrich. Virchows Arch. path. Anat. 335, 491–512 (1962)Google Scholar
  549. Lennert, K., Löffler, H., Leder, L.-D.: Fermenthistochemische Untersuchungen des Lymphknotens. I. Mitt. Alkalische Phosphatase in Schnitt und Ausstrich. Virchows Arch. path. Anat. 334, 399–418 (1961)Google Scholar
  550. Lennert, K., Löffler, H., Leder, L.-D.: Fermenthistochemische Untersuchungen am lymphoretikulären Gewebe. In: Zyto- und Histochemie in der Hämatologie, pp. 363–383. Merker, H., Ed. Berlin-Göttingen-Heidelberg: Springer 1963Google Scholar
  551. Lennert, K., Mestdagh, J.: Lymphogranulomatosen mit konstant hohem Epitheloidzellgehalt. Virchows Arch. A 344, 1–20 (1968)Google Scholar
  552. Lennert, K., Mohri, N.: Zur Pathologie der Leukämien und malignen Lymphome im Kindesalter. (Referat) Verh. dtsch. Ges. Path. 55, 216–269 (1971)Google Scholar
  553. Lennert, K., Mohri, N.: Histologische Klassifizierung und Vorkommen des M. Hodgkin. Internist 15, 57–65 (1974)Google Scholar
  554. Lennert, K., Mohri, N., Stein, H., Kaiserling, E.: The histopathology of malignant lymphoma. Brit. J. Haemat. 31 (Suppl.), 193–203 (1975)Google Scholar
  555. Lennert, K., Nagai, K., Schwarze, E.-W.: Patho-anatomical features of the bone marrow. Clin. Haemat. 4, 331–351 (1975)PubMedGoogle Scholar
  556. Lennert, K., Stein, H., Kaiserling, E.: New criteria for the classification of malignant lymphomas. In: Present Problems in Haematology, pp. 113–119. Líbanský, J., Donner, L., Eds. Amsterdam: Excerpta Medica 1974Google Scholar
  557. Lennert, K., Stein, H., Kaiserling, E.: Cytological and functional criteria for the classification of malignant lymphomata. Brit. J. Cancer 31, Suppl. II, 29–43 (1975)Google Scholar
  558. Levine, P.H., Cho, B.R., Connelly, R.R., Berard, C.W., O’Conor, G.T., Dorfman, R.F., Easton, J.M., DeVita, V.T.: The American Burkitt lymphoma registry: A progress report. Ann. intern. Med. 83, 31–36 (1975)PubMedGoogle Scholar
  559. Li, F.P., Willard, D.R., Goodman, R., Vawter, G.: Malignant lymphoma after diphenylhydantoin (Dilantin) therapy. Cancer (Philad.) 36, 1359–1362 (1975)Google Scholar
  560. Liebow, A.A., Carrington, C.B.: Diffuse pulmonary lymphoreticular infiltrations associated with dysproteinemia. Med. Clin. N. Amer. 57, 809–843 (1973)PubMedGoogle Scholar
  561. Lille, I., Desplaces, A., Meeus, L., Saracino, R.T., Brouet, J.C.: Thymus-derived proliferating lymphocytes in chronic lymphocytic leukaemia. Lancet 1973, II, pp. 263–264Google Scholar
  562. Lindqvist, K.J., Ragab, A.H., Osterland, C.K.: Paraproteinemia in a child with leukemia. Blood 35, 213–221 (1970)PubMedGoogle Scholar
  563. Linke, A., Freudenberger, B.: Über die Chemotherapie der Hämoblastosen und malignen Tumoren. In: Symposien aktueller therapeutischer Probleme, H. 3, pp. 38–134. Stuttgart: F. Enke 1960Google Scholar
  564. Litovitz, T.L., Lutzner, M.A.: Quantitative measurements of blood lymphocytes from patients with chronic lymphocytic leukemia and the Sézary syndrome. J. nat. Cancer Inst. 53, 75–77 (1974)PubMedGoogle Scholar
  565. Löffler, H.: Zur Differenzierung unreifzelliger (akuter) Leukosen mit cytochemischen Methoden. Folia haemat. (Frankfurt) N.F. 8, 112–117 (1963)Google Scholar
  566. Löffler, H.: Eine Klassifizierung als Grundlage der Behandlung unreifzelliger Leukosen. In: Hämatologie u. Bluttransfusion 8, 105–107. München: J.F. Lehmanns 1969aGoogle Scholar
  567. Löffler, H.: Zytochemische Klassifizierung der akuten Leukosen. In: Chemo- und Immuntherapie der Leukosen und malignen Lymphome, pp. 120–127. Stacher, A., Ed. Wien: Bohmann 1969bGoogle Scholar
  568. Löffler, H.: Cytologische Befunde beim Sézary-Syndrom. Verh. dtsch. Ges. inn. Med. 78, 285–287 (1972 a)PubMedGoogle Scholar
  569. Löffler, H.: Cytochemie bei Leukosen: Einleitung und Übersicht. In: Leukämie, pp. 119–126. Gross, R., van de Loo, J., Eds. Berlin-Heidelberg-New York: Springer 1972bGoogle Scholar
  570. Löffler, H.: Indications and limits of cytochemistry in acute leukemia. In: Recent Results in Cancer Res. 43, 57–62. Berlin-Heidelberg-New York: Springer 1973Google Scholar
  571. Löffler, H., Graubner, M., Desaga, J.F., Jung, M.: Prolymphocytic leukemia with T cell properties and tartrate resistant acid phosphatase. In: Immunological Diagnosis of Leukemias and Lymphomas. Haematology and Blood Transfusion, Vol. 20, pp. 175–178. Thierfelder, S., Rodt, H., Thiel, E., Eds. Berlin-Heidelberg-New York: Springer 1977Google Scholar
  572. Löffler, H., Kaltenbach, T.: Koexistenz von chronischer lymphatischer Leukämie und Lymphogranulomatose bei zwei Patienten. Verh. dtsch. Ges. inn. Med. 75, 513–515 (1969)PubMedGoogle Scholar
  573. Löffler, H., Meyhöfer, W., Lange, R.H., Ehlers, G., Remmele, W.: Sézary-Syndrom — eine leukämische Variante der Mykosis fungoides. Dtsch. med. Wschr. 99, 429–434 (1974)PubMedGoogle Scholar
  574. Löffler, H., Pralle, H., Lück, R., Fischer, J., Roux, A.: Behandlungsergebnisse bei cytochemisch klassifizierten unreifzeiligen Leukosen. Verh. dtsch. Ges. inn. Med. 79, 357–360 (1973)PubMedGoogle Scholar
  575. Löffler, H., Pralle, H., Lück, R., Fischer, J., Roux, A.: Der cytochemisch ermittelte Leukosetyp als prognostischer Parameter bei unreifzeiligen Leukosen. Klin. Wschr. 52, 134–137 (1974)PubMedGoogle Scholar
  576. Loesch, J.: Systematische reticulo-endotheliale Hyperplasien mit tumorähnlichen Bildungen in einem Falle von chronischer lymphatischer Leukämie. Frankfurt. Z. Path. 44, 351–359 (1933)Google Scholar
  577. Long, J.C., Aisenberg, A.C.: Richter’s syndrome. A terminal complication of chronic lymphocytic leukemia with distinct clinicopathologic features. Amer. J. clin. Path. 63, 786–795 (1975)Google Scholar
  578. Long, J.C., Mihm, M.C.: Mycosis fungoides with extracutaneous dissemination: A distinct clinicopathologic entity. Cancer (Philad.) 34, 1745–1755 (1974)Google Scholar
  579. Lorbacher, P., Yam, L.T., Mitus, W.J.: Cytochemical demonstration of β-glucuronidase activity in blood and bone marrow cells. J. Histochem. Cytochem. 15, 680–687 (1967)PubMedGoogle Scholar
  580. Lorenz, W.: Über die Bedeutung der Lymphknotenpunktion für die Strahlenheilkunde. Strahlentherapie 79, 435–464 (1949)Google Scholar
  581. Lortholary, P., Boiron, M., Ripault, J., Levacher, A., Mielot, F., Bernard, J.: Trois observations de transformation aiguë d’hémopathies lymphocytaires chroniques. Nouv. Rev. franç, Hémat. 6, 637–656 (1966)Google Scholar
  582. Lortholary, P., Boiron, M., Ripault, P., Levy, J.P., Manus, A., Bernard, J.: Leucémie lymphoide chronique secondairement associée à une réticulopathie maligne, syndrome de Richter. Nouv. Rev. franç. Hémat. 4, 621–644 (1964)Google Scholar
  583. Louwagie, A.C., Desmet, V.J., van den Berghe, H.: Coexistence of a myelo- and lymphoproliferative disorder. Scand. J. Haemat. 11, 350–355 (1973)PubMedGoogle Scholar
  584. Lowenbraun, S., Sutherland, J.C., Feldman, M.J., Serpick, A.A.: Transformation of reticulum cell sarcoma to acute leukemia. Cancer (Philad.) 27, 579–585 (1971)Google Scholar
  585. Loyau, G., Barré, J.P., L’Hirondel, J.L., Lanièce, M., Preud’Homme, J.L.: Maladie des chaînes lourdes gamma. À propos d’une nouvelle observation. Nouv. Presse méd. 4, 957–959 (1975)PubMedGoogle Scholar
  586. Lucas, P.F.: Lymph node smears in the diagnosis of lymphadenopathy: a review. Blood 10, 1030–1054 (1955)PubMedGoogle Scholar
  587. Lüdin, H.: Die Organpunktion in der klinischen Diagnostik. Basel: S. Karger 1955Google Scholar
  588. Lukes, R.J.: The American concept of malignant lymphoma. Saishin Igaku 19, 1630–1648 (1964)Google Scholar
  589. Lukes, R.J.: A review of the American concept of malignant lymphoma. The evolution of a modern classification. In: Progress in Lymphology. Proc. of Int. Symp. on Lymphology, Zurich, July 1966, pp. 109–119. Rüttimann, A., Ed. Stuttgart: G. Thieme 1967Google Scholar
  590. Lukes, R.J.: The pathologic picture of the malignant lymphomas. In: Proceedings of the International Conference on Leukemia-Lymphoma, pp. 333–356. Zarafonetis, C.J.D., Ed. Philadelphia: Lea & Febiger 1968Google Scholar
  591. Lukes, R.J.: Discussion. Workshop on Non-Hodgkin’s Lymphomas, Chicago, June 1973Google Scholar
  592. Lukes, R.J., Collins, R.D.: New observations on follicular lymphoma. In: Malignant Diseases of the Hematopoietic System. GANN Monograph on Cancer Research, Vol. 15, pp. 209–215. Akazaki, K., Rappaport, H., Berard, C.W., Bennett, J.M., Ishikawa, E., Eds. Tokyo: University of Tokyo Press 1973Google Scholar
  593. Lukes, R.J., Collins, R.D.: A functional approach to the classification of malignant lymphoma. In: Recent Results in Cancer Res. 46, 18–30. Berlin-Heidelberg-New York: Springer 1974aGoogle Scholar
  594. Lukes, R.J., Collins, R.D.: Immunologic characterization of human malignant lymphomas. Cancer (Philad.) 34, 1488–1503 (1974b)Google Scholar
  595. Lukes, R.J., Collins, R.D.: New approaches to the classification of the lymphomata. Brit. J. Cancer 31, Suppl. II, 1–28 (1975a)Google Scholar
  596. Lukes, R.J., Collins, R.D.: A functional classification of malignant lymphomas. In: The Reticuloendothelial System. Monographs in Pathology, No. 16, pp. 213–242. Rebuck, J.W., Berard, C.W., Abell, M.R., Eds. Baltimore: Williams & Wilkins 1975bGoogle Scholar
  597. Lukes, R.J., Lennert, K.: Malignant lymphoma, Slide Seminar. 10. Int. Congr. Int. Acad. Path., Hamburg 1974Google Scholar
  598. Lukes, R.J., Tindle, B.H.: Workshop on Classification of Non-Hodgkin’s Lymphomas, Chicago, June 1973Google Scholar
  599. Lukes, R.J., Tindle, B.H.: Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin’s disease. New Engl. J. Med. 292, 1–12 (1975)PubMedGoogle Scholar
  600. Lumb, G.: Tumours of Lymphoid Tissue. Edinburgh-London: Livingstone 1954Google Scholar
  601. Lumb, G., Newton, K.A.: Prognosis in tumors of lymphoid tissue. An analysis of 602 cases. Cancer (Philad.) 10, 976–993 (1957)Google Scholar
  602. Lutzner, M.A., Emerit, I., Durepaire, R., Flandrin, G., Grupper, C., Prunieras, M.: Cytogenetic, cytophotometric, and ultrastructural study of large cerebriform cells of the Sézary syndrome and description of a small-cell variant. J. nat. Cancer Inst. 50, 1145–1162 (1973)PubMedGoogle Scholar
  603. Lutzner, M.A., Hobbs, J.W., Horvath, P.: Ultrastructure of abnormal cells. In Sezary syndrome, mycosis fungoides, and parapsoriasis en plaque. Arch. Derm. 103, 375–386 (1971)PubMedGoogle Scholar
  604. Lutzner, M.A., Jordan, H.W.: The ultrastructure of an abnormal cell in Sézary’s syndrome. Blood 31, 719–726 (1968)PubMedGoogle Scholar
  605. Machado, J.C., Jamra, M., Okuyama, M.H., Marigo, C.: Lymphoreticular tumors in Sao Paulo, Brazil. J. nat. Cancer Inst. 50, 1651–1655 (1973)PubMedGoogle Scholar
  606. Mackenzie, M.R., Fudenberg, H.H.: Macroglobulinemia: An analysis for forty patients. Blood 39, 874–889 (1972)PubMedGoogle Scholar
  607. Märki, H.H., Siegenthaler, R.: Über eine unter dem Bilde einer Paraleukoblastenleukämie verlaufende Form der Makroglobulinämie. Schweiz. med. Wschr. 94, 1557–1561 (1964)Google Scholar
  608. Magrath, I.T.: Burkitt’s lymphoma: A B or T cell tumour? Europ. J. Cancer 10, 83–88 (1974)Google Scholar
  609. Maldonado, J.E., Williams, Jr., R.C., Silverstein, M.N., Harrison, Jr., E.G.: Lymphosarcoma with Bence-Jones proteinuria (type K) and IgG serum M-component (type L): A bitypic gammopathy. Mayo Clin. Proc. 45, 413–425 (1970)PubMedGoogle Scholar
  610. Mallarmé, J.: L’adénogramme des sarcomes ganglionnaires. Sang 26, 553–568 (1955)PubMedGoogle Scholar
  611. de Man, J.C.H., Meiners, W.B.H.: Crystals of protein nature in the cytoplasm of lymphatic cells in a case of lymphoreticular malignancy. Blood 20, 492–500 (1962)Google Scholar
  612. Mann, R.B., Jaffe, E.S., Braylan, R.C., Eggleston, J.C., Ransom, L., Kaizer, H., Berard, C.W.: Immunologic and morphologic studies of T cell lymphoma. Amer. J. Med. 58, 307–313 (1975)PubMedGoogle Scholar
  613. Mann, R.B., Jaffe, E.S., Braylan, R.C., Nanba, K., Frank, M.M., Ziegler, J.L., Berard, C.W.: Non-endemic Burkitt’s lymphoma. A B-cell tumor related to germinal centers. New Engl. J. Med. 295, 685–691 (1976)PubMedGoogle Scholar
  614. Mann, H.B., Whitney, D.R.: On a test of whether one of two random variables is stochastically larger than the other. Ann. math. Statist. 18, 50–60 (1947)Google Scholar
  615. Manolov, G., Manolova, Y.: Marker band in one chromosome 14 from Burkitt lymphomas. Nature (Lond.) 237, 33–34 (1972)Google Scholar
  616. Marchal, G., Fine, J.-M., Bilski-Pasquier, G.: Macroglobulinémie dans un cas de leucose plasmo-cytaire. Presse méd. 70, 425–428 (1962)PubMedGoogle Scholar
  617. Maresch, R.: Über ein plasmazelluläres Lymphogranulom. Verh. dtsch. Ges. Path. 13, 257–263 (1909)Google Scholar
  618. Marin-Padilla, M., Fahimi, H.D., Moloney, W.C.: Leukemic reticulum-cell sarcoma (reticulumcell sarcoma terminating in acute leukemia). Report of two cases and review of the literature. Amer. J. clin. Path. 41, 402–410 (1964)Google Scholar
  619. Marsden, H.B., Steward, J.K.: Non-leukaemic reticuloendothelial tumours and leucosarcomas. In: Tumours in Children. Recent Results in Cancer Research, Vol. 13, pp. 63–85. Marsden, H.B., Steward, J.K., Eds. Berlin-Heidelberg-New York: Springer 1968Google Scholar
  620. Marshall, A.H.E.: An Outline of the Cytology and Pathology of the Reticular Tissue, p. 129ff. Edinburgh-London: Oliver & Boyd 1956.Google Scholar
  621. Martini, G.A., Wenderoth, H.: Zur Klinik und Pathologie des follikulären Lymphoblastoms (Brill-Symmers). Z. klin. Med. 147, 235–260 (1950)Google Scholar
  622. Mathé, G., Belpomme, D., Dantchev, D., Khalil, A., Afifi, A.M., Taleb, N., Pouillart, P., Schwarzenberg, L., Hayat, M., de Vassal, F., Jasmin, C., Misset, J.L., Musset, M.: Immunoblastic lymphosarcoma, a cytological and clinical entity? Biomedicine 22, 473–488 (1975)PubMedGoogle Scholar
  623. Mathé, G., Belpomme, D., Dantchev, D., Pouillart, P., Jasmin, C., Misset, J.L., Musset, M., Amiel, J.L., Schlumberger, J.R., Schwarzenberg, L., Hayat, M., de Vassal, F., Lafleur, M.: Immunoblastic acute lymphoid leukaemia: An undescribed type. Biomedicine 20, 333–340 (1974)PubMedGoogle Scholar
  624. Mathé, G., Belpomme, D., Dantchev, D., Pouillart, P., Navares, L., Hauss, G., Schlumberger, J.R., Lafleur, M.: Search for correlations between cytological types and therapeutic sensitivity of acute leukaemias. Blood Cells 1, 37–52 (1975)Google Scholar
  625. Mathé, G., Gérard-Marchant, R., Texier, J.L., Schlumberger, J.R., Berumen, L., Paintrand, M.: The two varieties of lymphoid tissue “reticulosarcomas”, histiocytic and histioblastic types. Brit. J. Cancer 24, 687–695 (1970)PubMedGoogle Scholar
  626. Mathé, G., Pouillart, P., Sterescu, M., Amiel, J.L., Schwarzenberg, L., Schneider, M., Hayat, M., de Vassal, F., Jasmin, C., Lafleur, M.: Subdivision of classical varieties of acute leukemia. Correlation with prognosis and cure expectancy. Europ. J. clin. biol. Res. 16, 554–560 (1971)Google Scholar
  627. Mathé, G., Pouillart, P., Weiner, R., Hayat, M., Steresco, M., Lafleur, M.: Classification and subclassification of acute leukemias correlated with clinical expression, therapeutic sensitivity and prognosis. In: Nomenclature, Methodology and Results of Clinical Trials in Acute Leukemias. Recent Results in Cancer Research, Vol. 43, pp. 6–20. Mathé, G., Pouillart, P., Schwarzenberg, L., Eds. Berlin-Heidelberg-New York: Springer 1973Google Scholar
  628. Mathé, G., Rappaport, H., O’Conor, G.T., Torloni, H.: Histological and cytological typing of neoplastic diseases of haematopoietic and lymphoid tissues. (International Histological Classification of Tumors, No. 14.) Geneva: World Health Organization 1976Google Scholar
  629. Mayer, Jr., S., Thomas, H.M.: Follicular lymphoblastoma and a related form of lymphosarcoma. Bull. Johns Hopkins Hosp. 64, 315–338 (1939)Google Scholar
  630. McKenna, R.W., Bloomfield, C.D., Brunning, R.D.: Nodular lymphoma: Bone marrow and blood manifestations. Cancer (Philad.) 36, 428–440 (1975)Google Scholar
  631. McNutt, D.R., Fudenberg, H.H.: IgG myeloma and Waldenström macroglobulinemia. Arch. intern. Med. 131, 731–734 (1973)PubMedGoogle Scholar
  632. Meister, H., Fuchs, R.: Zytochemie der malignen Erythroblastose. Folia haemat. (Lpz.) 98, 71–80 (1972)Google Scholar
  633. Michaux, J.-L., Heremans, J.F.: Thirty cases of monoclonal immunoglobulin disorders other than myeloma or macroglobulinemia. A classification of diseases associated with the production of monoclonal-type immunoglobulins. Amer. J. Med. 46, 562–579 (1969)PubMedGoogle Scholar
  634. Michlmayr, G., Huber, C., Fink, U., Falkensammer, M., Huber, H.: T-Lymphozyten in peripherem Blut und Lymphknoten bei lymphatischen Systemerkrankungen. Schweiz. med. Wschr. 104, 815–820 (1974)PubMedGoogle Scholar
  635. Michlmayr, G., Pathouli, C., Falkensammer, M., Huber, C., Huber, H., Braunsteiner, H.: Rosettentests bei lymphoproliferativen Erkrankungen. Schweiz. med. Wschr. 106, 794–799 (1976)PubMedGoogle Scholar
  636. Mielke, H.-G.: Serumeiweiß-Befunde beim Retothel- und Lympho-Sarkom. Ärztl. Wschr. 11, 1086–1089 (1956)Google Scholar
  637. Miller, D.G.: Immunological deficiency and malignant lymphoma. Cancer (Philad.) 20, 579–588 (1967 a)Google Scholar
  638. Miller, D.G.: The association of immune disease and malignant lymphoma. Ann. intern. Med. 66, 507–521 (1967 b)PubMedGoogle Scholar
  639. Millett, Y.L., Bennett, M.H., Jelliffe, A.M., Farrer-Brown, G.: Nodular sclerotic lymphosarcoma. A further review. Brit. J. Cancer 23, 683–692 (1969)PubMedGoogle Scholar
  640. Minowada, J., Klein, G., Clifford, P., Klein, E., Moore, G.E.: Studies of Burkitt lymphoma cells. I. Establishment of a cell line (B35M) and its characteristics. Cancer (Philad.) 20, 1430–1437 (1967)Google Scholar
  641. Mintz, U., Sachs, L.: Changes in the surface membrane of lymphocytes from patients with chronic lymphocytic leukemia and Hodgkin’s disease. Int. J. Cancer 15, 253–259 (1975)PubMedGoogle Scholar
  642. Missmahl, H.P.: Amyloidose. Klinik, Therapie, Prognose. Fortschr. Med. 85, 621–626 (1967)Google Scholar
  643. Missmahl, H.P.: Amyloidosen bei chronisch-rheumatischen Erkrankungen. Verh. dtsch. Ges. inn. Med. 74, 1102–1116 (1968)PubMedGoogle Scholar
  644. Missmahl, H.P., Gafni, J.: Peri-collagen and peri-reticular amyloidoses — their differentiation by polarization microscopy. Path. et Microbiol. (Basel) 27, 826–832 (1964)Google Scholar
  645. Mitchell, L.A.: Malignant monoblastoma. A variant of monocytic leukemia. Ann. intern. Med. 8, 1387–1403 (1935)Google Scholar
  646. Mitrou, P., Schubert, J.C.F., Martin, H.: Die Behandlung der Makroglobulinämie Waldenström mit Procarbazin. Dtsch. med. Wschr. 97, 1864–1869 (1972)PubMedGoogle Scholar
  647. Mitus, A.: Presentation at Meeting of the International Society of Paediatric Oncology, Manchester, October 1972.Google Scholar
  648. Mitus, W.J., Bergna, L.J., Mednicoff, I.B., Dameshek, W.: Cytochemical studies of glycogen content of lymphocytes in lymphocytic proliferations. Blood 13, 748–756 (1958)PubMedGoogle Scholar
  649. Mitus, W.J., Mednicoff, I.B., Wittels, B., Dameshek, W.: Neoplastic lymphoid reticulum cells in the peripheral blood: A histochemical study. Blood 17, 206–215 (1961)PubMedGoogle Scholar
  650. Moeschlin, S.: Klinik der Reticulosen — mit speziellem Hinweis auf Sensibilisierungserscheinungen durch die gebildeten Paraproteine. Helv. med. Acta 28, 306–338 (1961)PubMedGoogle Scholar
  651. Moeschlin, S.: Macroglobulinemia Waldenström with miliary lung infiltrations and terminal plasmacell-leukemia. Acta med. scand. Suppl. 445, 154–162 (1966)Google Scholar
  652. Mohr, U., Kinzel, V.: Das Burkitt-Lymphom. Dtsch. med. Wschr. 93, 2229–2231 (1968)PubMedGoogle Scholar
  653. Mollo, F., Monga, G., Coda, R., Palestro, G.: Ultrastructural features of human lymphomas. Acta neuropath. (Berl.) Suppl. 6, 17–20 (1975)Google Scholar
  654. Moore, D.F., Migliore, P.J., Shullenberger, C.C., Alexanian, R.: Monoclonal macroglobulinemia in malignant lymphoma. Ann. intern. Med. 72, 43–47 (1970)PubMedGoogle Scholar
  655. Moore, G.E., Minowada, J.: T or B lymphocytes in chronic lymphocytic leukemia. Lancet 1972, I, pp. 38–39Google Scholar
  656. Mori, Y., Lennert, K.: Electron microscopic atlas of lymph node cytology and pathology. Berlin-Heidelberg-New York: Springer 1969Google Scholar
  657. Morrison, M., Samwick, A.A., Rubinstein, J., Stich, M., Loewe, L.: Lymph node aspiration. Am. J. clin. Path. 22, 255–262 (1952)PubMedGoogle Scholar
  658. Morrow, R.H., Pike, M.C., Kisuule, A.: Survival of Burkitt’s lymphoma patients in Mulago Hospital, Uganda. Brit. med. J. 1967, IV, pp. 323–327Google Scholar
  659. Morrow, R.H., Pike, M.C., Smith, P., Ziegler, J.L.: Preliminary epidemiological findings of Burkitt’s lymphoma in the Mengo Districts, Uganda, 1959–1968. [Abstr.] Cancer Res. 34, 1211–1212 (1974)PubMedGoogle Scholar
  660. Moss, W.T., Ackerman, L.V.: Plasma cell leukemia. Blood 1, 396–406 (1946)PubMedGoogle Scholar
  661. Mueller, J., Brun del Re, G., Buerki, H., Keller, H.-U., Hess, M.W., Cottier, H.: Nonspecific esterase activity: A criterion for differentiation of T and B lymphocytes in mouse lymph nodes. Europ. J. Immunol. 5, 270–274 (1975)Google Scholar
  662. Müller-Hermelink, H.K., Kaiserling, E.: Seminar für elektronenmikroskopisch-histochemische Techniken. Verh. dtsch. Ges. Path. 59, 522–527 (1975)Google Scholar
  663. Müller-Hermelink, H.K., Kaiserling, E., Lennert, K.: Pseudofollikuläre Nester von Plasmazellen (eines besonderen Typs?) in der paracorticalen Pulpa menschlicher Lymphknoten. Virchows Arch. B 14, 47–56 (1973)Google Scholar
  664. Mundt, E.: Das Retothelsarkom und die Retothelsarkomatose. Ergebn. inn. Med. Kinderheilk. N.F. 3, 365–374 (1952)Google Scholar
  665. Musger, A.: Zur Kenntnis der Reticulohistiocytosen der Haut. Hautarzt 5, 56–62 (1954)PubMedGoogle Scholar
  666. Musger, A.: Erythrodermatische Retikulose der Haut mit analogen feingeweblichen Veränderungen der hautnahen Lymphknoten und subleukämischem Blutbild. Wien. klin. Wschr. 68, 403–405 (1956)PubMedGoogle Scholar
  667. Musger, A.: Erythrodermatische Hautretikulosen. (Vorkommen, Krankheitsbild, Pathogenese). Hautarzt 17, 148–152 (1966)PubMedGoogle Scholar
  668. Musshoff, K.: Therapy and prognosis of two different forms of organ involvement in cases of malignant lymphoma (Hodgkin’s disease, reticulum cell sarcoma, lymphosarcoma) as well as a report about stage division in these diseases. Klin. Wschr. 48, 673–678 (1970)PubMedGoogle Scholar
  669. Musshoff, K.: Die Strahlenbehandlung der Hodgkinschen Erkrankung. In: Maligne Lymphome und monoklonale Gammopathien. Hämatologie und Bluttransfusion, Bd. 18, pp. 119–134. Löffler, H., Ed. München: Lehmanns 1976Google Scholar
  670. Musshoff, K., Schmidt-Vollmer, H., Lennert, K., Sandritter, W.: Preliminary clinical findings on the Kiel classification of malignant lymphomas. Z. Krebsforsch. 87, 229–238 (1976)Google Scholar
  671. Musshoff, K., Slanina, J.: Stadieneinteilung der malignen Lymphome. Zugleich ein Beitrag über die Bedeutung der Laparotomie mit Splenektomie. Klin. Wschr. 52, 109–117 (1974)PubMedGoogle Scholar
  672. Naeim, F., Smith, G.S.: Leukemic reticuloendotheliosis. Cancer (Philad.) 34, 1813–1821 (1974)Google Scholar
  673. Nagayo, M.: Reticulum cellular lymphosarcoma. Chiryo-oyobi-Shoho 10, 1255–1259 (1929), cit. of Akazaki, 1973Google Scholar
  674. Nanba, K., Itagaki, T., Iijima, S.: Enzyme histochemical investigations of human malignant lymphomas. Beitr. Path. 154, 233–242 (1975)Google Scholar
  675. Nathwani, B.N., Kim, H., Rappaport, H.: Malignant lymphoma, lymphoblastic. Cancer (Philad.) 38, 964–983 (1976)Google Scholar
  676. Neidhardt, M., Foltin, E. (Eds.): Maligne Tumoren im Kindesalter. Ergebnisse einer kooperativen Therapiestudie mit Operation, Bestrahlung und Polychemotherapie. Arbeitsgemeinschaft „Tumoren im Kindesalter“. Dtsch. med. Wschr. 98, 2267–2274 (1973)Google Scholar
  677. Nelson, M.G., Lyons, A.R.: Plasmacytoma of lymph glands. Cancer (Philad.) 10, 1275–1280 (1957)Google Scholar
  678. Neuhold, R., Wolfram, S.: Über Reticulohistiocytosen der Haut. Beitr. path. Anat. 112, 137–149 (1952)Google Scholar
  679. Newall, J., Friedman, M.: Reticulum-cell sarcoma. Part III: Prognosis. Radiology 97, 99–102 (1970)PubMedGoogle Scholar
  680. Nezelof, C., Basset, F., Rousseau, M.F.: Histiocytosis X. Histogenetic arguments for a Langerhans cell origin. Biomedicine 18, 365–371 (1973)PubMedGoogle Scholar
  681. Ngu, V.A.: The African lymphoma (Burkitt tumour): Survivals exceeding two years. Brit. J. Cancer 19, 101–107 (1965)PubMedGoogle Scholar
  682. Ngu, V.A., Burkitt, D.P., Osunkoya, B.O.: Clinical and related evidence of host defence mechanisms. In: Burkitt’s Lymphoma, pp. 158–163. Burkitt, D.P., Wright, D.H., Eds. Edinburgh-London: Livingstone 1970Google Scholar
  683. Nies, K.M., Marshall, J., Oberlin, M.A., Halpern, M.S., Brown, J.C.: Chronic lymphocytic leukemia with gamma chain cytoplasmic inclusions. Amer. J. clin. Path. 65, 948–956 (1976)<Google Scholar
  684. Nieuwenhuis, P., Keuning, F.J.: Germinal centres and the origin of the B-cell system. II. Germinal centres in the rabbit spleen and popliteal lymph nodes. Immunology 26, 509–519 (1974)PubMedGoogle Scholar
  685. Nkruhmah, F.K., Perkins, I.V.: Burkitt’s lymphoma. A clinical study of 110 patients. Cancer (Philad.) 37, 671–676 (1976a)Google Scholar
  686. Nkrumah, F.K., Perkins, I.V.: Relapse in Burkitt’s lymphoma. Int. J. Cancer 17, 455–460 (1976b)PubMedGoogle Scholar
  687. Oberling, C.: Les réticulosarcomes et les réticulo-endothélio-sarcomes de la moelle osseuse (sarcomes d’Ewing). Bull. Ass. franç. Cancer 17, 259–296 (1928)Google Scholar
  688. Oberling, C., Haguenau, F.: Histogénèse des tumeurs du système lymphatique. Acta Un. int. Cancr. 10, 177–187 (1954)PubMedGoogle Scholar
  689. O’Conor, G.T.: Malignant lymphoma in African children. II. A pathological entity. Cancer (Philad.) 14, 270–283 (1961)Google Scholar
  690. O’Conor, G.T.: Significant aspects of childhood lymphoma in Africa. Cancer Res. 23, 1514–1518 (1963)PubMedGoogle Scholar
  691. O’Conor, G.T.: Persistent immunologic stimulation as a factor in oncogenesis, with special reference to Burkitt’s tumor. Amer. J. Med. 48, 279–285 (1970)Google Scholar
  692. O’Conor, G.T., Davies, J.N.P.: Malignant tumors in African children. With special reference to malignant lymphoma. J. Pediat. 56, 526–535 (1960)PubMedGoogle Scholar
  693. O’Conor, G.T., Rappaport, H., Smith, E.B.: Childhood lymphoma resembling “Burkitt tumor” in the United States. Cancer (Philad.) 18, 411–417 (1965)Google Scholar
  694. Oehme, J.: Akute Leukämie im Kindesalter. Häufigkeit, Disposition, Behandlung. Dtsch. med. Wschr. 82, 110–113 (1957)PubMedGoogle Scholar
  695. Oehme, J., Janssen, W., Hagitte, C.: Leukämie im Kindesalter. Beiträge zur Morphologie, Klinik, Pathophysiologie und Therapie. (Abhandl. aus d. Gebiet d. prakt. Kinderheilk., Bd. 4.) Leipzig: Thieme 1958Google Scholar
  696. Oehmichen, M., Gärtner, H.-V., Knittel-Jung, U.: T cell type immunoblastic sarcoma diagnosed primarily by CSF cell membrane features. Klin. Wschr. 55, 37–40 (1977)PubMedGoogle Scholar
  697. Oettgen, H.F., Murphy, M.L.: Malignant lymphoma of childhood in the United States and Burkitt’s tumour in Africa: Therapeutic results. In: Treatment of Burkitt’s Tumour. UICC Monograph Series, Vol. 8, pp. 105–108. Burchenal, J.H., Burkitt, D.P., Eds. Berlin-Heidelberg-New York: Springer 1967aGoogle Scholar
  698. Oettgen, H.F., Murphy, M.L.: Malignant lymphoma in the United States and Burkitt’s tumour in Africa: Some aspects of their natural history. In: Treatment of Burkitt’s Tumour. UICC Monograph Series, Vol. 8, pp. 7–10. Burchenal, J.H., Burkitt, D.P., Eds. Berlin-Heidelberg-New York: Springer 1967bGoogle Scholar
  699. Oettgen, H.F., Quitmann, K.: Weitere Untersuchungen zur Morphologie der Makroglobulinämie Waldenström. Frankfurt. Z. Path. 67, 599–621 (1956)PubMedGoogle Scholar
  700. Oettlé, A.G.: Lymphoreticular malignant neoplasms in South African races, mortality and morbidity studies. In: Symposium on Lymphoreticular Tumours in Africa, Paris 1963, pp. 1–23. Roulet, F.C., Ed. Basel-New York: Karger 1964aGoogle Scholar
  701. Oettlé, A.G.: Primary malignant neoplasms of the lymphoreticular tissues (200–203, 205): A histopathological series from White and Bantu races in the Transvaal, 1949–1953. In: Symposium on Lymphoreticular Tumours in Africa, Paris 1963, pp. 24–35. Roulet, F.C., Ed., Basel-New York: Karger 1964bGoogle Scholar
  702. Ogata, T.: Über die Geschwülste des reticuloendothelialen Systems. GANN 33, 455–478 (1939), cit. of Akazaki, 1973Google Scholar
  703. O’Gorman Hughes, D.W.: The prognosis of acute leukaemia in childhood. Med. J. Aust. 1974, I, pp. 991–994Google Scholar
  704. Okano, H., Azar, H.A., Osserman, E.F.: Plasmacytic reticulum cell sarcoma. Case report with electron microscopic studies. Amer. J. clin. Path. 46, 546–555 (1966)Google Scholar
  705. Old, L.J., Boyse, E.A., Oettgen, H.F., de Harven, E., Geering, G., Williamson, B., Clifford, P.: Precipitating antibody in human serum to an antigen present in cultured Burkitt’s lymphoma cells. Proc. nat. Acad. Sci. (Wash.) 56, 1699–1704 (1966)Google Scholar
  706. de Oliveira, G.: Über die Stellung der Retothelsarkome im System der Lymphdrüsengeschwülste. Virchows Arch. path. Anat. 298, 464–514 (1936)Google Scholar
  707. Oliver, R.T.D.: Linking lymphomas with immunodeficiency. Nature (Lond.) 256, 262–263 (1975)Google Scholar
  708. Olmer, J., Mongin, M., Muratore, R., Denizet, D.: Myélomes. Macroglobulinémies et dysglobulinémies voisines. Paris: Masson et Cie. 1961Google Scholar
  709. Orsós, F.: Das Bindegewebsgerüst der Lymphknoten im normalen und pathologischen Zustand. Beitr. path. Anat. 75, 15–134 (1926)Google Scholar
  710. Osserman, E.F., Takatsuki, K.: Clinical and immunochemical studies of four cases of heavy (Hγ2) chain disease. Amer. J. Med. 37, 351–373 (1964)PubMedGoogle Scholar
  711. Osunkoya, B.O., McFarlane, H., Luzzatto, L., Udeozo, I.O.K., Mottram, F.C., Williams, A.I.O., Ngu, V.A.: Immunoglobulin synthesis by fresh biopsy cells and established cell lines from Burkitt’s lymphoma. Immunology 14, 851–860 (1968)PubMedGoogle Scholar
  712. Otani, M., Maruya, K., Shibue, K.: On the correlation between the reticulumcell and the monocyte in lymphatic reticulosarcomatosis. Extr. No. 268. 43. Annual Meeting Jap. Path. Soc. 1954. Acta path. jap. 4, 205 (1954)Google Scholar
  713. Paltauf, R.: Lymphosarkom (Lymphosarkomatose, Pseudoleukämie, Myelom, Chlorom). Ergebn. allg. Path. path. Anat. 3, 652–691 (1897)Google Scholar
  714. Paltauf, R., von Zumbusch, L.: Mycosis fungoides der Haut und inneren Organe. Arch. Derm. Syph. (Berl.) 118, 699–742 (1913)Google Scholar
  715. Palutke, M., McDonald, J.M.: Monoclonal gammopathies associated with malignant lymphomas. Amer. J. clin. Path. 60, 157–165 (1973)Google Scholar
  716. Palutke, M., Tranchida, L.: T-cell lymphoma. Report of a case. Amer. J. clin. Path. 64, 26–33 (1975)Google Scholar
  717. Pascoe, H.R.: Tumors composed of immature granulocytes occurring in the breast in chronic granulocytic leukemia. Cancer (Philad.) 25, 697–704 (1970)Google Scholar
  718. Patchefsky, A.S., Brodovsky, H.S., Menduke, H., Southard, M., Brooks, J., Nicklas, D., Hoch, W.S.: Non-Hodgkin’s lymphomas: A clinicopathologic study of 293 cases. Cancer (Philad.) 34, 1173–1186 (1974)Google Scholar
  719. Paufique, L., Girard, P., Schott, B., Creyssel, R., Trillet, M., Chazot, G.: Pseudolymphome de l’orbite macroglobulino-secrétant associé à une méningolymphomatose avec macroglobulino-rachie. Ann. Oculist. (Paris) 202, 1033–1045 (1969)Google Scholar
  720. Pautrier, L.-M., Woringer, F.: Mycosis fongoïde généralisé, forme érythrodermique et tumorale. Le ganglion mycosique. Bull. Soc. franç. Derm. Syph. 49, 498–505 (1939)Google Scholar
  721. Pavlovsky, A.: La Puncion Ganglionar. Buenos Aires: Aniceto Lopez 1934Google Scholar
  722. Pavlovsky, A.: Contribution of cytology to the study of lymphopathies. Acta haemat. (Basel) 36, 296–312 (1966)Google Scholar
  723. Payet, M., Camain, R., Pene, P., Sankale, M., Lambert, D.: Les hématosarcomes en Afrique Noire Occidentale et Centrale francophone. II. Considérations cliniques, biologiques et anatomo-pathologiques. In: Symposium on Lymphoreticular Tumours in Africa, Paris 1963, pp. 104–118. Roulet, F.C., Ed. Basel-New York: Karger 1964Google Scholar
  724. Penn, I., Halgrimson, C.G., Starzl, T.E.: De novo malignant tumors in organ transplant recipients. Transplant. Proc. 3, 773–778 (1971)PubMedGoogle Scholar
  725. Penn, I., Starzl, T.E.: Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation 14, 407–417 (1972)PubMedGoogle Scholar
  726. Perera, D.J.B., Pegrum, G.D.: The lymphocyte in chronic lymphatic leukaemia. Lancet 1974, I, pp. 1207–1209Google Scholar
  727. Peters, M.V.: The contribution of radiation therapy in the control of early lymphomas. Amer. J. Roentgenol. 90, 956–967 (1963)PubMedGoogle Scholar
  728. Peterson, L.C., Bloomfield, C.D., Sundberg, R.D., Gajl-Peczalska, K.J., Brunning, R.D.: Morphology of chronic lymphocytic leukemia and its relationship to survival. Amer. J. Med. 59, 316–324 (1975)PubMedGoogle Scholar
  729. Pfisterer, H., Nennhuber, J., Bolland, H., Stich, W.: Lymphocytenabbau nach in-vitro-Markierung mit Na2 51CrO4. II. Untersuchungen bei chronischer lymphatischer Leukämie. Klin. Wschr. 45, 1073–1076 (1967)PubMedGoogle Scholar
  730. Pike, M.C.: Chemotherapy in Burkitt’s tumour. Lancet 1966, II, p. 856Google Scholar
  731. Pinkel, D.: Five-year follow-up of “total therapy” of childhood lymphocytic leukemia. J. Amer. med. Ass. 216, 648–652 (1971)Google Scholar
  732. Pinkel, D., Johnson, W., Aur, R.J.A.: Non-Hodgkin’s lymphoma in children. Brit. J. Cancer 31, Suppl. II, 298–323 (1975)Google Scholar
  733. Plenderleith, I.H.: Hairy cell leukemia. Canad. med. Ass. J. 102, 1056–1060 (1970)PubMedGoogle Scholar
  734. Polliack, A., Braylan, R., Golomb, H.: [Letter to the Editor] Scanning electron microscopy of hairy cells in hairy-cell leukaemia. Lancet 1974, II, pp. 1013–1014Google Scholar
  735. Poole, A.G., Marchetta, F.C.: Extramedullary plasmacytoma of the head and neck. Cancer (Philad.) 22, 14–21 (1968)Google Scholar
  736. Pope, J.H., Horne, M.K., Wetters, E.J.: Significance of a complement-fixing antigen associated with herpes-like virus and detected in the Raji cell line. Nature (Lond.) 222, 186–187 (1969)Google Scholar
  737. Popkes, B.: Über Größe und Polymorphie der Zellkerne bei Lymphadenose und Lymphosarkom. Frankfurt. Z. Path. 66, 252–267 (1955)PubMedGoogle Scholar
  738. Poujol, G.: Un cas de tumeur primitive des ganglions lymphatiques d’origine réticulo-endothéliale. Bull. Ass. franç. Cancer 16, 627–655 (1927)Google Scholar
  739. Preud’Homme, J.L., Seligmann, M.: Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases. Blood 40, 777–794 (1972)PubMedGoogle Scholar
  740. Prigogina, E.L., Fleischman, E.W.: Marker chromosome 14q+ in two non-Burkitt lymphomas. Humangenetik 30, 109–112 (1975)PubMedGoogle Scholar
  741. Prunieras, M.: DNA content and cytogenetics of the Sezary cell. Mayo Clin. Proc. 49, 548–552 (1974)PubMedGoogle Scholar
  742. Pruzanski, W., Platts, M.E., Ogryzlo, M.A.: Leukemic form of immunocytic dyscrasia (plasma cell leukemia). A study of ten cases and a review of the literature. Amer. J. Med. 47, 60–74 (1969)PubMedGoogle Scholar
  743. Pulvertaft, R.J.V.: The use of tissue culture in the diagnosis of Burkitt’s tumour. In: Treatment of Burkitt’s Tumour. UICC Monograph Series, Vol. 8, pp. 24–28. Burchenal, J.H., Burkitt, D.P., Eds. Berlin-Heidelberg-New York: Springer 1967Google Scholar
  744. Pulvertaft, R.J.V., Platt, H.S.: Tissue culture of bone marrow and biopsy material in African childhood lymphoma. A preliminary report. In: Symposium on Lymphoreticular Tumours in Africa, Paris 1963, pp. 285–288. Roulet, F.C., Ed. Basel-New York: Karger 1964Google Scholar
  745. Qazi, R., Aisenberg, A.C., Long, J.C.: The natural history of nodular lymphoma. Cancer (Philad.) 37, 1923–1927 (1976)Google Scholar
  746. Quaglino, D., Cowling, D.C., Hayhoe, F.G.J.: Cytochemical and autoradiographic studies on normal and leukaemic cells in short-term tissue cultures. Brit. J. Haemat. 10, 417–436 (1964)PubMedGoogle Scholar
  747. Quaglino, D., Hayhoe, F.G.J.: Observations on the periodic acid-Schiff reaction in lymphoproliferative diseases. J. Path. 78, 521–532 (1959)Google Scholar
  748. Radaszkiewicz, T., Lennert, K.: Lymphogranulomatosis X. Klinisches Bild, Therapie und Prognose. Dtsch. med. Wschr. 100, 1157–1163 (1975)PubMedGoogle Scholar
  749. Rai, K.R., Sawitzky, A., Cronkite, E.P., Chanana, A.D., Levy, R.N., Pasternack, B.S.: Clinical staging of chronic lymphocytic leukemia. Blood 46, 219–234 (1975)PubMedGoogle Scholar
  750. Rain, J.D., Flandrin, G., Binet, J.L., Bernard, J.: Formes ganglionnaires tumorales des leucémies lymphoïdes chroniques. Nouv. Rev. franç. Hémat. 11, 447–452 (1971)PubMedGoogle Scholar
  751. Ramot, B.: Malabsorption due to lymphomatous disease. Ann. Rev. Med. 22, 19–24 (1971)PubMedGoogle Scholar
  752. Ramot, B., Hulu, N.: Primary intestinal lymphoma and its relation to alpha heavy chain disease. Brit. J. Cancer 31, Suppl. II, 343–349 (1975)Google Scholar
  753. Ramot, B., Many, A.: Primary intestinal lymphoma: Clinical manifestations and possible effect of environmental factors. In: Current Problems in the Epidemiology of Cancer and Lymphomas. Recent Results in Cancer Research, Vol. 39, pp. 193–199. Grundmann, E., Tulinius, H., Eds. Berlin-Heidelberg-New York: Springer 1972Google Scholar
  754. Ramot, B., Shahin, N., Bubis, J.J.: Malabsorption syndrome in lymphoma of small intestine. A study of 13 cases. Israel J. med. Sci. 1, 221–226 (1965)PubMedGoogle Scholar
  755. Rappaport, H.: The histologic aspects of malignant lymphoreticular neoplasms. In: Symposium on Lymphoreticular Tumours in Africa, Paris 1963, pp. 174–210. Roulet, F.C., Ed. Basel-New York: Karger 1964aGoogle Scholar
  756. Rappaport, H.: Classification of neoplastic diseases of the reticular system. In: Symposium on Lymphoreticular Tumours in Africa, Paris 1963, pp. 394–409. Roulet, F.C., Ed. Basel-New York: Karger 1964bGoogle Scholar
  757. Rappaport, H.: Tumors of the Hematopoietic System. Atlas of Tumor Pathology, Sect. 3, Fasc. 8. Washington, D.C.: Armed Forces Institute of Pathology 1966Google Scholar
  758. Rappaport, H.: Nouveaux concepts dans la classification des hémopathies malignes. Bull. Cancer 61, 11–22 (1974)PubMedGoogle Scholar
  759. Rappaport, H.: The pathologic anatomy of α chain disease. In: Maligne Lymphome und monoklonale Gammopathien. Hämatologie und Bluttransfusion, Bd 18, pp. 377–382. Löffler, H., Ed. München: Lehmanns 1976Google Scholar
  760. Rappaport, H., Braylan, R.C.: Changing concepts in the classification of malignant neoplasms of the hematopoietic system. In: The Reticuloendothelial System. IAP Monograph No. 16, pp. 1–19. Baltimore, Md.: Williams & Wilkins 1975Google Scholar
  761. Rappaport, H., Edgcomb, J., Thomas, L.: Mycosis fungoides: A reevaluation of its position in the scheme of lymphoreticular neoplasms. [Abstr.] Amer. J. clin. Path. 50, 625 (1968)Google Scholar
  762. Rappaport, H., Johnson, F.B.: Intracellular protein resembling Russell bodies in malignant lymphomas associated with acquired hemolytic anemia. Blood 10, 132–144 (1955)PubMedGoogle Scholar
  763. Rappaport, H., Moran, E.M.: Angio-immunoblastic (immunoblastic) lymphadenopathy. New Engl. J. Med. 292, 42–43 (1975)PubMedGoogle Scholar
  764. Rappaport, H., Ramot, B., Hulu, N., Park, J.K.: The pathology of so-called Mediterranean abdominal lymphoma with malabsorption. Cancer (Philad.) 29, 1502–1511 (1972)Google Scholar
  765. Rappaport, H., Thomas, L.B.: Mycosis fungoides: The pathology of extracutaneous involvement. Cancer (Philad.) 34, 1198–1229 (1974)Google Scholar
  766. Rappaport, H., Winter, W.J., Hicks, E.B.: Follicular lymphoma. A re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer (Philad.) 9, 792–821 (1956)Google Scholar
  767. Rau, R., Mueller-Eckhardt, C., Huth, K., Löffler, H.: Paraproteinämie und Antikörpermangel-syndrom bei chronischer lymphatischer Leukämie. Med. Welt 19 (N.F.), 801–806 (1968)Google Scholar
  768. Reed, D.M.: On the pathological changes in Hodgkin’s disease, with especial reference to its relation to tuberculosis. Johns Hopkins Hosp. Rep. 10, 133–196 (1902)Google Scholar
  769. Reedman, B.M., Klein, G.: Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int. J. Cancer 11, 499–520 (1973)PubMedGoogle Scholar
  770. Rehman, K.L., Rosner, F., Grünwald, H.W.: The leukemic phase of histiocytic lymphoma: Report of four cases. Amer. J. med. Sci. 268, 353–359 (1974)PubMedGoogle Scholar
  771. Reis, H.E.: Immunsuppression, Tumorentstehung und Tumorwachstum. Z. Krebsforsch. 78, 42–50 (1972)Google Scholar
  772. Rennke, H., Lennert, K.: Käsig-tuberkuloide Reaktion bei Lymphknotenmetastasen lymphoepithelialer Carcinome (Schmincke-Tumoren). Virchows Arch. A 358, 241–247 (1973)Google Scholar
  773. Reynaud, J., Quéré, M.A., Lambert, D.: Les hématosarcomes de la face chez l’enfant en Afrique Occidentale et Centrale francophone. II. Aspects cliniques, radiologiques et biologiques. In: Symposium on Lymphoreticular Tumours in Africa, Paris 1963, pp. 137–149. Roulet, F.C., Ed. Basel-New York: Karger 1964Google Scholar
  774. Richter, M.N.: Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia. Amer. J. Path. 4, 285–299 (1928)PubMedGoogle Scholar
  775. Richter, M.N.: Origin of leukemic cells in monocytic leukemia. Lab. Invest. 5, 155–161 (1956)PubMedGoogle Scholar
  776. Rieber, E.P., v. Heyden, H.W., Linke, R.P., Saal, J.G., Riethmüller, G., Waller, H.D.: Haarzell-Leukämie. Charakterisierung der leukämischen Zelle: Oberflächenimmunglobuline, Fc-Rezeptoren und Stimulation durch Mitogene. Klin. Wschr. 54, 1011–1019 (1976)PubMedGoogle Scholar
  777. Riegel, R.: Plasmazellenleukämie nach Behandlung mit Thorium X. Ärztl. Wschr. 11, 1093–1096 (1956)Google Scholar
  778. Riehm, H., Gadner, H., Welte, K.: Die West-Berliner Studie zur Behandlung der akuten lympho-blastischen Leukämie des Kindes — Erfahrungsbericht nach 6 Jahren. Klin. Pädiat. 189, 89–102 (1977)Google Scholar
  779. Rilke, F., Clemente, C., Pilotti, S., Musumeci, R.: II linfoma linfoblastico a cellule convolute. Tumori 61, 377–391 (1975)PubMedGoogle Scholar
  780. Rind, H.: Zytomorphologie und Prognose der Leukämie des Kindes. In: Chemo- und Immunotherapie der Leukosen und malignen Lymphome, pp. 183–184. Stacher, A., Ed. Wien: Bohmann 1969Google Scholar
  781. Rinneberg, H., Lennert, K.: Fermenthistochemische Untersuchungen des Lymphknotens. III. Adenosintriphosphatase und 5-Nucleotidase in den Zellen des Lymphknotentupfpräparates. Klin. Wschr. 39, 971 (1961)PubMedGoogle Scholar
  782. Ritter, J., Gaedicke, G., Winkler, K., Beckmann, H., Landbeck, G.: Possible T-cell origin of lymphoblasts in acid-phosphatase-positive acute lymphatic leukaemia. Lancet 1975, II, p. 75Google Scholar
  783. Ritter, J., Gaedicke, G., Winkler, K., Landbeck, G.: Immunologische Oberflächenmarker von Lymphoblasten bei der saure Phosphatase-positiven akuten Leukämie. Z. Kinderheilk. 120, 211–215 (1975)PubMedGoogle Scholar
  784. Roath, S., Israels, M.C.G., Wilkinson, J.F.: The acute leukaemias: A study of 580 patients. Quart. J. Med. N.S. 33, 257–283 (1964)Google Scholar
  785. Robb-Smith, A.H.T.: Reticulosis and reticulosarcoma: A histological classification. J. Path. 47, 457–480 (1938)Google Scholar
  786. Robb-Smith, A.H.T.: The lymph-node biopsy. In: Recent Advances in Clinical Pathology, pp. 350–370. Dyke, S.C., Ed. London: J. & A. Churchill 1947Google Scholar
  787. Robb-Smith, A.H.T.: Introduction: The classification and natural history of the lymphadenopathies. In: Lymphomas and Related Diseases. Treatment of Cancer and Allied Diseases, Vol. 9, pp. 1–27. Pack, G.T., Ariel, I.M., Eds. New York: Hoeber Medical Division, Harper & Row 1964Google Scholar
  788. Robb-Smith, A.H.T.: Immuno-topography of lymphoreticular disorders. Lancet 1974, I, pp. 513–514Google Scholar
  789. Rodt, H., Thiel, E., Thierfelder, S., Huhn, D., Götze, D., Brehm, G.: Spezifisches Anti-T-Lymphocyten-Globulin (sATG) für die Diagnostik lymphoproliferativer Erkrankungen. Klin. Wschr. 54, 361–366 (1976)PubMedGoogle Scholar
  790. Rössle, R.: Das Retothelsarkom der Lymphdrüsen. Seine Formen und Verwandtschaften. Beitr. path. Anat. 103, 385–415 (1939)Google Scholar
  791. Rohr, K.: Das menschliche Knochenmark. 3. Ed. Stuttgart: G. Thieme 1960Google Scholar
  792. Rosas-Uribe, A., Rappaport, H.: Malignant lymphoma, histiocytic type with sclerosis (sclerosing reticulum cell sarcoma). Cancer (Philad.) 29, 946–953 (1972)Google Scholar
  793. Rosas-Uribe, A., Variakojis, D., Molnar, Z., Rappaport, H.: Mycosis fungoides: An ultrastructural study. Cancer (Philad.) 34, 634–645 (1974)Google Scholar
  794. Rosas-Uribe, A., Variakojis, D., Rappaport, H.: Proteinaceous precipitate in nodular (follicular) lymphomas. Cancer (Philad.) 31, 534–542 (1973)Google Scholar
  795. Rosenberg, S.A., Diamond, H.D., Dargeon, H.W., Craver, L.F.: Lymphosarcoma in childhood. New Engl. J. Med. 259, 505–512 (1958)PubMedGoogle Scholar
  796. Rosenberg, S.A., Diamond, H.D., Jaslowitz, B., Craver, L.F.: Lymphosarcoma: A review of 1269 cases. Medicine (Baltimore) 40, 31–84 (1961)Google Scholar
  797. Rosenberg, S.A., Dorfman, R.F., Kaplan, H.S.: A summary of the results of a review of 405 patients with non-Hodgkin’s lymphoma at Stanford University. Brit. J. Cancer 31, Suppl. II, 168–173 (1975)Google Scholar
  798. Rosenthal, N.: The lymphomas and leukemias. Bull. N.Y. Acad. Med. 2. Ser. 30, 583–600 (1954)Google Scholar
  799. Rosenthal, N., Dreskin, O.H., Vural, I.L., Zak, F.G.: The significance of hematogones in blood, bone marrow and lymph node aspiration in giant follicular lymphoblastoma. Acta haemat. (Basel) 8, 368–377 (1952)Google Scholar
  800. Rossier, P.-H., Spühler, O.: Beitrag zum großfollikulären Lymphoblastom, Brill-Symmers Krankheit. Schweiz. med. Wschr. 78, 1246–1249 (1948)PubMedGoogle Scholar
  801. Roulet, F.: Das primäre Retothelsarkom der Lymphknoten. Virchows Arch. path. Anat. 277, 15–47 (1930)Google Scholar
  802. Roulet, F.: Weitere Beiträge zur Kenntnis des Retothelsarkoms der Lymphknoten und anderer Lymphoiden-Organe. Virchows Arch. path. Anat. 286, 702–732 (1932)Google Scholar
  803. Roulet, F.: Das Verhalten der Milz beim Retothelsarkom der Lymphknoten. Schweiz. Z. Path. Suppl. 10, 88–101 (1947)Google Scholar
  804. Roulet, F.C.: Die ausgesprochen blastomatösen Retikulosen. Verh. dtsch. Ges. Path. 37, 105–127 (1953)Google Scholar
  805. Roulet, F.C. (Ed.): Symposion on Lymphoreticular Tumours in Africa. Basel-New York: Karger 1964Google Scholar
  806. Rowlands, B., Shaw, N.: Extramedullary plasmocytoma. Brit. med. J. 1954, I, pp. 1302–1303Google Scholar
  807. Rubin, A.D., Douglas, S.D., Chessin, L.N., Glade, P.R., Dameshek, W.: Chronic reticulolymphocytic leukemia. Reclassification of “leukemic reticuloendotheliosis” through functional characterization of the circulating mononuclear cells. Amer. J. Med. 47, 149–162 (1969)PubMedGoogle Scholar
  808. Rubin, A.D., Havemann, K., Dameshek, W.: Studies in chronic lymphocytic leukemia: Further studies of the proliferative abnormality of the blood lymphocyte. Blood 33, 313–328 (1969)PubMedGoogle Scholar
  809. Rudders, R.A.: B lymphocyte subpopulations in chronic lymphocytic leukemia. Blood 47, 229–235 (1976)PubMedGoogle Scholar
  810. Rüttner, J.R., von Albertini, A.: Das großfollikuläre Lymphoblastom. Schweiz. Z. Path. Suppl. 10, 119–124 (1947)Google Scholar
  811. Salmon, S.E., McIntyre, O.R., Ogawa, M.: IgE myeloma: Total body tumor cell number and synthesis of IgE and DNA. Blood 37, 696–705 (1971)PubMedGoogle Scholar
  812. Salmon, S.E., Seligmann, M.: B-cell neoplasia in man. Lancet 1974, II, p. 1230Google Scholar
  813. Sandilands, G.P., Gray, K., Cooney, A., Browning, J.D., Grant, R.M., Anderson, J.R.: Lymphocytes with T and B cell properties in a lymphoproliferative disorder. Lancet 1974, I, pp. 903–904Google Scholar
  814. Satodate, R., Schwarze, E.-W., Lennert, K.: Gewebsmastzellenzahl bei Immunocytom und chronischer lymphatischer Leukämie. Virchows Arch. A 373, 303–309 (1977)Google Scholar
  815. Schamaun, M.: Zur pathologischen Anatomie der sog. Macroglobulinaemie Waldenstroem. Schweiz. Z. allg. Path. 17, 25–46 (1954)Google Scholar
  816. Schaub, F.: Zum Krankheitsbild und zur Differentialdiagnose der Makroglobulinanämie Waldenström. Schweiz. med. Wschr. 82, 890–895 (1952)PubMedGoogle Scholar
  817. Schaub, F.: Gleichzeitiges Vorkommen von Makroglobulinämie Waldenström und von malignen Tumoren. Schweiz. med. Wschr. 83, 1256–1257 (1953)PubMedGoogle Scholar
  818. Scheinberg, M., Brenner, A.I., Sullivan, A.L., Cathcart, E.S., Katayama, I.: The heterogeneity of leukemic reticuloendotheliosis, “hairy cell leukemia”. Evidence for its monocytic origin. Cancer (Philad.) 37, 1302–1307 (1976)Google Scholar
  819. Scheurlen, P.G., Haun, W., Mäusle, E., Wolff, G.: Generalisierte tumorförmige Lymphknotenamyloidose mit Polyneuropathie und Makroglobulinämie. Dtsch. med. Wschr. 98, 1947–1951 (1973)PubMedGoogle Scholar
  820. Scheurlen, P.G., Schwarz, J.A.: Immunglobulinmangel und Defekte der spezifischen immunologischen Abwehr. In: Innere Medizin in Praxis und Klinik, Bd. III, pp. 11-115–11-120. Hornbostel, H., Kaufmann, W., Siegenthaler, W., Eds. Stuttgart: Thieme 1973Google Scholar
  821. Schick, P.: Lymphocytenkinetik bei lymphatischen Systemerkrankungen (chronische lymphatische Leukämie, Lymphogranulomatose). Verh. dtsch. Ges. inn. Med. 79, 154–158 (1973)PubMedGoogle Scholar
  822. Schild, C.-A.: Notions générales sur le réticulosarcome des ganglions lymphatiques et des formations lymphoïdes. Oncologia (Basel) 2, 1–19 (1949)Google Scholar
  823. Schilling, V.: Das Blutbild und seine klinische Verwertung. Jena: G. Fischer 1943Google Scholar
  824. Schleicher, E.M.: Giant Russell bodies in neoplastic cells in a case of leukemic lymphosarcomatosis. Minn. Med. 48, 1125–1130 (1965)PubMedGoogle Scholar
  825. Schmalzl, F., Huhn, D., Asamer, H., Braunsteiner, H.: Hairy cell leukemia (‘leukemic reticuloendotheliosis’), reticulosarcoma, and monocytic leukemia. Cytochemical and ultrastructural investigations. Acta haemat. (Basel) 53, 257–276 (1975)Google Scholar
  826. Schnitzer, B.: Classification of non-Hodgkin lymphomas. [Letter to the Editor.] Brit. med. J. 1975, I, p. 680Google Scholar
  827. Schnitzer, B., Hammack, W.J.: B-lymphocyte nature of hairy cells in hairy-cell leukaemia. [Letter to the Editor.] Lancet 1974, II, p. 649Google Scholar
  828. Schnitzer, B., Kass, L.: Leukemic phase of reticulum cell sarcoma (histiocytic lymphoma). Cancer (Philad.) 31, 547–559 (1973)Google Scholar
  829. Schnitzer, B., Kass, L.: Hairy-cell leukemia. A clinicopathologic and ultrastructural study. Amer. J. clin. Path. 61, 176–187 (1974)Google Scholar
  830. Schnitzer, B., Loesel, L.S., Reed, R.E.: Lymphosarcoma cell leukemia. A clinicopathologic study. Cancer (Philad.) 26, 1082–1096 (1970)Google Scholar
  831. Schoen, R., Heckner, F., Marsch, A.: Das vielseitige Erscheinungsbild der lymphatischen Leukämie. Dtsch. med. Wschr. 78, 515–518 (1953)PubMedGoogle Scholar
  832. Schrek, R., Donnelly, W.J.: “Hairy” cells in blood in lymphoreticular neoplastic disease and “flagellated” cells of normal lymph nodes. Blood 27, 199–211 (1966)PubMedGoogle Scholar
  833. Schrek, R., Donnelly, W.J.: Cytology in lymphosarcoma cell leukemia. Amer. J. clin. Path. 55, 646–654 (1971)Google Scholar
  834. Schrek, R., Knospe, W.H., Trobaugh, Jr., F.E.: Chromatin and other cytologic indices in chronic lymphocytic leukemia. J. Lab. clin. Med. 75, 217–224 (1970)PubMedGoogle Scholar
  835. Schubert, J.C.F., Mondorf, W.: Doppelerkrankung an Makroglobulinämie Waldenström und multiplem Myelom. In: Fortschritte der Krebsforschung, pp. 419–422. Schmidt, C.G., Wetter, O., Eds. Stuttgart-New York: F.K. Schattauer 1969Google Scholar
  836. Schwartz, R.S., André-Schwartz, J.: Malignant lymphoproliferative diseases: Interactions between immunological abnormalities and oncogenic viruses. Ann. Rev. Med. 19, 269–282 (1968)PubMedGoogle Scholar
  837. Schwarze, E.-W., Radaszkiewicz, T., Pülhorn, G., Goos, M., Lennert, K.: Maligne und benigne Lymphome des Auges, der Lid- und Orbitalregion. Virchows Arch. A 370, 85–96 (1976)Google Scholar
  838. Schwarze, E.-W., Ude, P.: Immunoblastic sarcoma with leukemic blood picture in the terminal stage of mycosis fungoides. Virchows Arch. A 369, 165–172 (1975)Google Scholar
  839. Schwenk, H.U.: Immunological cell markers on lymphoblasts of patients with acute lymphatic leukemia. Z. Kinderheilk. 118, 87–95 (1974)PubMedGoogle Scholar
  840. Scott, R.B., Robb-Smith, A.H.T.: Histiocytic medullary reticulosis. Lancet 1939, II, pp. 194–198Google Scholar
  841. Seeber, S., Schmidt, C.G.: Makromolekulare Besonderheiten des Lymphocyten der chronisch-lymphatischen Leukämie (CLL). Klin. Wschr. 52, 1093–1102 (1974)PubMedGoogle Scholar
  842. Seligmann, M.: Principaux caractères des maladies des chaînes lourdes. Bull. Cancer 59, 381–388 (1972a)PubMedGoogle Scholar
  843. Seligmann, M.: Heavy chain diseases. Rev. europ. Étud. clin. biol. 17, 349–355 (1972b)Google Scholar
  844. Seligmann, M.: Immunochemical, clinical, and pathological features of α-chain disease. Arch. intern. Med. 135, 78–82 (1975)PubMedGoogle Scholar
  845. Seligmann, M., Brouet, J.-C., Preud’Homme, J.-L.: The immunological diagnosis of human leukemias and lymphomas: an overview. In: Immunological Diagnosis of Leukemias and Lymphomas. Haematology and Blood Transfusion, Vol. 20, pp. 1–15. Thierfelder, S., Rodt, H., Thiel, E., Eds. Berlin-Heidelberg-New York: Springer 1977Google Scholar
  846. Seligmann, M., Danon, F., Hurez, D., Mihaesco, E., Preud’Homme, J.-L.: Alpha-chain disease: A new immunoglobulin abnormality. Science 162, 1396–1397 (1968)PubMedGoogle Scholar
  847. Seligmann, M., Preud’Homme, J.-L., Brouet, J.-C.: B and T cell markers in human proliferative blood diseases and primary immunodeficiencies, with special reference to membrane bound immunoglobulins. Transplant. Rev. 16, 85–113 (1973)PubMedGoogle Scholar
  848. Seligmann, M., Preud’Homme, J.L., Brouet, J.C.: Surface cell markers in human lymphoid malignancies. In: Lymphocytes, Macrophages, and Cancer. Recent Results in Cancer Research, Vol. 56, pp. 91–97. Mathé, G., Florentin, I., Simmler, M.-C., Eds. Berlin-Heidelberg-New York: Springer 1976Google Scholar
  849. Sen, L., Borella, L.: Clinical importance of lymphoblasts with T markers in childhood acute leukemia. New Engl. J. Med. 292, 828–832 (1975)PubMedGoogle Scholar
  850. Seno, S., Monden, H., Shibata, T., Seki, S., Asakura, H., Hamada, H., Matsuoka, K., Toyama, Y., Katano, T., Hayashi, K., Nakatsuka, A.: Leukemia autopsies in Japan. Acta Med. Okayama 18, 45–52 (1964)PubMedGoogle Scholar
  851. Serck-Hanssen, A., Purohit, G.P.: Histiocytic medullary reticulosis. Brit. J. Cancer 22, 506–516 (1968)PubMedGoogle Scholar
  852. Serck-Hanssen, A.: Histiocytic medullary reticulosis. In: Tumours in a Tropical Country. Recent Results in Cancer Research, Vol. 41, pp. 292–297. Templeton, A.C., Ed. Berlin-Heidelberg-New York: Springer 1973Google Scholar
  853. Sézary, A.: Une nouvelle réticulose cutanée. La réticulose maligne leucémique à histio-monocytes monstrueux et à forme d’érythrodermie œdémateuse et pigmentée. Ann. Derm. Syph. (Paris) Sér. 8, 9,5–22 (1949)Google Scholar
  854. Sézary, A., Bouvrain, Y.: Erythrodermie avec présence de cellules monstrueuses dans le derme et le sang circulant. Bull. Soc. franç. Derm. Syph. 45, 254–260 (1938)Google Scholar
  855. Sézary, A., Horowitz, A., Maschas, H.: Erythrodermie avec présence de cellules monstrueuses dans le derme et dans le sang circulant (second cas). Bull. Soc. franç. Derm. Syph. 45, 395–400 (1938)Google Scholar
  856. Shahid, M.J., Alami, S.Y., Nassar, V.H., Balikian, J.B., Salem, A.A.: Primary intestinal lymphoma with paraproteinemia. Cancer (Philad.) 35, 848–858 (1975)Google Scholar
  857. Shaw, M.T., Ishmael, D.R.: Acute lymphocytic leukemia with atypical cytochemical features. Amer. J. clin. Path. 63, 415–420 (1975)Google Scholar
  858. Sheldon, P.J., Holborow, E.J.: H-rosette formation in T-cell-proliferative diseases. Brit. med. J. 1975, IV, pp. 381–383Google Scholar
  859. Sherr, C.J., Uhr, J.W.: Immunoglobulin synthesis and secretion. VI. Synthesis and intracellular transport of immunoglobulin in nonsecretory lymphoma cells. J. exp. Med. 133, 901–920 (1971)PubMedGoogle Scholar
  860. Shevach, E., Edelson, R., Frank, M., Lutzner, M., Green, I.: A human leukemia cell with both B and T cell surface receptors. Proc. nat. Acad. Sci. (Wash.) 71, 863–866 (1974)Google Scholar
  861. Shevach, E.M., Herberman, R., Frank, M.M., Green, I.: Receptors for complement and immunoglobulin on human leukemic cells and human lymphoblastoid cell lines. J. clin. Invest. 51, 1933–1938 (1972)PubMedGoogle Scholar
  862. Shevach, E.M., Jaffe, E.S., Green, I.: Receptors for complement and immunoglobulin on human and animal lymphoid cells. Transplant. Rev. 16, 3–28 (1973)PubMedGoogle Scholar
  863. Shimkin, M.B., Loveland, D.B.: A note on mortality from lymphatic leukemia in oriental populations of the United States. Blood 17, 763–766 (1961)Google Scholar
  864. Shimoyama, M., Mikuni, M.: Some clinical characteristics of reticulum cell sarcoma and lymphoblastic lymphosarcoma with reference to leukemic transformation. Recent Advanc. RES Res. 12, 166–182 (1973)Google Scholar
  865. Shirakura, T., Kobayashi, Y., Murai, Y., Inoue, T., Imamura, Y.: A case of gamma heavy chain disease associated with autoimmune haemolytic anaemia: Clinical, haematological, immunological and pathological details. Scand. J. Haemat. 16, 387–393 (1976)PubMedGoogle Scholar
  866. Shope, T., Dechairo, D., Miller, G.: Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus. Proc. nat. Acad. Sci. (Wash.) 70, 2487–2491 (1973)Google Scholar
  867. Shtern, R.D.: Topography of organic affections in reticuloblastomatosis. [Russisch.] Probl. Gemat. 13, 17–23 (1968)PubMedGoogle Scholar
  868. Shtern, R.D.: Reticulosarcoma. [Russisch.] Arkh. Pat. 32, 9–24 (1970)PubMedGoogle Scholar
  869. Silberman, S., Schrek, R.: Surface immunoglobulins of lymphocytes in chronic lymphocytic leukemia and disseminated lymphosarcoma. Exp. mol. Path. 20, 33–39 (1974)Google Scholar
  870. Silhol, J., Rouslacroix, A.: Sarcome d’origine ganglionnaire à disposition strictement périthéliale. (Tumeur de l’aisselle). Bull. Ass. franç. Cancer 13, 739–744 (1924)Google Scholar
  871. Silvestrini, R., Piazza, R., Riccardi, A., Rilke, F.: Correlation of cell kinetic findings with morphology of non-Hodgkin’s malignant lymphomas. J. nat. Cancer Inst. 58, 499–504 (1977)PubMedGoogle Scholar
  872. Simon, M.A., Eidlow, S.: Plasmacytoma of lymph node. Report of a case with multiple myeloma. New Engl. J. Med. 243, 335–338 (1950)PubMedGoogle Scholar
  873. Sjoevall, E.: Die diagnostischen Kennzeichen des Retikelzellsarkoms in den Lymphdrüsen. [Abstr.] Verh. 6. skand. Path. Kongr., Oslo 1935. Zbl. allg. Path. path. Anat. 65, 125 (1936)Google Scholar
  874. Skinner, J.M., Manousos, O.N., Economidou, J., Nicolaou, A., Merikas, G.: Alpha-chain disease with localized plasmacytoma of the intestine. Immunoperoxidase study. Clin. exp. Immunol. 25, 112–116 (1976)PubMedGoogle Scholar
  875. Sluiter, J.T.F.: De histologie van de ziekte van Brill in haar verschillende phasen. Diss. med., Amsterdam 1956Google Scholar
  876. Smith, J.L., Barker, C.R., Clein, G.P., Collins, R.D.: Characterisation of malignant mediastinal lymphoid neoplasm (Sternberg sarcoma) as thymic in origin. Lancet 1973, I, pp. 74–77Google Scholar
  877. Snapper, I., Kahn, A.: Myelomatosis. Fundamentals and Clinical Features. Basel-München-Paris-London-New York-Sydney: Karger 1971Google Scholar
  878. Söderström, N.: Cytologie der Milz in Punktaten. In: Die Milz — The Spleen, pp. 1–10. Lennert, K., Harms, D., Eds. Berlin-Heidelberg-New York: Springer 1970Google Scholar
  879. Söderström, N., Norberg, B.: Observations regarding the specific post-capillary venules of lymph nodes in malignant lymphomas. Acta path. microbiol. scand. A 82, 71–79 (1974)Google Scholar
  880. Solnik, C., Gleichmann, H., Kavanah, M., Schwartz, R.S.: Immunosuppression and malignant lymphomas in graft-versus-host reactions. Cancer Res. 33, 2068–2077 (1973)PubMedGoogle Scholar
  881. Spiro, S., Galton, D.A.G., Wiltshaw, E., Lohmann, R.C.: Follicular lymphoma: A survey of 75 cases with special reference to the syndrome resembling chronic lymphocytic leukaemia. Brit. J. Cancer 31, Suppl. II, 60–72 (1975)Google Scholar
  882. Stacher, A., Böhnel, J.: Über die Relation von lymphatischen Leukämien bzw. Reaktionen zu Malignomen. Wien. klin. Wschr. 78, 633–636 (1966)Google Scholar
  883. Stacher, A., Waldner, R., Theml, H. (Kieler Lymphomgruppe): Klinik der malignen Non-Hodgkin-Lymphome entsprechend der Kieler Klassifikation: Lymphoplasmozytoides Lymphom (LPL) und chronisch lymphatische Leukämie (CLL). In: Maligne Lymphome und monoklonale Gammopathien. Hämatologie und Bluttransfusion, Bd. 18, pp. 199–209. Löffler, H., Ed. München: Lehmanns 1976Google Scholar
  884. Stahel, R.: Diagnostische Drüsenpunktion. Leipzig: Thieme 1939Google Scholar
  885. Stahel, R.: Über großfollikuläres Lymphoblastom (Brill Symmers disease). Helv. med. Acta Ser. A 15, 448–456 (1948)Google Scholar
  886. Stegagno, G.: L’adenocitogramma nella leucemia linfatica acuta dell’infanzia. Arch. ital. Pediat. 15, 397–427 (1950)Google Scholar
  887. Stein, H.: Immunchemische und immunzytologische Befunde bei Non-Hodgkin-Lymphomen. In: Maligne Lymphome und monoklonale Gammopathien. Hämatologie und Bluttransfusion, Bd. 18, pp. 167–183. Löffler, H., Ed. München: Lehmanns 1976Google Scholar
  888. Stein, H., Kaiserling, E.: Surface immunoglobulins and lymphocyte-specific surface antigens on leukaemic reticuloendotheliosis cells. Clin. exp. Immunol. 18, 63–71 (1974)PubMedGoogle Scholar
  889. Stein, H., Kaiserling, E., Lennert, K.: Neue Gesichtspunkte zur Systematik maligner Lymphome auf dem Boden immunchemischer Analysen. In: Leukämien und maligne Lymphome, pp. 195–201. Stacher, A., Ed. München-Berlin-Wien: Urban & Schwarzenberg 1973Google Scholar
  890. Stein, H., Kaiserling, E., Lennert, K.: Evidence for B-cell origin of reticulum cell sarcoma. Virchows Arch. A 364, 51–67 (1974a)Google Scholar
  891. Stein, H., Kaiserling, E., Lennert, K.: Immunoglobulin-production and surface-bound immunoglobulins in chronic lymphocytic leukemia, lymphosarcoma, and so-called reticulum cell sarcoma. In: Modern Trends in Human Leukemia. Hämatologie und Bluttransfusion, Vol. 14, pp. 97–106. Neth, R., Gallo, R.C., Spiegelman, S., Stohlman, Jr., F., Eds. München: J.F. Lehmanns 1974bGoogle Scholar
  892. Stein, H., Kaiserling, E., Lennert, K., Parwaresch, M.R.: Makroglobulinbildende chronische lymphatische Leukämie ohne Makroglobulinämie. Klin. Wschr. 51, 389–396 (1973)PubMedGoogle Scholar
  893. Stein, H., Lennert, K., Parwaresch, M.R.: Malignant lymphomas of B-cell type. Lancet 1972, II, pp. 855–857Google Scholar
  894. Stein, H., Petersen, N., Gaedicke, G., Lennert, K., Landbeck, G.: Lymphoblastic lymphoma of convoluted or acid phosphatase type — a tumor of T precursor cells. Int. J. Cancer 17, 292–295 (1976)PubMedGoogle Scholar
  895. Sternberg, C.: Über eine eigenartige unter dem Bilde der Pseudoleukämie verlaufende Tuberculose des lymphatischen Apparates. Ztschr. Heilk. 19, 21–90 (1898)Google Scholar
  896. Sternberg, C.: Über Leukosarcomatose. Wien. klin. Wschr. 21, 475–480 (1908)Google Scholar
  897. Sternberg, C.: Leukosarkomatose und Myeloblastenleukämie. Beitr. Path. 61, 75–100 (1916)Google Scholar
  898. Stjernswård, J., Clifford, P., Svedmyr, E.: General and tumor-distinctive cellular immunological reactivity. In: Burkitt’s Lymphoma, pp. 164–171. Burkitt, D.P., Wright, D.H., Eds. Edinburgh-London: Livingstone 1970Google Scholar
  899. Stoop, J.W., Ballieux, R.E., Hijmans, W., Zegers, B.J.M.: Alpha-chain disease with involvement of the respiratory tract in a Dutch child. Clin. exp. Immunol. 9, 625–635 (1971)PubMedGoogle Scholar
  900. Stoop, J.W., Zegers, B.J.M., van der Heiden, C., Ballieux, R.E.: Monoclonal gammopathy in a child with leukemia. Blood 32, 774–786 (1968)PubMedGoogle Scholar
  901. Storti, E.: L’istochimica applicata all’ematologia. C.R. 3. Congr. Soc. europ. Hémat., Rome 1951, pp. 79–112. Rome: Edizioni Mediche e Scientifiche 1952Google Scholar
  902. Stout, A.P., Kenney, F.R.: Primary plasma-cell tumors of the upper air passages and oral cavity. Cancer (Philad.) 2, 261–278 (1949)Google Scholar
  903. Strunge, T.: La Ponction des ganglions lymphatiques. Kopenhagen: Munksgaard 1944Google Scholar
  904. Stutte, H.J., Schlüter, E.: Zur Ätiologie von Fibrinpräcipitaten in den Lymphfollikeln der menschlichen Milz. Untersuchungen an autoptischem Material. Virchows Arch. A 356, 32–41 (1972)Google Scholar
  905. Suchi, T., Ota, K.: Clinical, cytological, and histopathological studies of cases of reticulum cell sarcoma-like tumors developing during the terminal phase of chronic myelogenous leukemia. In: Malignant Diseases of the Hematopoietic System. GANN Monograph on Cancer Research, Vol. 15, pp. 97–110. Akazaki, K., Rappaport, H., Berard, C.W., Bennett, J.M., Ishikawa, E., Eds. Tokyo: University of Tokyo Press 1973Google Scholar
  906. Suchi, T., Sato, T., Kobayashi, H., Akatsuka, H., Akaza, T., Kurita, S., Hoshino, M.: Reticulum cell sarcoma. Some characteristics of reticulum-cell-sarcoma cells. [Japanese.] Jap. J. Cancer Clin. 19, 419–425 (1973)Google Scholar
  907. Suissa, L., LaRosa, J., Linn, B.: Plasmacytoma of lymph nodes. A case report. J. Amer. med. Ass. 197, 136–140 (1966)Google Scholar
  908. Sumiya, M., Mizoguchi, H., Kosaka, K., Miura, Y., Takaku, F., Yata, J.: Chronic lymphocytic leukaemia of T-cell origin? Lancet 1973, II, p. 910Google Scholar
  909. Sundberg, R.D.: Lymphocytogenesis in human lymph nodes. J. Lab. clin. Med. 32, 777–792 (1947)PubMedGoogle Scholar
  910. Švejda, J., Kostelník, J., Churý, Z.: Beitrag zu den pathologisch-anatomischen Befunden bei Waldenströms Makroglobulinämie. Zbl. allg. Path. path. Anat. 98, 497–504 (1958)Google Scholar
  911. Symmers, D.: Follicular lymphadenopathy with splenomegaly. A newly recognized disease of the lymphatic system. Arch. Path. 3, 816–820 (1927)Google Scholar
  912. Symmers, D.: Giant follicular lymphadenopathy with or without splenomegaly. Arch. Path. 26, 603–647 (1938)Google Scholar
  913. Symmers, D.: Lymphoid diseases. Arch. Path. 45, 73–131 (1948)PubMedGoogle Scholar
  914. Symmers, W.StC.: Primary malignant diseases of the lymphoreticular system. In: Cancer 2, 2: Pathology of Malignant Tumours, pp. 448–483. Raven, R.W., Ed. London: Butterworth 1958Google Scholar
  915. Symmers, W.StC.: Survey of the eventual diagnosis in 226 cases referred for a second histological opinion after an initial biopsy diagnosis of reticulum cell sarcoma. J. clin. Path. 21, 654–655 (1968)PubMedGoogle Scholar
  916. Takatsuki, K., Uchiyama, T., Sagawa, K., Yodoi, J.: Adult T-cell leukemia in Japan. Proc. 16th Int. Congr. Hematol., in press.Google Scholar
  917. Talal, N., Bunim, J.J.: The development of malignant lymphoma in the course of Sjogren’s syndrome. Amer. J. Med. 36, 529–540 (1964)PubMedGoogle Scholar
  918. Talal, N., Sokoloff, L., Barth, W.F.: Extrasalivary lymphoid abnormalities in Sjogren’s syndrome (reticulum cell sarcoma, ‘pseudolymphoma’, macroglobulinemia). Amer. J. Med. 43, 50–65 (1967)PubMedGoogle Scholar
  919. Talerman, A.: Clinico-pathological study of malignant lymphoma in Jamaica. Brit. J. Cancer 24, 37–47 (1970)PubMedGoogle Scholar
  920. Talerman, A., Platenburg, H.P.J.M.: Follicular lymphoma with deposits of amorphous hyaline material. J. Path. 112, 27–31 (1974)PubMedGoogle Scholar
  921. Tanaka, N.: Malignant reticulohistiocytosis. Border-line lesion between reactive and neoplastic. In: Malignant Diseases of the Hematopoietic System. GANN Monograph on Cancer Research, Vol. 15, pp. 123–143. Akazaki, K., Rappaport, H., Berard, C.W., Bennett, J.M., Ishikawa, E., Eds. Tokyo: University of Tokyo Press 1973Google Scholar
  922. Taswell, H.F., Winkelmann, R.K.: Sézary syndrome—a malignant reticulemic erythroderma. J. Amer. med. Ass. 177, 465–472 (1961)Google Scholar
  923. Taylor, C.R.: The nature of Reed-Sternberg cells and other malignant “reticulum” cells. Lancet 1974, II, pp. 802–807Google Scholar
  924. Ten Seldam, R.E.J., Cooke, R., Atkinson, L.: Childhood lymphoma in the Territories of Papua and New Guinea. Cancer (Philad.) 19, 437–446 (1966)Google Scholar
  925. Theml, H., Trepel, F., Schick, P., Kaboth, W., Begemann, H.: Kinetics of lymphocytes in chronic lymphocytic leukemia: Studies using continuous 3H-thymidine infusion in two patients. Blood 42, 623–636 (1973)Google Scholar
  926. Thiel, E., Rodt, H., Huhn, D., Thierfelder, S.: Decrease and altered distribution of human T antigen on chronic lymphatic leukemia cells of T type, suggesting a clonal origin. Blood 47, 723–736 (1976)PubMedGoogle Scholar
  927. Thierbach, R., Huth, J.: Ein speicherndes Lymphoreticulom der Lunge. Frankfurt. Z. Path. 73, 127–137 (1963)PubMedGoogle Scholar
  928. Thomas, L.B., Rappaport, H.: Mycosis fungoides and its relationship to other malignant lymphomas. In: The Reticuloendothelial System. Monographs in Pathology, No. 16, pp. 243–261. Rebuck, J.W., Berard, C.W., Abell, M.R., Eds. Baltimore: Williams & Wilkins 1975Google Scholar
  929. Tindle, B.H., Parker, J.W., Lukes, R.J.: “Reed-Sternberg cells” in infectious mononucleosis? Amer. J. clin. Path. 58, 607–617 (1972)Google Scholar
  930. Tischendorf, W.: Diagnostische Lymphdrüsenpunktion. Münch. med. Wschr. 1938, 853–854Google Scholar
  931. Tischendorf, W.: Über die Verwertbarkeit von Lymphknotenpunktaten zur Differentialdiagnose der Lymphdrüsenerkrankungen. Dtsch. Arch. klin. Med. 183, 448–466 (1939)Google Scholar
  932. Tischendorf, W.: Lymphosarkomatose und Leukämiebegriff. Dtsch. med. Wschr. 71, 220–224 (1946)PubMedGoogle Scholar
  933. Tischendorf, W.: Cytodiagnostik des Lymphknotenpunktates. Erg. inn. Med. Kinderheilk., N.F. 2, 183–263 (1951)Google Scholar
  934. Tischendorf, W.: Lymphknoten. In: Handbuch der gesamten Hämatologie, 2. Aufl., Bd. I, pp. 453–488. München-Berlin-Wien: Urban & Schwarzenberg 1957Google Scholar
  935. Tischendorf, W., Hartmann, F.: Makroglobulinaemie (Waldenström) mit gleichzeitiger Hyperplasie der Gewebsmastzellen. Acta haemat. (Basel) 4, 374–383 (1950)Google Scholar
  936. Tischendorf, W., Heckner, F.: Zur Zytologie und Klinik der großfollikulären Lymphadenopathie (Brill-Symmerssche Krankheit). Neue med. Welt 1950, 1013–1018Google Scholar
  937. Tornyos, K., Macossay, C.R., Gyorkey, F.: Chronic lymphocytic leukemia and Hodgkin’s disease in the same patient. Report of a case, giving immunological and diagnostic considerations. Cancer (Philad.) 20, 552–557 (1967)Google Scholar
  938. Trepel, F., Schick, P.: Proliferation und Wachstum von lymphatischen Zellpopulationen bei Malignen Lymphomen. In: Maligne Lymphome und monoklonale Gammopathien. Hämatologie und Bluttransfusion, Bd. 18, pp. 33–47. Löffler, H., Ed. München: Lehmanns 1976Google Scholar
  939. Trepel, F., Theml, H., Schick, P., Schneble, G., Bremer, K., Fliedner, T.M., Begemann, H.: Kontinuierliche 3H-Thymidininfusion bei CLL: II. Proliferation der Lymphknotenzellen. In: Leukämie, pp. 187–191. Gross, R., van de Loo, J., Eds. Berlin-Heidelberg-New York: Springer 1972Google Scholar
  940. Trubowitz, S., Masek, B., Frasca, J.M.: Leukemic reticuloendotheliosis. Blood 38, 288–298 (1971)PubMedGoogle Scholar
  941. Trujillo, J.M., Butler, J.J., Ahearn, M.J., Shullenberger, C.C., List-Young, B., Gott, C., Anstall, H.B., Shively, J.A.: Long-term culture of lymph node tissue from a patient with lymphocytic lymphoma. II. Preliminary ultrastructural, immunofluorescence and cytogenetic studies. Cancer (Philad.) 20, 215–224 (1967)Google Scholar
  942. Tubiana, M., Le Bourgeois, J.-P.: La classification et le bilan des hématosarcomes. Bull. Cancer 61, 39–50 (1974)PubMedGoogle Scholar
  943. Uhlmann, E.M.: The significance of giant follicular lymphadenopathy. (Brill-Symmers disease). Radiology 50, 147–156 (1948)PubMedGoogle Scholar
  944. Undritz, E.: Hämatologische Tafeln. Sandoz 1952Google Scholar
  945. van Unnik, J.A.M., Breur, K., Burgers, J.M.V., Cleton, F., Hart, A.A.M., Stenfert Kroese, W.F., Somers, R., van Turnhout, J.M.M.P.M.: Non-Hodgkin’s lymphomata: Clinical features in relation to histology. Brit. J. Cancer 31, Suppl. II, 201–207 (1975)Google Scholar
  946. Variakojis, D., Rosas-Uribe, A., Rappaport, H.: Mycosis fungoides: Pathologic findings in staging laparotomies. Cancer (Philad.) 33, 1589–1600 (1974)Google Scholar
  947. Veronesi, U., Musumeci, R., Pizzetti, F., Gennari, L., Bonadonna, G.: The value of staging laparotomy in non-Hodgkin’s lymphomas. Cancer (Philad.) 33, 446–459 (1974)Google Scholar
  948. Vette, J.P.: De ziekte van Brill en de folliculaire reticulosen. Thesis, Amsterdam 1950Google Scholar
  949. Videbaek, A.: Unusual cases of myelomatosis. Brit. med. J. 1971, II, p. 326Google Scholar
  950. Videbaek, A.: Leukaemia and cancer in relation to immunosuppressive therapy. Scand. J. Haemat. 10, 241–243 (1973)PubMedGoogle Scholar
  951. Videbaek, A., Poulsen, H.: Myelofibrosis complicated by lymphogenous leukaemia. Acta haemat. (Basel) 17, 250–256 (1957)Google Scholar
  952. Virchow, R.: Weißes Blut. Neue Notizen aus dem Gebiet der Natur- und Heilkunde. Froriep’s neue Notizen 36. 151–156 (1845)Google Scholar
  953. Virchow, R.: Zur pathologischen Physiologie des Bluts. II. Weißes Blut (Leukämie). Virchows Arch. path. Anat. 1, 563–572 (1847)Google Scholar
  954. Virchow, R.: Die krankhaften Geschwülste. Dreißig Vorlesungen, gehalten während des Winter-semesters 1862–1863 an der Universität zu Berlin. Vol. 2. Berlin: A. Hirschwald 1864–65Google Scholar
  955. Waitz, R., Mayer, S., Bigel, P., Fitzenkam-Saito, A.: Myéloscléroses chroniques à forme lymphoïde. Nouv. Rev. franç. Hémat. 3, 490–496 (1963)PubMedGoogle Scholar
  956. Waitz, R., Mayer, G., Mayer, S.: Myélophtisies à réaction lymphoïde. Importance de l’étude histologique de la moelle osseuse pour le diagnostic différentiel des états lymphoïdes dits subleucémiques. Rev. belge Path. 24, 399–409 (1955)PubMedGoogle Scholar
  957. Wakasa, H.: Histopathological differential diagnosis of malignant lymphogranulomatosis (Hodgkin’s disease) from lymphatic reticulosarcomatosis. Tohoku J. exp. Med. 68, 325–335 (1958)Google Scholar
  958. Waldenström, J.G.: Incipient myelomatosis or “essential” hyperglobulinemia with fibrinogenopenia — a new syndrome? Acta med. scand. 117, 216–247 (1944)Google Scholar
  959. Waldenström, J.G.: Die Makroglobulinämie. Ergebn. inn. Med. Kinderheilk. 9, 586–621 (1958)PubMedGoogle Scholar
  960. Waldenström, J.G.: Monoclonal and Polyclonal Hypergammaglobulinemia. Clinical and Biological Significance. London: Cambridge University Press 1968Google Scholar
  961. Waldenström, J.G.: Diagnosis and Treatment of Multiple Myeloma. New York-London: Grune & Stratton 1970Google Scholar
  962. Waldmann, T.A., Strober, W., Blaese, R.M.: Immunodeficiency disease and malignancy. Various immunologic deficiencies of man and the role of immune processes in the control of malignant disease. Ann. intern. Med. 77, 605–628 (1972)Google Scholar
  963. Wanner, J., Siebenmann, R.: Über eine subakut verlaufende osteolytische Form der Makroglobulinämie Waldenström mit Plasmazellenleukämie. Schweiz. med. Wschr. 87, 1243–1246 (1957)PubMedGoogle Scholar
  964. Warner, N.L., Potter, M., Metcalf, D. (Eds.): Multiple Myeloma and Related Immunoglobulin-Producing Neoplasms. (UICC Technical Report Series, Vol. 13.) Geneva: International Union Against Cancer 1974Google Scholar
  965. Wasastjerna, C., Vuorinen, E., Lehtinen, M., Ikkala, E., Huhtala, E.: The cytochemical β-glucuronidase reaction in the differential diagnosis of acute leukaemias. Acta haemat. (Basel) 53, 277–284 (1975)Google Scholar
  966. Waubke, R.: Epstein-Barr-Virus, infektiöse Mononukleose und Burkitt-Lymphom. Dtsch. med. Wschr. 95, 1572–1578 (1970)PubMedGoogle Scholar
  967. Weiszer, L.: Zur Frage der Ausscheidung des Bence-Jones’-Eiweißkörpers. Z. klin. Med. 140, 30–44 (1942)Google Scholar
  968. Werner, J., Wolf, H., Apodaca, J., Zur Hausen, H.: Lymphoproliferative disease in a cotton-top marmoset after inoculation with infectious mononucleosis-derived Epstein-Barr virus. Int. J. Cancer 15, 1000–1008 (1975)PubMedGoogle Scholar
  969. Westerhausen, M.: Immunglobulinveränderungen bei chronischer Lymphadenose. In: Der Lymphozyt, pp. 171–175. Pietschmann, H., Ed. Wien: Verlag der Wiener Medizinischen Akademie 1972Google Scholar
  970. Westerhausen, M.: Immunglobulinveränderungen bei der chronischen Lymphadenose (CLL). In: Leukämien und maligne Lymphome, pp. 268–272. Stacher, A., Ed. München-Berlin-Wien: Urban & Schwarzenberg 1973Google Scholar
  971. Wetherley-Mein, G., Smith, P., Geake, M.R., Anderson, H.J.: Follicular lymphoma. Quart. J. Med. N.S. 21, 327–351 (1952)Google Scholar
  972. Wetter, O.: μ-Kettenkrankheit und Hyper-γ-Globulinämie — eine ungewöhnliche Immunglobulinstörung mit allgemeiner Lymphadenopathie. Verh. dtsch. Ges. inn. Med. 79, 350–352 (1973)PubMedGoogle Scholar
  973. Widmann, H.: Akute subleukämische Plasmozytose — auf der Basis eines Retikulosarkoms mit erworbener hämolytischer Anämie. Dtsch. med. Wschr. 82, 1298–1301 (1957)PubMedGoogle Scholar
  974. Wilcoxon, F.: Individual comparisons by ranking methods. Biomet. Bull. 1, 80–83 (1945)Google Scholar
  975. Willemin-Clog, L., Cavaroc, M., Menut, G., Raynaud, J.-E.: La maladie de Burkitt hors d’Afrique. Nouv. Rev. franç. Hémat. 7, 367–380 (1967)PubMedGoogle Scholar
  976. Williams, M.C.: Implications of the geographical distribution of Burkitt’s lymphoma. In: Treatment of Burkitt’s Tumour. UICC Monograph Series, Vol. 8, pp. 42–51. Burchenal, J.H., Burkitt, D.P., Eds. Berlin-Heidelberg-New York: Springer 1967Google Scholar
  977. Willis, R.A.: Pathology of Tumours. London: Butterworths 1960Google Scholar
  978. Wilms, H.: Beitrag zum Germinoblastom (Noduläres Lymphom, Brill-Symmers). Zytophotometrische Untersuchungen. Diss. med., Kiel 1970Google Scholar
  979. Wilson, J.D., Nossal, G.J.V.: Identification of human T and B lymphocytes in normal peripheral blood and in chronic lymphocytic leukaemia. Lancet 1971, II, pp. 788–791Google Scholar
  980. Wiltshaw, E.: The natural history of extramedullary plasmacytoma and its relation to solitary myeloma of bone and myelomatosis. Thesis submitted for the Degree of Doctor of Medicine at the University of Wales, 1969Google Scholar
  981. Wiltshaw, E.: Extramedullary plasmacytoma. Myeloma Workshop, London 1971. Brit. med. J. 1971, II, pp. 319–328Google Scholar
  982. Winkelmann, R.K.: Clinical studies of T-cell erythroderma in the Sezary syndrome. Mayo Clin. Proc. 49, 519–525 (1974)PubMedGoogle Scholar
  983. Winkelmann, R.K., Perry, H.O., Muller, S.A., Schroeter, A.L., Jordon, R.E., Rogers, R.S.: The pre-Sezary erythroderma syndrome. Mayo Clin. Proc. 49, 588–589 (1974)PubMedGoogle Scholar
  984. Winkler, K., Gaedicke, G., Grosch-Wörner, I., Marsmann, G., Landbeck, G.: Zur Behandlung der akuten lymphoblastischen Leukämie im Kindesalter — Erfahrungsbericht. Klin. Pädiat. 189, 74–88 (1977)Google Scholar
  985. Wislocki, G.B., Rheingold, J.J., Dempsey, E.W.: The occurrence of the periodic acid-Schiff reaction in various normal cells of blood and connective tissue. Blood 4, 562–568 (1949)PubMedGoogle Scholar
  986. Wöckel, W., Schreiber, D.: Ein Beitrag zum Gestaltwandel der Brill-Symmersschen Krankheit. Frankfurt. Z. Path. 68, 97–108 (1957)PubMedGoogle Scholar
  987. Wolf, H., Werner, J., Zur Hausen, H.: EBV DNA in nonlymphoid cells of nasopharyngeal carcinomas and in a malignant lymphoma obtained after inoculation of EBV into cottontop marmosets. Cold Spr. Harb. Symp. quant. Biol. 39, 791–796 (1975)Google Scholar
  988. Wolf, H., Zur Hausen, H., Becker, V.: EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nature [New Biol.] 244, 245–247 (1973)Google Scholar
  989. Wolff, J.A., Brubaker, C.A., Murphy, M.L., Pierce, M.I., Severo, N.: Prednisone therapy of acute childhood leukemia: Prognosis and duration of response in 330 treated patients. J. Pediat. 70, 626–631 (1967)PubMed